{"bill": {"#text": "\n\t", "form": {"current-chamber": {"#tail": "\n\t\t", "@display": "yes", "#text": "IN THE HOUSE OF\n\t\t  REPRESENTATIVES"}, "#text": "\n\t\t", "congress": {"#tail": "\n\t\t", "@display": "yes", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "H. R. 1919"}, "official-title": {"#tail": "\n\t", "#text": "To amend the Federal Food, Drug, and\n\t\t  Cosmetic Act with respect to the pharmaceutical distribution supply chain, and\n\t\t  for other purposes.", "@display": "yes", "pagebreak": {"#tail": "\n    "}}, "session": {"#tail": "\n\t\t", "@display": "yes", "#text": "1st Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "IB"}, "action": [{"action-date": {"#tail": "\n\t\t\t", "@date": "20130509", "#text": "May 9, 2013"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "committee-name": {"@deleted-display-style": "strikethrough", "#tail": "\n      ", "@committee-id": "HIF00", "@added-display-style": "italic", "#text": "Committee on Energy and\n\t\t\t Commerce"}, "sponsor": {"#tail": " (for\n\t\t\t himself, ", "#text": "Mr. Latta", "@name-id": "L000566"}, "cosponsor": [{"#tail": ",\n\t\t\t ", "#text": "Mr. Matheson", "@name-id": "M001142"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. Upton", "@name-id": "U000031"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. Dingell", "@name-id": "D000355"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. Cassidy", "@name-id": "C001075"}, {"#tail": ",\n\t\t\t ", "#text": "Mrs. Blackburn", "@name-id": "B001243"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. McKinley", "@name-id": "M001180"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. Rogers of Michigan", "@name-id": "R000572"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. Burgess", "@name-id": "B001248"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. Shimkus", "@name-id": "S000364"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. Guthrie", "@name-id": "G000558"}, {"#tail": ", and\n\t\t\t ", "#text": "Mr. Johnson of Ohio", "@name-id": "J000292"}, {"#tail": ") introduced the\n\t\t\t following bill; which was referred to the\n\t\t\t ", "#text": "Mr. Schneider", "@name-id": "S001190"}]}, "#text": "\n\t\t\t"}, {"action-date": {"#tail": "\n\t\t\t", "@date": "20130603", "#text": "June 3, 2013"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t", "#text": "Additional sponsors: ", "cosponsor": [{"#tail": ", ", "#text": "Mr.\n\t\t\t Olson", "@name-id": "O000168"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. Long", "@name-id": "L000576"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. Latham", "@name-id": "L000111"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. Valadao", "@name-id": "V000129"}, {"#tail": ", ", "#text": "Mr. Rush", "@name-id": "R000515"}, {"#tail": ", ", "#text": "Mr. Veasey", "@name-id": "V000131"}, {"#tail": ", and ", "#text": "Mr.\n\t\t\t Walberg", "@name-id": "W000798"}, {"#tail": "\n      ", "#text": "Mrs.\n\t\t\t Walorski", "@name-id": "W000813"}]}, "#text": "\n\t\t\t"}, {"action-date": {"#tail": "\n\t\t\t", "@date": "20130603", "#text": "June 3, 2013"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t\t", "#text": "Reported with an amendment, committed to the Committee of\n\t\t\t the Whole House on the State of the Union, and ordered to be\n\t\t\t printed"}, "#text": "\n\t\t\t", "action-instruction": [{"#tail": "\n\t\t\t", "#text": "Strike out all after the enacting clause and insert\n\t\t\t the part printed in italic"}, {"#tail": "\n\t\t", "#text": "For text of introduced bill, see copy of bill as\n\t\t\t introduced on May 9, 2013"}]}, {"#tail": "\n\t\t", "#text": "\n\t\t\t", "@display": "yes", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "@display": "yes", "pagebreak": {"#tail": "\n      "}}}], "associated-doc": {"#tail": "\n\t\t", "@display": "yes", "#text": "[Report No.\n\t\t  113\u201393]", "@role": "report"}, "calendar": {"#tail": "\n\t\t", "@display": "yes", "#text": "Union Calendar No. 65"}, "legis-type": {"#tail": "\n\t\t", "#text": "A BILL"}}, "@bill-stage": "Reported-in-House", "@bill-type": "olc", "endorsement": {"action-date": {"#tail": "\n\t\t", "@date": "20130603", "#text": "June 3, 2013"}, "#tail": "\n", "@display": "yes", "action-desc": {"#tail": "\n\t", "#text": "Reported with an amendment, committed to the Committee of\n\t\t  the Whole House on the State of the Union, and ordered to be\n\t\t  printed"}, "#text": "\n\t\t"}, "@dms-id": "HB830F70FF7E04CC7932F2128960E6408", "@public-private": "public", "legis-body": {"@style": "OLC", "@committee-id": "HIF00", "@changed": "added", "#tail": "\n\t", "section": [{"@section-type": "section-one", "#tail": "\n    ", "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n\t\t\t", "#text": "Short title"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "quote": {"short-title": {"#tail": "\n          ", "#text": "Safeguarding America\u2019s\n\t\t\t Pharmaceuticals Act of 2013"}, "#tail": ".", "#text": "\n            "}, "#text": "This Act may be cited\n\t\t\t as the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "Short\n\t\t\t title"}, "#text": "\n        ", "@id": "HB88E0A48A74C493AB4F992D0BF0BFF92"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t\t", "#text": "The table of\n\t\t\t contents of this Act is as follows:", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Table of\n\t\t\t contents"}, "toc": {"@committee-id": "HIF00", "@changed": "added", "#tail": "\n\t\t\t", "@lowest-level": "section", "@regeneration": "yes-regeneration", "toc-entry": [{"@idref": "H79792FEB82EA419EB942B9CE314F64FA", "#tail": "\n\t\t\t\t\t", "#text": "Sec.\u20021.\u2002Short title.", "@level": "section"}, {"@idref": "H8C3B46F2AAE44EE2BECDF948ECC53678", "#tail": "\n\t\t\t\t\t", "#text": "Sec.\u20022.\u2002Pharmaceutical distribution supply\n\t\t\t\tchain.", "@level": "section"}, {"@idref": "HA83B5AC46DD248C5807C0CAD38E0EBCE", "#tail": "\n\t\t\t\t\t", "#text": "Sec.\u20023.\u2002Enhanced drug distribution\n\t\t\t\tsecurity.", "@level": "section"}, {"@idref": "H275CD30A7EED4A5C864C253ABCAEFE7D", "#tail": "\n\t\t\t\t\t", "#text": "Sec.\u20024.\u2002National standards for wholesale\n\t\t\t\tdistributors.", "@level": "section"}, {"@idref": "H234964F3A89244CA806374D5863C9AFF", "#tail": "\n\t\t\t\t\t", "#text": "Sec.\u20025.\u2002National licensure standards for\n\t\t\t\tthird-party logistics providers.", "@level": "section"}, {"@idref": "H98BFCC8873964CF8BC1EA3D5994BAD56", "#tail": "\n\t\t\t\t\t", "#text": "Sec.\u20026.\u2002Penalties.", "@level": "section"}, {"@idref": "H65A0970BAB5D488AB99FA4A9B23BF9D6", "#tail": "\n\t\t\t\t\t", "#text": "Sec.\u20027.\u2002Uniform national policy.", "@level": "section"}, {"@idref": "H25613E0FA319451691D41BB6A9CAAABD", "#tail": "\n\t\t\t\t", "#text": "Sec.\u20028\u2002Electronic labeling.", "@level": "section"}], "@quoted-block": "no-quoted-block", "@reported-display-style": "italic", "@lowest-bolded-level": "division-lowest-bolded", "@container-level": "legis-body-container", "#text": "\n\t\t\t\t\t"}, "#text": "\n        ", "@id": "HD0FE84B9703A434F990FEA4DBF87D105"}], "#text": "\n      ", "@id": "H79792FEB82EA419EB942B9CE314F64FA"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "#text": "\n        ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by adding at the end the\n\t\t\t following:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Chapter V of the Federal Food, Drug, and\n\t\t\t Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/ch:V"}, "@entity-type": "law-citation", "#text": "\n          ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "uscode", "#text": "21 U.S.C. 351 et seq.", "@value": "usc/21/351/etseq"}, "@parsable-cite": "usc/21/351", "#text": "\n            ", "@legal-doc": "usc"}}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n      ", "#text": "Pharmaceutical\n\t\t\t distribution supply chain"}, "quoted-block": {"@style": "OLC", "@committee-id": "HIF00", "@changed": "added", "after-quoted-block": {"#tail": "\n      ", "#text": "."}, "#tail": "\n\t\t", "@reported-display-style": "italic", "subchapter": {"#tail": "\n        ", "section": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "In this subchapter:", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n            ", "#text": "581."}, "header": {"#tail": "\n            ", "#text": "Definitions"}, "paragraph": [{"#tail": "\n            ", "@id": "H8B1E882F1EC9449BBACC1CA61DC8A3ED", "enum": {"#tail": "\n              ", "#text": "(1)"}, "header": {"#tail": "\n              ", "#text": "Authorized"}, "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": " means\u2014", "#text": "authorized"}, "#text": "The\n\t\t\t\tterm "}, "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "; and", "@entity-type": "act", "#text": "section 510", "@value": "Federal Food, Drug, and Cosmetic Act/s:510"}, "#text": "in the case of a\n\t\t\t\tmanufacturer or repackager, having a valid registration in accordance with\n\t\t\t\t"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "H644BC46E3F024BFC827F01FB5CB1AE30", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "in the case of a\n\t\t\t\twholesale distributor, third-party logistics provider, or dispenser, licensed\n\t\t\t\t(as defined in this section)."}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "H5B4E184E697940C29AA2CF7554A755B1", "#text": "\n                "}]}, {"#tail": "\n            ", "@id": "HA33D1AEE1668450BA41C457215CA7B3A", "enum": {"#tail": "\n              ", "#text": "(2)"}, "header": {"#tail": "\n              ", "#text": "Dispenser"}, "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": "\u2014", "#text": "dispenser"}, "#text": "The\n\t\t\t\tterm "}, "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", means a retail\n\t\t\t\tpharmacy, hospital pharmacy, a group of chain pharmacies under common ownership\n\t\t\t\tand control, or any other person authorized by law to dispense or administer\n\t\t\t\tprescription drugs, to the extent such pharmacy, group, or person does not act\n\t\t\t\tas a wholesale distributor;", "@entity-type": "act", "#text": "subparagraph (C)", "@value": "Federal Food, Drug, and Cosmetic Act/s:581/p:2/sp:C", "@proposed": "true"}, "#text": "subject to ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "HAC394C80778F4579BEA6678F202356F8", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " that are members of an affiliated group pursuant to ", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:581/p:2/sp:A", "@proposed": "true"}, {"#tail": ", to the extent such warehouses and\n\t\t\t\tdistribution centers do not act as a wholesale distributor; and", "@entity-type": "act", "#text": "section\n\t\t\t\t1504(a) of the Internal Revenue Code of 1986", "@value": "Internal Revenue Code of 1986/s:1504/ss:a"}], "#text": "includes warehouses and\n\t\t\t\tdistribution centers under common ownership or control of entities described in\n\t\t\t\t"}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "HE89413C5EA114F5B88A70FC35CE4F1BD", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "section 512(a)(5)", "@value": "Federal Food, Drug, and Cosmetic Act/s:512/ss:a/p:5"}, "#text": "does not include a\n\t\t\t\tperson who only dispenses prescription drug product to be used in animals in\n\t\t\t\taccordance with "}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "@id": "H79D94EFD35DD4BD187012DE073F263BB", "#text": "\n                "}]}, {"#tail": "\n            ", "@id": "H57653DD85229495698132DD412561E5E", "enum": {"#tail": "\n              ", "#text": "(3)"}, "header": {"#tail": "\n              ", "#text": "Disposition"}, "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": ", with respect to a prescription drug product\n\t\t\t\twithin the possession and control of an entity\u2014", "#text": "disposition"}, "#text": "The\n\t\t\t\tterm "}, "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "means the removal of such\n\t\t\t\tprescription drug product, or taking measures to prevent the introduction of\n\t\t\t\tsuch prescription drug product, from the pharmaceutical distribution supply\n\t\t\t\tchain; and"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "H5549A510D8A849D1B9B119D05BD91BC2", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "may include disposal,\n\t\t\t\treturn of the prescription drug product for disposal, or other appropriate\n\t\t\t\thandling and other actions such as retaining a sample of the prescription drug\n\t\t\t\tproduct for additional physical examination or laboratory analysis by a\n\t\t\t\tmanufacturer or regulatory or law enforcement agency."}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "H5AF6A8A3885C4123AD64CD23CF55E394", "#text": "\n                "}]}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "term": [{"#tail": " and\n\t\t\t\t", "#text": "distribute"}, {"#tail": " mean the sale, purchase, trade, delivery, handling,\n\t\t\t\tor storage of a prescription drug product.", "#text": "distribution"}], "#text": "The terms "}, "enum": {"#tail": "\n              ", "#text": "(4)"}, "header": {"#tail": "\n              ", "#text": "Distribute or\n\t\t\t\tdistribution"}, "#text": "\n              ", "@id": "HFBF55E2F437142479A3425966E974B9B"}, {"#tail": "\n            ", "@id": "H75A31DDA881E4126926412B837C4F867", "enum": {"#tail": "\n              ", "#text": "(5)"}, "header": {"#tail": "\n              ", "#text": "Illegitimate\n\t\t\t\tprescription drug product"}, "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": " means a prescription drug product which a\n\t\t\t\tmanufacturer has confirmed\u2014", "#text": "illegitimate\n\t\t\t\tprescription drug product"}, "#text": "The term "}, "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "is counterfeit, diverted,\n\t\t\t\tor stolen;"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "H15831FEB240F4759AACCCFF3D5F53EED", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "is intentionally\n\t\t\t\tadulterated such that the prescription drug product would result in serious\n\t\t\t\tadverse health consequences or death to humans; or"}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "HA1E0F073220E4E72B50C2D55D8749437", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "is otherwise unfit for\n\t\t\t\tdistribution such that the prescription drug product is reasonably likely to\n\t\t\t\tcause serious adverse human health consequences or death."}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "@id": "H94D7B8AA9B604E1A89223F4E855368C2", "#text": "\n                "}]}, {"#tail": "\n            ", "@id": "H17C1E8A648644D7491CCB6B998DAABEF", "enum": {"#tail": "\n              ", "#text": "(6)"}, "header": {"#tail": "\n              ", "#text": "Licensed"}, "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": " means\u2014", "#text": "licensed"}, "#text": "The\n\t\t\t\tterm "}, "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "act", "#text": "section 583", "@value": "Federal Food, Drug, and Cosmetic Act/s:583", "@proposed": "true"}, "#text": "in the case of a wholesale distributor,\n\t\t\t\thaving a valid license to make wholesale distributions consistent with the\n\t\t\t\tstandards under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "HF0BDDB6C559344AD884546A15CCC983D", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "in the case of a third-party logistics\n\t\t\t\tprovider, having a valid license to engage in the activities of a third-party\n\t\t\t\tlogistics provider in accordance with section 584; and", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "H5815676100154298952A43193640F481", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "in the case of a\n\t\t\t\tdispenser, having a valid license to dispense prescription drugs under State\n\t\t\t\tlaw."}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "@id": "HFBA864DF524E40FF87BAA8EBC96DDC5B", "#text": "\n                "}]}, {"#tail": "\n            ", "@id": "HCDF00DD6155C4D97B26BA655F52B5E99", "enum": {"#tail": "\n              ", "#text": "(7)"}, "header": {"#tail": "\n              ", "#text": "Manufacturer"}, "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": " means, with respect to a prescription drug\n\t\t\t\tproduct\u2014", "#text": "manufacturer"}, "#text": "The\n\t\t\t\tterm "}, "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or a license issued under\n\t\t\t\t", "@entity-type": "act", "#text": "section 505", "@value": "Federal Food, Drug, and Cosmetic Act/s:505"}, {"#tail": " for such prescription drug\n\t\t\t\tproduct, or if such prescription drug product is not the subject of an approved\n\t\t\t\tapplication or license, the person who manufactured the prescription drug\n\t\t\t\tproduct;", "@entity-type": "act", "#text": "section 351 of the Public Health Service Act", "@value": "Public Health Service Act/s:351"}], "#text": "a person that\n\t\t\t\tholds an application approved under "}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "HAC1AC4934E944E0D942613AA7AA7EDCB", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " that obtains the\n\t\t\t\tprescription drug product directly from the person described in such\n\t\t\t\tsubparagraph; or", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:581/p:7/sp:A", "@proposed": "true"}, "#text": "a co-licensed\n\t\t\t\tpartner of the person described in "}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "HDB2E6A6CCACD428D9CA6706EB73DBDC2", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "a person that\u2014", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "clause": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ") to which a person described in ", "@entity-type": "act", "#text": "section 1504(a) of the Internal\n\t\t\t\tRevenue Code of 1986", "@value": "Internal Revenue Code of 1986/s:1504/ss:a"}, {"#tail": " or ", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:581/p:7/sp:A", "@proposed": "true"}, {"#tail": " is\n\t\t\t\talso a member; and", "@entity-type": "act", "#text": "(B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:581/p:7/sp:B", "@proposed": "true"}], "#text": "is\n\t\t\t\ta member of an affiliated group (as defined in "}, "enum": {"#tail": "\n                  ", "#text": "(i)"}, "@id": "HA87D05A6049E493B8ABDE9A4E23A5BD7", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "\n\t\t\t\tor ", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:581/p:7/sp:A", "@proposed": "true"}, {"#tail": ".", "@entity-type": "act", "#text": "(B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:581/p:7/sp:B", "@proposed": "true"}], "#text": "receives the\n\t\t\t\tprescription drug product directly from a person described in "}, "enum": {"#tail": "\n                  ", "#text": "(ii)"}, "@id": "H1A1BD6FE392E48A0A90D6317785ACD85", "#text": "\n                  "}], "#text": "\n                ", "@id": "H776F5A304F5947F8A629D75BD7D290C1"}]}, {"#tail": "\n            ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": " means the smallest individual saleable unit of\n\t\t\t\tprescription drug product for distribution in interstate commerce by a\n\t\t\t\tmanufacturer or repackager that is intended by the manufacturer for ultimate\n\t\t\t\tsale to the dispenser of such prescription drug product.", "#text": "package"}, "#text": "The term\n\t\t\t\t", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "header": {"#tail": "\n                ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n                ", "@id": "H4E830B88CB774FD09ADDE5792149FC39"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": " means the smallest container of\n\t\t\t\tprescription drug product introduced into interstate commerce by the\n\t\t\t\tmanufacturer or repackager that is intended by the manufacturer for individual\n\t\t\t\tsale to a dispenser.", "#text": "individual saleable unit"}, "#text": "The term\n\t\t\t\t", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "header": {"#tail": "\n                ", "#text": "Individual saleable\n\t\t\t\tunit"}, "#text": "\n                ", "@id": "HD265CD0309564BB9ADB241D75AEF11B8"}], "enum": {"#tail": "\n              ", "#text": "(8)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Package"}, "#text": "\n              ", "@id": "H3E86CD8A340B4872B42AA8270B6808F4"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "section 503(b)(1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503/ss:b/p:1"}, "term": {"#tail": " means a drug for\n\t\t\t\thuman use subject to ", "#text": "prescription drug"}, "#text": "The term "}, "enum": {"#tail": "\n              ", "#text": "(9)"}, "header": {"#tail": "\n              ", "#text": "Prescription\n\t\t\t\tdrug"}, "#text": "\n              ", "@id": "H5038C35A6C8B42EA80DE74F2375BFAFB"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "term": {"#tail": " means a prescription drug in a finished\n\t\t\t\tdosage form for administration to a patient without substantial further\n\t\t\t\tmanufacturing (such as capsules, tablets, and lyophilized prescription drug\n\t\t\t\tproducts before reconstitution).", "#text": "prescription drug product"}, "#text": "The term\n\t\t\t\t", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(10)"}, "header": {"#tail": "\n              ", "#text": "Prescription drug\n\t\t\t\tproduct"}, "#text": "\n              ", "@id": "H55D5C0AEBE704AE4ACFFD04157732600"}, {"#tail": "\n            ", "@id": "HB05FCF09890046889E75989AB369AC0E", "enum": {"#tail": "\n              ", "#text": "(11)"}, "header": {"#tail": "\n              ", "#text": "Prescription drug\n\t\t\t\tproduct identifier"}, "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": " means a standardized graphic that\u2014", "#text": "prescription drug product\n\t\t\t\tidentifier"}, "#text": "The term "}, "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "includes the standardized\n\t\t\t\tnumerical identifier, lot number, and expiration date of a prescription drug\n\t\t\t\tproduct; and"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "H284781F9CC85426781D93D9DBB72DEA4", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "is in both human-readable\n\t\t\t\tform and on a machine-readable data carrier that conforms to the standards\n\t\t\t\tdeveloped by a widely recognized international standards development\n\t\t\t\torganization."}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "H0D0BAA8B5C25429D9FEE703D165AA1F2", "#text": "\n                "}]}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "term": {"#tail": " means to\n\t\t\t\tstore or identify a product, for the purpose of preventing distribution or\n\t\t\t\ttransfer of the product, in a physically separate area clearly identified for\n\t\t\t\tsuch use, or through use of other procedures such as automated\n\t\t\t\tdesignation.", "#text": "quarantine"}, "#text": "The term ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(12)"}, "header": {"#tail": "\n              ", "#text": "Quarantine"}, "#text": "\n              ", "@id": "HD839656653FF491D9E70F09655FD7238"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "term": {"#tail": " means a person who owns or operates an\n\t\t\t\testablishment that repacks and relabels a prescription drug product or package\n\t\t\t\tfor further sale or distribution.", "#text": "repackager"}, "#text": "The\n\t\t\t\tterm "}, "enum": {"#tail": "\n              ", "#text": "(13)"}, "header": {"#tail": "\n              ", "#text": "Repackager"}, "#text": "\n              ", "@id": "H1F5A2AA815AB48A0BAB64A903617F5DB"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "term": {"#tail": " means\n\t\t\t\tproviding prescription drug product to the authorized trading partner or\n\t\t\t\ttrading partners from which such prescription drug product was purchased or\n\t\t\t\treceived, or to a returns processor for handling of such prescription drug\n\t\t\t\tproduct.", "#text": "return"}, "#text": "The term ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(14)"}, "header": {"#tail": "\n              ", "#text": "Return"}, "#text": "\n              ", "@id": "HAF9B3CB8E7D345C6A27E9B1F63EBEF04"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "term": {"#tail": " mean a person\n\t\t\t\twho owns or operates an establishment that provides for the disposition of or\n\t\t\t\totherwise processes saleable and nonsaleable prescription drug product received\n\t\t\t\tfrom an authorized trading partner such that the prescription drug product may\n\t\t\t\tbe processed for credit to the purchaser, manufacturer, seller, or disposed of\n\t\t\t\tfor no further distribution.", "#text": "returns processor"}, "#text": "The terms "}, "enum": {"#tail": "\n              ", "#text": "(15)"}, "header": {"#tail": "\n              ", "#text": "Returns\n\t\t\t\tprocessor"}, "#text": "\n              ", "@id": "HA8EB3B1BE8734199A24D30B0D73599C2"}, {"#tail": "\n            ", "@id": "HB7AE3D7C313240148DF14BAF242C7D5B", "enum": {"#tail": "\n              ", "#text": "(16)"}, "header": {"#tail": "\n              ", "#text": "Specific patient\n\t\t\t\tneed"}, "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": "\u2014", "#text": "specific patient need"}, "#text": "The term "}, "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "means with respect to the\n\t\t\t\ttransfer of a prescription drug product from one pharmacy to another, to fill a\n\t\t\t\tprescription for an identified patient; and"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "H25E64375028343149875EB284066C303", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "does not include the\n\t\t\t\ttransfer of a prescription drug product from one pharmacy to another for the\n\t\t\t\tpurpose of increasing or replenishing stock in anticipation of a potential\n\t\t\t\tneed."}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "H5797FD4647FC4BDD99CB103EC956B78C", "#text": "\n                "}]}, {"#tail": "\n            ", "@id": "H3D393434A6734D2D91B421F66084E0AB", "enum": {"#tail": "\n              ", "#text": "(17)"}, "header": {"#tail": "\n              ", "#text": "Standardized numerical\n\t\t\t\tidentifier"}, "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": " means a set of numbers or\n\t\t\t\tcharacters that\u2014", "#text": "standardized numerical identifier"}, "#text": "The term\n\t\t\t\t", "@display-inline": "yes-display-inline"}, "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "is used to uniquely\n\t\t\t\tidentify each package or homogenous case of the prescription drug product;\n\t\t\t\tand"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "HD8D879B62B0B4E5993CC9923F3113FCC", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "is composed of the\n\t\t\t\tNational Drug Code that corresponds to the specific prescription drug product\n\t\t\t\t(including the particular package configuration) combined with a unique\n\t\t\t\talphanumeric serial number of up to 20 characters."}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "H5417404C4F144C60AC559A5899E4D41F", "#text": "\n                "}]}, {"#tail": "\n            ", "@id": "H4726F198A01B41BFBFCFF3BBC32C18E1", "enum": {"#tail": "\n              ", "#text": "(18)"}, "header": {"#tail": "\n              ", "#text": "Suspect prescription\n\t\t\t\tdrug product"}, "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": " means a prescription drug product for which there is reason to\n\t\t\t\tbelieve that such prescription drug product\u2014", "#text": "suspect prescription drug\n\t\t\t\tproduct"}, "#text": "The term "}, "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "is potentially\n\t\t\t\tcounterfeit, diverted, or stolen;"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "H2D4DDCFBD1E7425BA9B506AA797F47CA", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "is potentially\n\t\t\t\tintentionally adulterated such that the prescription drug product would result\n\t\t\t\tin serious adverse health consequences or death to humans; or"}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "H33FFC520A384473C948F81AFAF31D08E", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "appears otherwise unfit\n\t\t\t\tfor distribution such that the prescription drug product would result in\n\t\t\t\tserious adverse health consequences or death to humans."}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "@id": "H319808F2950A4952BA745D06DB43F10E", "#text": "\n                "}]}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "term": {"#tail": "\n\t\t\t\tmeans an entity that provides or coordinates warehousing, distribution, or\n\t\t\t\tother logistics services of a prescription drug product in interstate commerce\n\t\t\t\ton behalf of a manufacturer, wholesale distributor, or dispenser of a\n\t\t\t\tprescription drug product, but does not take ownership of the prescription drug\n\t\t\t\tproduct, nor have responsibility to direct the sale or disposition of, the\n\t\t\t\tprescription drug product.", "#text": "third-party logistics provider"}, "#text": "The term "}, "enum": {"#tail": "\n              ", "#text": "(19)"}, "header": {"#tail": "\n              ", "#text": "Third-party logistics\n\t\t\t\tprovider"}, "#text": "\n              ", "@id": "HE8092706465B4C7FB6283D58B474D43A"}, {"#tail": "\n            ", "@id": "H7C8B40D15EDA4C6DBB16145A2BEBFD32", "enum": {"#tail": "\n              ", "#text": "(20)"}, "header": {"#tail": "\n              ", "#text": "Trading\n\t\t\t\tpartner"}, "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": " means\u2014", "#text": "trading partner"}, "#text": "The term "}, "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "a manufacturer,\n\t\t\t\trepackager, wholesale distributor, or dispenser from whom a manufacturer,\n\t\t\t\trepackager, wholesale distributor, or dispenser accepts ownership of a\n\t\t\t\tprescription drug product or to whom a manufacturer, repackager, wholesale\n\t\t\t\tdistributor, or dispenser transfers ownership of a prescription drug product;\n\t\t\t\tor"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "H4C635903266C4161B91B7E70B2F5FAF8", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "a third-party logistics\n\t\t\t\tprovider from whom a manufacturer, repackager, wholesale distributor, or\n\t\t\t\tdispenser accepts possession of a prescription drug product or to whom a\n\t\t\t\tmanufacturer, repackager, wholesale distributor, or dispenser transfers\n\t\t\t\tpossession of a prescription drug product."}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "H6C4A0E0FD5564BA983AA6EB871F6EEBB", "#text": "\n                "}]}, {"#tail": "\n            ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": " means the transfer in\n\t\t\t\tinterstate commerce of prescription drug product between persons in which a\n\t\t\t\tchange of ownership occurs.", "#text": "transaction"}, "#text": "The term "}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "header": {"#tail": "\n                ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n                ", "@id": "H313ED093C0C44D31921084D23181A274"}, {"#tail": "\n              ", "clause": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ");", "@entity-type": "act", "#text": "\n                      ", "external-xref": {"#tail": " of the Internal Revenue Code of 1986", "@parsable-cite": "usc/26/1504", "#text": "section 1504(a)", "@legal-doc": "usc"}, "@value": "Internal Revenue Code of 1986/s:1504/ss:a"}, "#text": "intracompany distribution of any\n\t\t\t\tprescription drug product, including between members of an affiliated group (as\n\t\t\t\tdefined in ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(i)"}, "@id": "H7B9FBE9C32E64507814E213CC6A521AA", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the distribution of a\n\t\t\t\tprescription drug product among hospitals or other health care entities that\n\t\t\t\tare under common control;"}, "enum": {"#tail": "\n                  ", "#text": "(ii)"}, "@id": "H27893408864543E891A6B36F4D017501", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", except that a drug shortage not caused by a public health\n\t\t\t\temergency shall not constitute an emergency medical reason;", "@entity-type": "act", "#text": "section 319 of the Public Health\n\t\t\t\tService Act", "@value": "Public Health Service Act/s:319"}, "#text": "the distribution\n\t\t\t\tof a prescription drug product for emergency medical reasons including a public\n\t\t\t\thealth emergency declaration pursuant to "}, "enum": {"#tail": "\n                  ", "#text": "(iii)"}, "@id": "H9CC21FA53EB546EF848EF759C28B27AA", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "act", "#text": "section 503(b)(1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503/ss:b/p:1"}, "#text": "the dispensing of\n\t\t\t\ta prescription drug product pursuant to a valid prescription executed in\n\t\t\t\taccordance with "}, "enum": {"#tail": "\n                  ", "#text": "(iv)"}, "@id": "H8108AE378A7E47B28C7844F5E345DD57", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "act", "#text": "section 503(d)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503/ss:d"}, "#text": "the distribution\n\t\t\t\tof prescription drug product samples by a manufacturer or a licensed wholesale\n\t\t\t\tdistributor in accordance with "}, "enum": {"#tail": "\n                  ", "#text": "(v)"}, "@id": "H76D49990703C4AF8B4840128090E11AD", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the distribution of\n\t\t\t\tblood or blood components intended for transfusion;"}, "enum": {"#tail": "\n                  ", "#text": "(vi)"}, "@id": "H9A8EDA950BBD4BCBB4BA4CD3B05CD8A0", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the distribution of\n\t\t\t\tminimal quantities of prescription drug product by a licensed retail pharmacy\n\t\t\t\tto a licensed practitioner for office use;"}, "enum": {"#tail": "\n                  ", "#text": "(vii)"}, "@id": "H839E3DADD7D64659840F4A1B3E4211CD", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the distribution of a\n\t\t\t\tprescription drug product by a charitable organization to a nonprofit affiliate\n\t\t\t\tof the organization to the extent otherwise permitted by law;"}, "enum": {"#tail": "\n                  ", "#text": "(viii)"}, "@id": "HAC21DC08871944119ACD4E7D36C2876B", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the distribution of a\n\t\t\t\tprescription drug product pursuant to the sale or merger of a pharmacy or\n\t\t\t\tpharmacies or a wholesale distributor or wholesale distributors, except that\n\t\t\t\tany records required to be maintained for the prescription drug product shall\n\t\t\t\tbe transferred to the new owner of the pharmacy or pharmacies or wholesale\n\t\t\t\tdistributor or wholesale distributors;"}, "enum": {"#tail": "\n                  ", "#text": "(ix)"}, "@id": "HDA4537D8575B41F3A58D7A9C8A7B0A4D", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "act", "#text": "section 512(b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:512/ss:b"}, "#text": "the dispensing of\n\t\t\t\ta prescription drug product approved under "}, "enum": {"#tail": "\n                  ", "#text": "(x)"}, "@id": "HF2009AF521084C9187CEA6B6D266ED7B", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or by a State pursuant to an agreement with such\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Nuclear Regulatory Commission", "@entity-id": "3100"}, {"#tail": " under ", "@entity-type": "federal-body", "#text": "Commission", "@entity-id": "3100"}], "#text": "the transfer of\n\t\t\t\tprescription drug products to or from any facility that is licensed by the\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ";", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "section 274 of the Atomic Energy Act of 1954", "@value": "Atomic Energy Act of 1954/s:274"}, {"#tail": ")", "@entity-type": "uscode", "#text": "42 U.S.C.\n\t\t\t\t2021", "@value": "usc/42/2021"}], "@entity-type": "law-citation", "#text": "\n                      "}}, "enum": {"#tail": "\n                  ", "#text": "(xi)"}, "#text": "\n                  ", "@id": "H2B480A6B803E4F919F7191FAB2730AA3", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the distribution of a\n\t\t\t\tcombination product that consists of\u2014"}, "enum": {"#tail": "\n                  ", "#text": "(xii)"}, "subclause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "a product comprised of\n\t\t\t\ttwo or more components that are each a drug, biological product, or device and\n\t\t\t\tthat are physically, chemically, or otherwise combined or mixed and produced as\n\t\t\t\ta single entity;"}, "enum": {"#tail": "\n                    ", "#text": "(I)"}, "#text": "\n                    ", "@id": "H1052C5DE2E294B9EA20B6DD11BB47786", "@commented": "no"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "two or more separate\n\t\t\t\tproducts packaged together in a single package or as a unit and comprised of a\n\t\t\t\tdrug and device or a device and biological product; or"}, "enum": {"#tail": "\n                    ", "#text": "(II)"}, "#text": "\n                    ", "@id": "HD74855D380E84CCEB33859FF23AF8E00", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "act", "#text": "clause\n\t\t\t\t(xiv)", "@value": "Federal Food, Drug, and Cosmetic Act/s:581/p:21/sp:B/cl:xiv", "@proposed": "true"}, "#text": "two or more\n\t\t\t\tfinished devices plus one or more drug or biological products which are\n\t\t\t\tpackaged together in a medical convenience kit described in "}, "enum": {"#tail": "\n                    ", "#text": "(III)"}, "#text": "\n                    ", "@id": "HAC5CEAD3272B441D8DD04A31DD6C3B9C", "@commented": "no"}], "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "H57EF2A69E06D41559E0DEDD8EAFC7F59", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the distribution of a\n\t\t\t\tmedical convenience kit which is a collection of finished products (consisting\n\t\t\t\tof devices or drugs) assembled in kit form strictly for the convenience of the\n\t\t\t\tpurchaser or user if\u2014"}, "enum": {"#tail": "\n                  ", "#text": "(xiii)"}, "subclause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " as a medical device manufacturer;", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}, "#text": "the medical\n\t\t\t\tconvenience kit is assembled in an establishment that is registered with the\n\t\t\t\t"}, "enum": {"#tail": "\n                    ", "#text": "(I)"}, "@id": "H3FE3A186C3D84706875E7AF9F0FEC36F", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the person who\n\t\t\t\tmanufacturers the medical convenience kit purchased the prescription drug\n\t\t\t\tproduct directly from the manufacturer or from a wholesale distributor that\n\t\t\t\tpurchased the prescription drug product directly from the manufacturer;"}, "enum": {"#tail": "\n                    ", "#text": "(II)"}, "@id": "H227AC309C8F5494399596454A9836460", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the person who\n\t\t\t\tmanufacturers the medical convenience kit does not alter the primary container\n\t\t\t\tor label of the prescription drug product as purchased from the manufacturer or\n\t\t\t\twholesale distributor;"}, "enum": {"#tail": "\n                    ", "#text": "(III)"}, "@id": "H5C0F3BCCBA5541EB86559EF6795DB660", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "); and", "@entity-type": "act", "#text": "section\n\t\t\t\t102 of the Controlled Substances Act", "@value": "Controlled Substances Act/s:102"}, "#text": "the medical\n\t\t\t\tconvenience kit does not contain a controlled substance (as defined in "}, "enum": {"#tail": "\n                    ", "#text": "(IV)"}, "@id": "H82267702EE224E3D9EEACC4F507FE17B", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "the prescription drug\n\t\t\t\tproducts contained in the medical convenience kit are\u2014"}, "enum": {"#tail": "\n                    ", "#text": "(V)"}, "item": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "intravenous solutions\n\t\t\t\tintended for the replenishment of fluids and electrolytes;"}, "enum": {"#tail": "\n                      ", "#text": "(aa)"}, "@id": "H4FCCC2F29FC740888044B4DB6765DB5B", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "drugs intended to\n\t\t\t\tmaintain the equilibrium of water and minerals in the body;"}, "enum": {"#tail": "\n                      ", "#text": "(bb)"}, "@id": "H696444582C214C8CAC15203C65781589", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "drugs intended for\n\t\t\t\tirrigation or reconstitution;"}, "enum": {"#tail": "\n                      ", "#text": "(cc)"}, "@id": "HF02BFF053595496D89F49851252AD642", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "anesthetics;"}, "enum": {"#tail": "\n                      ", "#text": "(dd)"}, "@id": "HEFE79215C0184D19A0C7992609586DE2", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "anticoagulants;"}, "enum": {"#tail": "\n                      ", "#text": "(ee)"}, "@id": "HB2D771A623DD4C5F85BB75BF6F3C8FAE", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "vasopressors; or"}, "enum": {"#tail": "\n                      ", "#text": "(ff)"}, "@id": "H036995BCCB0D4716ABB41627933053A9", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "sympathicomimetics;"}, "enum": {"#tail": "\n                      ", "#text": "(gg)"}, "@id": "H320B0F5BC7AB4B678684F1E6CE06B756", "#text": "\n                      "}], "#text": "\n                    ", "@id": "H671F3BA9C5D241D391C0E0BF8EA706B7"}], "#text": "\n                  ", "@id": "H04D6880E19D54B86AB794F9EF0177D2F"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the distribution of an\n\t\t\t\tintravenous prescription drug product that, by its formulation, is intended for\n\t\t\t\tthe replenishment of fluids and electrolytes (such as sodium, chloride, and\n\t\t\t\tpotassium) or calories (such as dextrose and amino acids);"}, "enum": {"#tail": "\n                  ", "#text": "(xiv)"}, "@id": "H1CDFAA92A9E54853822493D9B4D3771F", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the distribution of an\n\t\t\t\tintravenous prescription drug product used to maintain the equilibrium of water\n\t\t\t\tand minerals in the body, such as dialysis solutions;"}, "enum": {"#tail": "\n                  ", "#text": "(xv)"}, "@id": "HDBA271ED49794496920DF4CE078911F0", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the distribution of a\n\t\t\t\tprescription drug product that is intended for irrigation or reconstitution, or\n\t\t\t\tsterile water, whether intended for such purposes or for injection;"}, "enum": {"#tail": "\n                  ", "#text": "(xvi)"}, "@id": "HD1FDC2B822DF483BBFDD83B2098FDAEF", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the distribution of\n\t\t\t\tcompressed medical gas; or"}, "enum": {"#tail": "\n                  ", "#text": "(xvii)"}, "@id": "H561490ED284E4502BB872A4080064B5F", "#text": "\n                  "}, {"#tail": "\n              ", "subclause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the distribution of a product by a\n\t\t\t\tdispenser, or a wholesale distributor acting at the direction of the dispenser,\n\t\t\t\tto a repackager registered under section 510 for the purpose of repackaging the\n\t\t\t\tdrug for use by that dispenser or another health care entity that is under the\n\t\t\t\tdispenser\u2019s ownership or control, so long as the dispenser retains ownership of\n\t\t\t\tthe prescription drug product; and", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(I)"}, "@display-inline": "yes-display-inline", "#text": "\n                    ", "@id": "HF542095AC20D4BAF836072558148552A", "@commented": "no"}, {"@committee-id": "HIF00", "@changed": "added", "@indent": "up1", "#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "\n                      ", "italic": {"#tail": "the saleable or\n\t\t\t\tnonsaleable return by such repackager of such prescription drug product."}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(II)"}, "@reported-display-style": "italic", "#text": "\n                    ", "@id": "H333285D279F047F89C7E0B8D6076CB05"}], "enum": {"#tail": "\n                  ", "#text": "(xviii)"}, "@id": "HB0B88C4D25FC441EB9463A943C32643B", "#text": "\n                  "}], "enum": {"#tail": "\n                ", "#text": "(B)"}, "header": {"#tail": "\n                ", "#text": "Exemptions"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "term": {"#tail": " does not include\u2014", "#text": "transaction"}, "#text": "The\n\t\t\t\tterm "}, "#text": "\n                ", "@id": "HFF63C60B0E3D49CB9B0391829E6177AF"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", the term\n\t\t\t\t", "@entity-type": "act", "#text": "subparagraph (B)(xviii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:581/p:21/sp:B/cl:xviii", "@proposed": "true"}, "term": {"#tail": " means any substance in its gaseous or\n\t\t\t\tcryogenic liquid form that meets medical purity standards and has application\n\t\t\t\tin a medical or homecare environment, including oxygen and nitrous\n\t\t\t\toxide.", "#text": "compressed medical gas"}, "#text": "For purposes of "}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "header": {"#tail": "\n                ", "#text": "Compressed medical\n\t\t\t\tgas"}, "#text": "\n                ", "@id": "H51A33E388A4E4FA7BEDF787CD2FD00C0"}], "enum": {"#tail": "\n              ", "#text": "(21)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Transaction"}, "#text": "\n              ", "@id": "H8DB0EE3F3EB348FEAE29A59DE1419252"}, {"#tail": "\n            ", "@id": "H1F17DA2AB86640428900983A8003A9B8", "enum": {"#tail": "\n              ", "#text": "(22)"}, "header": {"#tail": "\n              ", "#text": "Transaction\n\t\t\t\thistory"}, "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": " means a\n\t\t\t\tstatement that\u2014", "#text": "transaction history"}, "#text": "The term "}, "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "includes the transaction\n\t\t\t\tinformation for each transaction conducted with respect to a prescription drug\n\t\t\t\tproduct beginning with the manufacturer or initial purchase distributor for\n\t\t\t\teach prior transaction going back to the manufacturer of the prescription drug\n\t\t\t\tproduct or to the initial purchase distributor; and"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "H95FFFB93BFAE47E3AC6FE7405723F0D4", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "is in paper or electronic form.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "H309D4679366A483F97305B733879AEA3", "#text": "\n                "}]}, {"#tail": "\n            ", "@id": "H20A617ADC9254C95B54E255BD42C4561", "enum": {"#tail": "\n              ", "#text": "(23)"}, "header": {"#tail": "\n              ", "#text": "Transaction\n\t\t\t\tinformation"}, "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": "\n\t\t\t\tmeans\u2014", "#text": "transaction information"}, "#text": "The term "}, "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "the proprietary or\n\t\t\t\testablished name or names of the prescription drug product;"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "HFF7F42222C0944B7A18337018D015CD2", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "the strength and dosage\n\t\t\t\tform of the prescription drug product;"}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "H53FCE29882074B96BB2E4BB28271CB97", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "the National Drug Code\n\t\t\t\tnumber of the prescription drug product;"}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "@id": "H7C1A54EE0C134F308259564F8D28187D", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "the container\n\t\t\t\tsize;"}, "enum": {"#tail": "\n                ", "#text": "(D)"}, "@id": "H9EC39389D41E41C0BB67DE590FC7F55B", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "the number of\n\t\t\t\tcontainers;"}, "enum": {"#tail": "\n                ", "#text": "(E)"}, "@id": "HF96FE567CB5644A8B4A34A792BBE383C", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "the lot number of the\n\t\t\t\tprescription drug product;"}, "enum": {"#tail": "\n                ", "#text": "(F)"}, "@id": "H101A7F6C83104F4C811F44640D4D5ED9", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "the date of the\n\t\t\t\ttransaction;"}, "enum": {"#tail": "\n                ", "#text": "(G)"}, "@id": "H18A69A07D96B497E8E06193F9C0B36F7", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "the business name and\n\t\t\t\taddress of the person from whom ownership is being transferred; and"}, "enum": {"#tail": "\n                ", "#text": "(H)"}, "@id": "H9EE35F5FF923494999C81E031719B54D", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "the business name and\n\t\t\t\taddress of the person to whom ownership is being transferred."}, "enum": {"#tail": "\n                ", "#text": "(I)"}, "@id": "H9EC53E86A9C14D60A588142A55C86345", "#text": "\n                "}]}, {"#tail": "\n            ", "@id": "HE88688870A8E43C5A3D18E5D8143E134", "enum": {"#tail": "\n              ", "#text": "(24)"}, "header": {"#tail": "\n              ", "#text": "Transaction\n\t\t\t\tstatement"}, "text": {"#tail": "\n\t\t\t\t\t\t\t", "quote": {"#tail": " is a\n\t\t\t\tstatement, which states that the manufacturer, repackager, wholesale\n\t\t\t\tdistributor, third-party logistics provider, or dispenser transferring\n\t\t\t\townership in a transaction\u2014", "#text": "transaction statement"}, "#text": "The "}, "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "is authorized;"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "HE63CF329D46846608D93153097FCF11F", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " from the prior owner of the\n\t\t\t\tprescription drug product;", "@entity-type": "act", "#text": "section 582", "@value": "Federal Food, Drug, and Cosmetic Act/s:582", "@proposed": "true"}, "#text": "received transaction information and a\n\t\t\t\ttransaction statement as required under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "HD2C0760EFDB846C8BBBDD383DEAACB3E", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "did not knowingly and\n\t\t\t\tintentionally ship an illegitimate prescription drug product;"}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "@id": "H64BCA1BE616A4318824924CA6A5575EE", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "did not knowingly and\n\t\t\t\tintentionally provide false transaction information; and"}, "enum": {"#tail": "\n                ", "#text": "(D)"}, "@id": "H4FE3E81C74F24776A1DD19A4C1161ADC", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "did not knowingly and\n\t\t\t\tintentionally alter the transaction history."}, "enum": {"#tail": "\n                ", "#text": "(E)"}, "@id": "H9477202F659A489B859EB198196F6B84", "#text": "\n                "}]}, {"#tail": "\n            ", "@id": "H343C28D7BE06463D85C8EBEA40A24D99", "enum": {"#tail": "\n              ", "#text": "(25)"}, "header": {"#tail": "\n              ", "#text": "Verification and\n\t\t\t\tverify"}, "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": [{"#tail": " and\n\t\t\t\t", "#text": "verification"}, {"#tail": "\u2014", "#text": "verify"}], "#text": "The terms "}, "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "mean determining whether\n\t\t\t\tthe prescription drug product identifier affixed to, or imprinted upon, a\n\t\t\t\tpackage or homogeneous case of the prescription drug product corresponds to the\n\t\t\t\tstandardized numerical identifier or lot number, and expiration date assigned\n\t\t\t\tto the prescription drug product by the manufacturer or the repackager, as\n\t\t\t\tapplicable; and"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "HD058FC2CEFF3439EBDCD9CF1B1D12FEB", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " using human-readable or machine-readable\n\t\t\t\tmethods.", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:581/p:25/sp:A", "@proposed": "true"}, "#text": "include making the\n\t\t\t\tdetermination under "}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "HAB39DE8B9D384391AA60259AEC7D8B37", "#text": "\n                "}]}, {"#tail": "\n          ", "@id": "H8B94F5CBE2F3447BA92CFE06E7F53FAA", "enum": {"#tail": "\n              ", "#text": "(26)"}, "header": {"#tail": "\n              ", "#text": "Wholesale\n\t\t\t\tdistributor"}, "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": "\u2014", "#text": "wholesale distributor"}, "#text": "The term\n\t\t\t\t", "@display-inline": "yes-display-inline"}, "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "); and", "@entity-type": "act", "#text": "section 583", "@value": "Federal Food, Drug, and Cosmetic Act/s:583", "@proposed": "true"}, "#text": "means a person\n\t\t\t\tengaged in wholesale distribution (as defined in "}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "H97D9A973417A4FF39D13151A0F70FC49", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "excludes\u2014"}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "clause": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "a manufacturer, a\n\t\t\t\tco-licensed partner of a manufacturer, or a third-party logistics provider, or\n\t\t\t\ta dispenser who does not engage in such wholesale distribution;"}, "enum": {"#tail": "\n                  ", "#text": "(i)"}, "@id": "HC00AB97D62FE460388D972CFA3440362", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "a repackager engaged in\n\t\t\t\tsuch wholesale distribution; or"}, "enum": {"#tail": "\n                  ", "#text": "(ii)"}, "@id": "HCB6152AD1CB54913833E9B562B04E7A5", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "section 582(e)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:e", "@proposed": "true"}, "#text": "the distribution of prescription drug\n\t\t\t\tproduct or an offer to distribute prescription drug product by an authorized\n\t\t\t\trepackager that has taken ownership or possession of the prescription drug\n\t\t\t\tproduct and repacked the prescription drug product in accordance with the\n\t\t\t\trequirements of ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(iii)"}, "@id": "HB718F3D089704CB3948288F6B67B56B9", "#text": "\n                  "}], "#text": "\n                ", "@id": "H874CD43BB6AA41C5979AC92301FB1226"}]}], "#text": "\n            ", "@id": "HBDC0BE4EABA44BD889E04267C63693C8"}, {"#tail": "\n        ", "enum": {"#tail": "\n            ", "#text": "582."}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "Requirements"}, "subsection": [{"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(a)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "In general"}, "paragraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "An entity that is a manufacturer, repackager, wholesale\n\t\t\t\tdistributor, third-party logistics provider, or dispenser shall comply with the\n\t\t\t\trequirements of this section. If an entity meets the definition of more than\n\t\t\t\tone of the entities referred to in the preceding sentence, such entity shall\n\t\t\t\tcomply with all applicable requirements of this section, but shall not be\n\t\t\t\trequired to comply with duplicative requirements."}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "Compliance\n\t\t\t\trequired"}, "#text": "\n                ", "@id": "HCF0482B6DE2044F29D61ECCB0113D9D1"}, {"#tail": "\n              ", "text": {"short-title": {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                  ", "@entity-type": "act", "#text": "Safeguarding America\u2019s\n\t\t\t\tPharmaceuticals Act of 2013", "@value": "Safeguarding America\u2019s Pharmaceuticals Act of 2013", "@proposed": "true"}, "#text": "\n                    "}, "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall, in consultation with\n\t\t\t\tother appropriate Federal officials, manufacturers, repackagers, wholesale\n\t\t\t\tdistributors, third-party logistics providers, and dispensers, establish, by\n\t\t\t\tregulation, standards for the exchange of transaction information for purposes\n\t\t\t\tof complying with this section. The standards established under this paragraph\n\t\t\t\tshall be in accordance with a form developed by a widely recognized\n\t\t\t\tinternational standards development organization. In establishing such\n\t\t\t\tstandards, the Secretary shall consider the feasibility of establishing\n\t\t\t\tstandardized documentation to be used by all members of the pharmaceutical\n\t\t\t\tdistribution supply chain to convey the transaction history and transaction\n\t\t\t\tstatement to the subsequent owner of a prescription drug product. The ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": "\n\t\t\t\tshall publish such standards not later than 180 days after the date of the\n\t\t\t\tenactment of the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#tail": "\n\t\t\t\t\t\t\t", "#text": "The ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Standards"}, "#text": "\n                ", "@id": "H78DC84D830D2485BA207A8F00B0694EB"}, {"#tail": "\n              ", "@id": "H6E08500AC52644AB80FBCEA80F49A7CB", "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n                ", "#text": "Waivers, exceptions,\n\t\t\t\tand exemptions"}, "text": {"short-title": {"#tail": ", the ", "#text": "Safeguarding America\u2019s\n\t\t\t\tPharmaceuticals Act of 2013"}, "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall promulgate a\n\t\t\t\tregulation to\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Not later than one year after the date of the\n\t\t\t\tenactment of the "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n\t\t\t\tmay grant, at the request of an authorized manufacturer, repackager, wholesale\n\t\t\t\tdistributor, or dispenser, a waiver from any of the requirements of this\n\t\t\t\tsection\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "establish a process by which the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " determines that such requirements would result in an undue\n\t\t\t\teconomic hardship; or", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "if\n\t\t\t\tthe "}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "HEDDC92608F8A4E49923DC39C10EC9DDD", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "act", "#text": "section 319 of the Public Health Service Act", "@value": "Public Health Service Act/s:319"}, "#text": "for emergency\n\t\t\t\tmedical reasons, including a public health emergency declaration pursuant to\n\t\t\t\t"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "H8DD0E8B98809467091B6D0A777F2D98F", "#text": "\n                    "}], "#text": "\n                  ", "@id": "H12023B6B588F4353B54FA6BE3F251D86"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", ", "@entity-type": "act", "#text": "paragraph (2) of\n\t\t\t\tsubsections (b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:b/p:2", "@proposed": "true"}, {"#tail": ", ", "@entity-type": "act", "#text": "(c)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:c/p:2", "@proposed": "true"}, {"#tail": ", and ", "@entity-type": "act", "#text": "(d)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:d/p:2", "@proposed": "true"}, {"#tail": " through which\u2014", "@entity-type": "act", "#text": "(e)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:e/p:2", "@proposed": "true"}], "#text": "establish a process, with respect to the\n\t\t\t\tprescription drug product identifier requirement under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "a manufacturer or\n\t\t\t\trepackager may request a waiver with respect to prescription drug products that\n\t\t\t\tare packaged in a container too small or otherwise unable to accommodate a\n\t\t\t\tlabel with sufficient space to bear the information required for compliance\n\t\t\t\twith such requirement; and"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "HDC8FFD6429614FADAB46E9946E4E40A3", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n\t\t\t\tdetermines whether to waive such requirement; and", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "the "}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "H4C423B30134843ABAE5BE144FD591811", "#text": "\n                    "}], "#text": "\n                  ", "@id": "HD597A3ADC14B44EA99917B6061EDD9AC"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n\t\t\t\tmay add the prescription drug products or transactions that are exempt from the\n\t\t\t\trequirements of this section.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "establish a process by which the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@id": "HC50F5802622B49D1BC834880925A85AC", "#text": "\n                  "}]}, {"#tail": "\n            ", "subparagraph": [{"#tail": "\n                ", "text": {"short-title": [{"#tail": ", the ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                    ", "@entity-type": "act", "#text": "Safeguarding America\u2019s Pharmaceuticals Act of\n\t\t\t\t2013", "@value": "Safeguarding America\u2019s Pharmaceuticals Act of 2013", "@proposed": "true"}, "#text": "\n                      "}, {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                    ", "@entity-type": "act", "#text": "Safeguarding America\u2019s Pharmaceuticals Act of\n\t\t\t\t2013", "@value": "Safeguarding America\u2019s Pharmaceuticals Act of 2013", "@proposed": "true"}, "#text": "\n                      "}], "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall specify, by regulation, whether and\n\t\t\t\tunder what circumstances the prescription drug product identifier requirement\n\t\t\t\tunder ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ", ", "@entity-type": "act", "#text": "paragraph (2) of subsections (b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:b/p:2", "@proposed": "true"}, {"#tail": ", ", "@entity-type": "act", "#text": "(c)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:c/p:2", "@proposed": "true"}, {"#tail": ", and ", "@entity-type": "act", "#text": "(d)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:d/p:2", "@proposed": "true"}, {"#tail": " shall apply to a\n\t\t\t\tprescription drug product that is in the supply chain or in a manufacturer\u2019s\n\t\t\t\tinventory on the date of the enactment of the ", "@entity-type": "act", "#text": "(e)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:e/p:2", "@proposed": "true"}], "#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Not later than one\n\t\t\t\tyear after the date of the enactment of the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n                  ", "@id": "H1FDF0AAD11954739B5FD2DDA1C16C0A6"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", a third-party logistics provider shall be considered\n\t\t\t\t", "@entity-type": "act", "#text": "section 584", "@value": "Federal Food, Drug, and Cosmetic Act/s:584", "@proposed": "true"}, {"#tail": " unless the ", "@entity-type": "act", "#text": "section 581(6)(B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:581/p:6/sp:B", "@proposed": "true"}, {"#tail": " has made a\n\t\t\t\tfinding that the third-party logistics provider does not utilize good handling\n\t\t\t\tand distribution practices and publishes notice thereof.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "quote": {"#tail": " under ", "#text": "licensed"}, "#text": "Until the date that is 1 year after the\n\t\t\t\teffective date of the third-party logistics provider licensing requirements\n\t\t\t\tunder ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Third-party logistics\n\t\t\t\tprovider licenses"}, "#text": "\n                  ", "@id": "H4D26B2355F9248D0B8DC9A9E3AB52179", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " in the\n\t\t\t\tannual report of an establishment, in accordance with section 314.70(d) of\n\t\t\t\tchapter 21, Code of Federal Regulations (or any successor regulation).", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Changes made to package labels solely to incorporate the\n\t\t\t\tprescription drug product identifier may be submitted to the "}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n                  ", "#text": "Label\n\t\t\t\tchanges"}, "#text": "\n                  ", "@id": "HE88CC0404697470F8196E845489E093E", "@commented": "no"}], "enum": {"#tail": "\n                ", "#text": "(4)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Grandfathered persons\n\t\t\t\tand prescription drug products"}, "#text": "\n                ", "@id": "HA53CA5B3F7AB41AD96F3D4052FEA262F"}], "#text": "\n              ", "@id": "H062630C88F9D433084307FA62BC86D4C"}, {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(b)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Manufacturer\n\t\t\t\trequirements"}, "paragraph": [{"#tail": "\n              ", "subparagraph": [{"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "prior to, or at the time\n\t\t\t\tof, each transaction in which such manufacturer transfers ownership of a\n\t\t\t\tprescription drug product, provide the subsequent owner with the transaction\n\t\t\t\thistory and a transaction statement; and"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "H13823D3F72B54929BEA1707BC5789394", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "maintain the transaction\n\t\t\t\tinformation for each such transaction for not less than 3 years after the date\n\t\t\t\tof the transaction."}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "H82E98E12834D48ED8AFA91FEFFD67C1F", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Beginning not later than January 1, 2015, a manufacturer\n\t\t\t\tshall\u2014"}, "#text": "\n                  ", "@id": "H55F06EE44AC84F75884E432CC5950075"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or other appropriate\n\t\t\t\tFederal or State official, in the event of a recall or for the purpose of\n\t\t\t\tinvestigating a suspect prescription drug product or an illegitimate\n\t\t\t\tprescription drug product, a manufacturer shall, not later than 2 business days\n\t\t\t\tafter receiving the request or in such reasonable time as determined by the\n\t\t\t\tSecretary, provide to the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " or other official, the applicable\n\t\t\t\ttransaction history and transaction statement for the prescription drug\n\t\t\t\tproduct.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "Upon a request by the "}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Requests for\n\t\t\t\tinformation"}, "#text": "\n                  ", "@id": "H0349463F2A324C05AD1677BD9242315D"}], "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Prescription drug\n\t\t\t\tproduct tracing"}, "#text": "\n                ", "@id": "H499B95FBCD7041D8B30ED4953291BDD3"}, {"#tail": "\n              ", "text": {"short-title": {"#tail": ", a manufacturer shall affix or imprint a prescription drug\n\t\t\t\tproduct identifier on each package and homogenous case of a prescription drug\n\t\t\t\tproduct intended to be introduced in a transaction. Such manufacturer shall\n\t\t\t\tmaintain the information in the prescription drug product identifier for such\n\t\t\t\tprescription drug product for not less than 3 years after the date of the\n\t\t\t\ttransaction.", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                  ", "@entity-type": "act", "#text": "Safeguarding America\u2019s Pharmaceuticals Act of\n\t\t\t\t2013", "@value": "Safeguarding America\u2019s Pharmaceuticals Act of 2013", "@proposed": "true"}, "#text": "\n                    "}, "#tail": "\n\t\t\t\t\t\t\t", "#text": "Beginning\n\t\t\t\tnot later than 5 years after the date of the enactment of the\n\t\t\t\t", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Prescription drug\n\t\t\t\tproduct identifier"}, "#text": "\n                ", "@id": "HDE7CE468DA2D40F280F69D4F9A63C3AA"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Beginning not later than January 1, 2015, a manufacturer\n\t\t\t\tshall ensure that each of its trading partners is authorized."}, "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n                ", "#text": "Authorized trading\n\t\t\t\tpartners"}, "#text": "\n                ", "@id": "HDC04103B31E342839284C8585BE4C4BD"}, {"#tail": "\n              ", "@id": "H8A6C9E478BD64C14AB0E3702F7D4CE54", "enum": {"#tail": "\n                ", "#text": "(4)"}, "header": {"#tail": "\n                ", "#text": "List of authorized\n\t\t\t\tdistributors of record"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Beginning not later than January 1, 2015,\n\t\t\t\teach manufacturer of a prescription drug shall\u2014", "@display-inline": "yes-display-inline"}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "maintain a list of the\n\t\t\t\tauthorized distributors of record of such drug at the corporate offices of such\n\t\t\t\tmanufacturer;"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "H0FA832F1A3FA48F9BECFB3EDCF0FC321", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "make such list publicly\n\t\t\t\tavailable, including placement on the Internet Website of such manufacturer;\n\t\t\t\tand"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "HECF44AA3F0294BF79E36287D0D7637C2", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "update such list not less\n\t\t\t\tthan once per quarter."}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@id": "H9C8CA07A809348B4918EF859AC2A6C2C", "#text": "\n                  "}]}, {"#tail": "\n            ", "@id": "H78A4FE6C509F40B4AAB3E738CB1453E3", "enum": {"#tail": "\n                ", "#text": "(5)"}, "header": {"#tail": "\n                ", "#text": "Verification"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Beginning not later than January 1, 2015, a\n\t\t\t\tmanufacturer shall implement systems and processes to enable the manufacturer\n\t\t\t\tto comply with the following requirements:", "@display-inline": "yes-display-inline"}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "verifying the\n\t\t\t\tprescription drug product at the package level;"}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "@id": "H2D790A436EFD416BABBD6AE4EE176391", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "validating any\n\t\t\t\tapplicable transaction history in the possession of the manufacturer;\n\t\t\t\tand"}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "@id": "H5197949A7227401AA47E3408B153ADAE", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "otherwise investigating\n\t\t\t\tto determine whether the prescription drug product is an illegitimate\n\t\t\t\tprescription drug product."}, "enum": {"#tail": "\n                      ", "#text": "(III)"}, "@id": "H62946C42A01440AE9AB9D8F22B996118", "#text": "\n                      "}], "enum": {"#tail": "\n                    ", "#text": "(i)"}, "header": {"#tail": "\n                    ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"short-title": {"#tail": ", such investigation shall\n\t\t\t\tinclude\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                      ", "@entity-type": "act", "#text": "Safeguarding\n\t\t\t\tAmerica\u2019s Pharmaceuticals Act of 2013", "@value": "Safeguarding America\u2019s Pharmaceuticals Act of 2013", "@proposed": "true"}, "#text": "\n                        "}, "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " that a prescription drug product within the possession or control\n\t\t\t\tof a manufacturer is a suspect prescription drug product, a manufacturer shall\n\t\t\t\tpromptly conduct an investigation in coordination with trading partners, as\n\t\t\t\tapplicable, to determine whether the prescription drug product is an\n\t\t\t\tillegitimate prescription drug product. Beginning not later than 5 years after\n\t\t\t\tthe date of the enactment of the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "Upon making a determination that a prescription drug\n\t\t\t\tproduct in the possession or control of the manufacturer is a suspect\n\t\t\t\tprescription drug product, or upon receiving a request for verification from\n\t\t\t\tthe "}, "#text": "\n                    ", "@id": "HAACD99B03C2C428E9B8C29C3A6A0302B"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " of such\n\t\t\t\tdetermination and such prescription drug product may be further\n\t\t\t\tdistributed.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "If the manufacturer determines that a\n\t\t\t\tsuspect prescription drug product is not an illegitimate prescription drug\n\t\t\t\tproduct, the manufacturer shall promptly notify the "}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "header": {"#tail": "\n                    ", "#text": "Cleared prescription\n\t\t\t\tdrug product"}, "#text": "\n                    ", "@id": "H44792B81751F44EFA4A437B6C1350C96"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "A\n\t\t\t\tmanufacturer shall keep records of its investigation of a suspect prescription\n\t\t\t\tdrug product for not less than 3 years after the conclusion of the\n\t\t\t\tinvestigation."}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "header": {"#tail": "\n                    ", "#text": "Records"}, "#text": "\n                    ", "@id": "HA55E12E42E8342FC8613712AA2061404"}], "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Suspect prescription\n\t\t\t\tdrug product"}, "#text": "\n                  ", "@id": "HD167C77B4FD24E589DE825BD0D315620"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "quarantine such\n\t\t\t\tprescription drug product from prescription drug product intended for\n\t\t\t\tdistribution; and"}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "@id": "HE4437D78BC2C426E8A925D937B9BC46E", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "provide for the\n\t\t\t\tdisposition of the illegitimate prescription drug product."}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "@id": "H45D3E9D825C84CA58E91A9788CDA4BFD", "#text": "\n                      "}], "enum": {"#tail": "\n                    ", "#text": "(i)"}, "header": {"#tail": "\n                    ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "Upon determining that a prescription drug product in the\n\t\t\t\tpossession or control of a manufacturer is an illegitimate prescription drug\n\t\t\t\tproduct, the manufacturer shall\u2014"}, "#text": "\n                    ", "@id": "HD07293914CE241599053595E38AE708D"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Upon determining that\n\t\t\t\ta prescription drug product in the possession or control of a trading partner\n\t\t\t\tis an illegitimate prescription drug product, the manufacturer shall take\n\t\t\t\treasonable steps to assist a trading partner to provide for the disposition of\n\t\t\t\tthe illegitimate prescription drug product.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "header": {"#tail": "\n                    ", "#text": "Trading\n\t\t\t\tpartner"}, "#text": "\n                    ", "@id": "HE252D40B27144C06B22B9EFC032DDD9A"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " of such determination\n\t\t\t\tnot later than 24 hours after making such determination. The ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " shall\n\t\t\t\tdetermine whether additional trading partner notification is\n\t\t\t\tappropriate.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "Upon determining that a prescription drug product in\n\t\t\t\tthe possession or control of the manufacturer is an illegitimate prescription\n\t\t\t\tdrug product, the manufacturer shall notify the "}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "header": {"#tail": "\n                    ", "#text": "Making a\n\t\t\t\tnotification"}, "#text": "\n                    ", "@id": "HC0E634F1216E4B3DA4E0F4117D852CF5"}, {"#tail": "\n                  ", "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "identify all illegitimate\n\t\t\t\tprescription drug products that are subject to such notification and in the\n\t\t\t\tpossession or control of the manufacturer, including any prescription drug\n\t\t\t\tproduct that is subsequently received; and"}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "@id": "HC8B32750C3D044AA883BDF24A14A8739", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "clause (i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:b/p:5/sp:B/cl:i", "@proposed": "true"}, "#text": "perform the activities\n\t\t\t\tdescribed in "}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "@id": "HDCDD3D0E26B04B4ABC2E97620DCCD33F", "#text": "\n                      "}], "enum": {"#tail": "\n                    ", "#text": "(iv)"}, "header": {"#tail": "\n                    ", "#text": "Responding to a\n\t\t\t\tnotification"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " that a determination has been made that a prescription drug product\n\t\t\t\tis an illegitimate prescription drug product, a manufacturer shall\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Upon the receipt of a notification from the\n\t\t\t\t"}, "#text": "\n                    ", "@id": "H7DAF61372B1F4EC0ADEE6B7F89DDA199"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "A\n\t\t\t\tmanufacturer shall keep records of the disposition of an illegitimate\n\t\t\t\tprescription drug product for not less than 3 years after the conclusion of the\n\t\t\t\tdisposition."}, "enum": {"#tail": "\n                    ", "#text": "(v)"}, "header": {"#tail": "\n                    ", "#text": "Records"}, "#text": "\n                    ", "@id": "H2975620D56CA49F78FBA3D2BEE8C3599", "@commented": "no"}], "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Illegitimate\n\t\t\t\tprescription drug product"}, "#text": "\n                  ", "@id": "HE9498B2405BB4CF6AEAE49B9B2D7A2AC"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "A manufacturer may satisfy the requirements of this\n\t\t\t\tparagraph through the use of a secure electronic database developed and\n\t\t\t\toperated by the manufacturer or another entity. The owner of such database\n\t\t\t\tshall establish the requirements and processes to respond to requests and may\n\t\t\t\tprovide for data access to other members of the pharmaceutical distribution\n\t\t\t\tsupply chain, as appropriate. The development and operation of such a database\n\t\t\t\tshall not relieve a manufacturer of the requirement under this paragraph to\n\t\t\t\trespond to a verification request submitted by means other than a secure\n\t\t\t\telectronic database."}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n                  ", "#text": "Electronic\n\t\t\t\tdatabase"}, "#text": "\n                  ", "@id": "H41E03423B67A45AAA2E18B3D2D28BFE0"}, {"#tail": "\n              ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "verify the prescription\n\t\t\t\tdrug product identifier for each sealed homogeneous case of such prescription\n\t\t\t\tdrug product; or"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "HF05A837ED5ED41829B02C6E51ED4A65F", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "if such prescription\n\t\t\t\tdrug product is not in a sealed homogeneous case, verify the prescription drug\n\t\t\t\tproduct identifier on each package."}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "H4EFE2313D17645788C825C54724944FC", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(D)"}, "header": {"#tail": "\n                  ", "#text": "Returned prescription\n\t\t\t\tdrug product"}, "text": {"short-title": {"#tail": ", upon receipt of a returned\n\t\t\t\tprescription drug product that the manufacturer intends to further distribute,\n\t\t\t\tbefore further distributing such prescription drug product, the manufacturer\n\t\t\t\tshall\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                    ", "@entity-type": "act", "#text": "Safeguarding America\u2019s\n\t\t\t\tPharmaceuticals Act of 2013", "@value": "Safeguarding America\u2019s Pharmaceuticals Act of 2013", "@proposed": "true"}, "#text": "\n                      "}, "#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Beginning not later than 5 years after the date of\n\t\t\t\tthe enactment of the "}, "#text": "\n                  ", "@id": "H21809632515742CBA7D5FD0C07BDA6C5"}]}], "#text": "\n              ", "@id": "HBE232761046C4FBA92325DADA03FCE9F"}, {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(c)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Wholesale distributor\n\t\t\t\trequirements"}, "paragraph": [{"#tail": "\n              ", "subparagraph": [{"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "not accept ownership of a\n\t\t\t\tprescription drug product unless the previous owner prior to, or at the time\n\t\t\t\tof, the transaction provides the applicable transaction history and a\n\t\t\t\ttransaction statement for the prescription drug product;"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "H8CFA8DED26514FD08538801B07A1A320", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "prior to, or at the time of, each\n\t\t\t\ttransaction in which the wholesale distributor transfers ownership of a\n\t\t\t\tprescription drug product\u2014", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "in the case that the\n\t\t\t\twholesale distributor purchased the prescription drug product directly from the\n\t\t\t\tmanufacturer, provide the subsequent owner with transaction history and a\n\t\t\t\ttransaction statement for the prescription drug product; or"}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "@id": "H3647E0012EEF4E4EB0387A5EE33AC2C1", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "in the case that the wholesale distributor\n\t\t\t\tdid not purchase the prescription drug product directly from the manufacturer,\n\t\t\t\tthe exclusive distributor of the manufacturer, or a repackager that purchased\n\t\t\t\tdirectly from the manufacturer, provide the subsequent owner with transaction\n\t\t\t\thistory beginning with the wholesale distributor that did purchase the product\n\t\t\t\tdirectly from the manufacturer, the exclusive distributor of the manufacturer,\n\t\t\t\tor a repackager that purchased directly from the manufacturer;", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "@id": "H0B757274439F4ACEAB530F6A6A420E01", "#text": "\n                      "}], "#text": "\n                    ", "@id": "HB5F249C6D5D74DD0818BD93D836BD5D0"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", if the\n\t\t\t\twholesale distributor purchased the prescription drug product directly from the\n\t\t\t\tmanufacturer, its exclusive distributor, or a repackager that purchased\n\t\t\t\tdirectly from the manufacturer or its authorized distributor of record\u2014", "@entity-type": "act", "#text": "clause (ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:c/p:1/sp:A/cl:ii", "@proposed": "true"}, "#text": "notwithstanding ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "provide an initial purchase transaction\n\t\t\t\tstatement on the invoice to the customer, stating that the wholesale\n\t\t\t\tdistributor purchased the prescription drug product package directly from the\n\t\t\t\tmanufacturer, exclusive distributor, or repackager;", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "@id": "HEEC1281626D64DB8AC56621D3A25E5DD", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " through any combination of\n\t\t\t\tself-generated paper, electronic data, or manufacturer-provided information on\n\t\t\t\tthe prescription drug product package; and", "@entity-type": "act", "#text": "clause (ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:c/p:1/sp:A/cl:ii", "@proposed": "true"}, "#text": "make available to the\n\t\t\t\timmediate subsequent recipient of such prescription drug product the\n\t\t\t\tinformation required under "}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "@id": "HB1F38B9C690846328F859E2C0AF7512D", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " and ", "@entity-type": "act", "#text": "subclauses (I)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:c/p:1/sp:A/cl:iii/scl:I", "@proposed": "true"}, {"#tail": ",\n\t\t\t\tneed not include any transactions occurring before the transfer of the\n\t\t\t\tprescription drug product to the wholesale distributor; and", "@entity-type": "act", "#text": "(II)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:c/p:1/sp:A/cl:iii/scl:II", "@proposed": "true"}], "#text": "for purposes of ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                      ", "#text": "(III)"}, "@id": "H98505C4659754EB0BC59AAAE2C7ACC0D", "#text": "\n                      "}], "#text": "\n                    ", "@id": "H5989E75961704BA7B3E1FC6255609089"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " and ", "@entity-type": "act", "#text": "clauses (i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:c/p:1/sp:A/cl:i", "@proposed": "true"}, {"#tail": " for not less than 3 years\n\t\t\t\tafter the transaction.", "@entity-type": "act", "#text": "(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:c/p:1/sp:A/cl:ii", "@proposed": "true"}], "#text": "maintain the transaction information for\n\t\t\t\teach transaction described in ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(iv)"}, "@id": "HE33A97501F224386B9D2CBBAFC3B4562", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Beginning not later than April 1, 2015, a wholesale\n\t\t\t\tdistributor shall\u2014"}, "#text": "\n                  ", "@id": "H68E7CC728E82417DAA040BFEFA4D5E10"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "accept returned prescription drug product\n\t\t\t\twithout a transaction history from a dispenser or repackager; and", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "#text": "\n                      ", "@id": "HAB12C195E2E64A3BBFF17BD45EDB6B79", "@commented": "no"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "distribute such returned prescription drug\n\t\t\t\tproduct with a transaction history that begins with the wholesale distributor\n\t\t\t\tthat so accepted the returned product.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "#text": "\n                      ", "@id": "H84D5139708564AEFA4C00ADDA54F40F0", "@commented": "no"}], "enum": {"#tail": "\n                    ", "#text": "(i)"}, "header": {"#tail": "\n                    ", "#text": "Saleable\n\t\t\t\treturns"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", a wholesale distributor may\u2014", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:c/p:1/sp:A", "@proposed": "true"}, "#text": "Notwithstanding\n\t\t\t\t", "@display-inline": "yes-display-inline"}, "#text": "\n                    ", "@id": "H864D5FA215F44880B7C88845B45B22E6", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:c/p:1/sp:A", "@proposed": "true"}, "#text": "A wholesale distributor may return a nonsaleable\n\t\t\t\tprescription drug to the manufacturer or repackager, to the wholesale\n\t\t\t\tdistributor from whom such prescription drug was purchased, or to a person\n\t\t\t\tacting on behalf of such a person, including a returns processor, without\n\t\t\t\tproviding the information required under "}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "header": {"#tail": "\n                    ", "#text": "Nonsaleable\n\t\t\t\treturns"}, "#text": "\n                    ", "@id": "HB517FED4316848F18FE7D698DF281429", "@commented": "no"}], "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Returns\n\t\t\t\texception"}, "#text": "\n                  ", "@id": "H94A2DF1218DD4FDDB4FECBE0BBDCC66B", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or other appropriate\n\t\t\t\tFederal or State official, in the event of a recall or for the purpose of\n\t\t\t\tinvestigating a suspect prescription drug product or an illegitimate\n\t\t\t\tprescription drug product a wholesale distributor shall, not later than 2\n\t\t\t\tbusiness days after receiving the request or in such other reasonable time as\n\t\t\t\tdetermined by the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ", provide the applicable transaction history and\n\t\t\t\ttransaction statements for the prescription drug product.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "Upon a request by the "}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n                  ", "#text": "Requests for\n\t\t\t\tinformation"}, "#text": "\n                  ", "@id": "H1365DBB78D5D417391B5B44867F14B9D"}], "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Prescription drug\n\t\t\t\tproduct tracing"}, "#text": "\n                ", "@id": "H2CACFB01C8B24E5C97A764A6A112F50F"}, {"#tail": "\n              ", "text": {"short-title": {"#tail": ", a wholesale distributor\n\t\t\t\tmay engage in transactions involving a prescription drug product only if such\n\t\t\t\tprescription drug product is encoded with a prescription drug product\n\t\t\t\tidentifier, except as provided in ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                  ", "@entity-type": "act", "#text": "Safeguarding\n\t\t\t\tAmerica\u2019s Pharmaceuticals Act of 2013", "@value": "Safeguarding America\u2019s Pharmaceuticals Act of 2013", "@proposed": "true"}, "#text": "\n                    "}, "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subsection (a)(4)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:a/p:4", "@proposed": "true"}, "#tail": "\n\t\t\t\t\t\t\t", "#text": "Beginning not later than 7 years after the\n\t\t\t\tdate of the enactment of the "}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Prescription drug\n\t\t\t\tproduct identifier"}, "#text": "\n                ", "@id": "H772F8CFAA3B6471AB8FBD6E9B5291CC5"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Beginning not later than January 1, 2015, a wholesale\n\t\t\t\tdistributor shall ensure that each of its trading partners is\n\t\t\t\tauthorized."}, "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n                ", "#text": "Authorized trading\n\t\t\t\tpartners"}, "#text": "\n                ", "@id": "H07BF27E1D8AC4D71BFEF70C3D25B84A1"}, {"#tail": "\n            ", "@id": "HF333AC5A949B4B238A360CCF11E09605", "enum": {"#tail": "\n                ", "#text": "(4)"}, "header": {"#tail": "\n                ", "#text": "Verification"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Beginning\n\t\t\t\tnot later than April 1, 2015, a wholesale distributor shall implement systems\n\t\t\t\tto enable the wholesale distributor to comply with the following\n\t\t\t\trequirements:"}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "verifying a package of\n\t\t\t\tthe prescription drug product;"}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "@id": "H3176A464301249A1A70AD0F443D29C5F", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "validating any\n\t\t\t\tapplicable transaction history in the possession of the wholesale distributor;\n\t\t\t\tand"}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "@id": "HBF4B01504D6140DA9C728988132F5CB6", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "otherwise investigating\n\t\t\t\tto determine whether the prescription drug product is an illegitimate\n\t\t\t\tprescription drug product."}, "enum": {"#tail": "\n                      ", "#text": "(III)"}, "@id": "H8B903DB77A40478A84501AF479EFC3EB", "#text": "\n                      "}], "enum": {"#tail": "\n                    ", "#text": "(i)"}, "header": {"#tail": "\n                    ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"short-title": {"#tail": ", such investigation shall include\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                      ", "@entity-type": "act", "#text": "Safeguarding America\u2019s Pharmaceuticals Act of\n\t\t\t\t2013", "@value": "Safeguarding America\u2019s Pharmaceuticals Act of 2013", "@proposed": "true"}, "#text": "\n                        "}, "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " that a prescription drug product within the possession or control\n\t\t\t\tof a wholesale distributor is a suspect prescription drug product, a wholesale\n\t\t\t\tdistributor shall promptly conduct an investigation to determine whether the\n\t\t\t\tprescription drug product is an illegitimate prescription drug product.\n\t\t\t\tBeginning not later than 7 years after the date of the enactment of the\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "Upon making a determination that a prescription drug\n\t\t\t\tproduct in the possession or control of the wholesale distributor is a suspect\n\t\t\t\tprescription drug product, or upon receiving a request for verification from\n\t\t\t\tthe "}, "#text": "\n                    ", "@id": "H8A4A10CDCC744F1C97CE2AD05F21C2F5"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " of\n\t\t\t\tsuch determination and such prescription drug product may be further\n\t\t\t\tdistributed.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "If the wholesale distributor determines\n\t\t\t\tthat a suspect prescription drug product is not an illegitimate prescription\n\t\t\t\tdrug product, the wholesale distributor shall promptly notify the "}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "header": {"#tail": "\n                    ", "#text": "Cleared prescription\n\t\t\t\tdrug product"}, "#text": "\n                    ", "@id": "HEF589B74EAB34DAD915BADF30675E1BA"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "A\n\t\t\t\twholesale distributor shall keep records of its investigation of a suspect\n\t\t\t\tprescription drug product for not less than 3 years after the conclusion of the\n\t\t\t\tinvestigation."}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "header": {"#tail": "\n                    ", "#text": "Records"}, "#text": "\n                    ", "@id": "H4AD980294A06495B8C56D51130A2E3F6"}], "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Suspect prescription\n\t\t\t\tdrug product"}, "#text": "\n                  ", "@id": "HC3DB982538034E74AB61BBB48F3D67F6"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "quarantine such prescription drug product\n\t\t\t\twithin the possession or control of the wholesale distributor from prescription\n\t\t\t\tdrug product intended for distribution; and", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "@id": "H0BB5EFCDAA6D4174A29125AE5861EEF3", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "provide for the disposition of the\n\t\t\t\tillegitimate prescription drug product within the possession or control of the\n\t\t\t\twholesale distributor.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "@id": "H51FFA1965CAB45998134E5CEF37B57C3", "#text": "\n                      "}], "enum": {"#tail": "\n                    ", "#text": "(i)"}, "header": {"#tail": "\n                    ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "Upon receiving notice that a manufacturer of a\n\t\t\t\tprescription drug product has determined that a prescription drug product in\n\t\t\t\tthe possession or control of a wholesale distributor is an illegitimate\n\t\t\t\tprescription drug product, the wholesale distributor shall\u2014"}, "#text": "\n                    ", "@id": "H44A92806ACD4450DBD6CE58508F5B289"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Upon determining that\n\t\t\t\ta prescription drug product in the possession or control of a trading partner\n\t\t\t\tis an illegitimate prescription drug product, the wholesale distributor shall\n\t\t\t\ttake reasonable steps to assist a trading partner to provide for the\n\t\t\t\tdisposition of the illegitimate prescription drug product.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "header": {"#tail": "\n                    ", "#text": "Trading\n\t\t\t\tpartner"}, "#text": "\n                    ", "@id": "HEE71784CC34C44D4A41CABD12CEF148C"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "\n\t\t\t\tof such determination not later than 24 hours after making such determination.\n\t\t\t\tThe ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " shall determine whether additional trading partner notification\n\t\t\t\tis appropriate.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "Upon determining that a prescription drug product in\n\t\t\t\tthe possession or control of the wholesale distributor is an illegitimate\n\t\t\t\tprescription drug product, the wholesale distributor shall notify the "}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "header": {"#tail": "\n                    ", "#text": "Making a\n\t\t\t\tnotification"}, "#text": "\n                    ", "@id": "HFF32E5285E0B44EDBFD214059CD7EB7C"}, {"#tail": "\n                  ", "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "identify all illegitimate\n\t\t\t\tprescription drug product subject to such notification that is in the\n\t\t\t\tpossession or control of the wholesale distributor, including any prescription\n\t\t\t\tdrug product that is subsequently received; and"}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "@id": "H15BB3DF3202345D5B32D6E57C2E3F3C9", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "clause (i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:c/p:4/sp:B/cl:i", "@proposed": "true"}, "#text": "perform the activities\n\t\t\t\tdescribed in "}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "@id": "HA5DC58F4BF2A40278C6850C21C7EC1F0", "#text": "\n                      "}], "enum": {"#tail": "\n                    ", "#text": "(iv)"}, "header": {"#tail": "\n                    ", "#text": "Responding to a\n\t\t\t\tnotification"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " that a determination has been made that a prescription drug product\n\t\t\t\tis an illegitimate prescription drug product, a wholesale distributor\n\t\t\t\tshall\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Upon the receipt of a notification from the\n\t\t\t\t"}, "#text": "\n                    ", "@id": "HD184603C02564639BC3B7004613368FC"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "A\n\t\t\t\twholesale distributor shall keep records of the disposition of an illegitimate\n\t\t\t\tprescription drug product for not less than 3 years after the conclusion of the\n\t\t\t\tdisposition."}, "enum": {"#tail": "\n                    ", "#text": "(v)"}, "header": {"#tail": "\n                    ", "#text": "Records"}, "#text": "\n                    ", "@id": "H45602614729B4E5EB7A3CBCAB844624A", "@commented": "no"}], "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Illegitimate\n\t\t\t\tprescription drug product"}, "#text": "\n                  ", "@id": "H41146CE172CF4F2CB7FB03E42A6E1CE5"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "A wholesale distributor may satisfy the requirements of\n\t\t\t\tthis paragraph through the use of a secure electronic database developed and\n\t\t\t\toperated by the manufacturer or another entity. The owner of such database\n\t\t\t\tshall establish the requirements and processes to respond to requests and may\n\t\t\t\tprovide for data access to other members of the pharmaceutical distribution\n\t\t\t\tsupply chain, as appropriate. The development and operation of such a database\n\t\t\t\tshall not relieve a wholesale distributor of the requirement under this\n\t\t\t\tparagraph to respond to a verification request submitted by means other than a\n\t\t\t\tsecure electronic database."}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n                  ", "#text": "Electronic\n\t\t\t\tdatabase"}, "#text": "\n                  ", "@id": "HF9212AE427CB482898E347C3CDB98B9D"}, {"#tail": "\n              ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "verify the prescription\n\t\t\t\tdrug product identifier for each sealed homogeneous case of such prescription\n\t\t\t\tdrug product; or"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "HACC3F42C905848A48449DFC0B06FC2ED", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "if such prescription\n\t\t\t\tdrug product is not in a sealed homogeneous case, verify the prescription drug\n\t\t\t\tproduct identifier on each package."}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "H606E75F0A0C64806A65836F53FFC7211", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(D)"}, "header": {"#tail": "\n                  ", "#text": "Returned prescription\n\t\t\t\tdrug product"}, "text": {"short-title": {"#tail": ", upon receipt of a returned\n\t\t\t\tprescription drug product that the wholesale distributor intends to further\n\t\t\t\tdistribute, before further distributing such prescription drug product, the\n\t\t\t\twholesale distributor shall\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                    ", "@entity-type": "act", "#text": "Safeguarding America\u2019s\n\t\t\t\tPharmaceuticals Act of 2013", "@value": "Safeguarding America\u2019s Pharmaceuticals Act of 2013", "@proposed": "true"}, "#text": "\n                      "}, "#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Beginning not later than 7 years after the date of\n\t\t\t\tthe enactment of the "}, "#text": "\n                  ", "@id": "HF911B824BEED42E4A86B1AF9AB2C715A"}]}], "#text": "\n              ", "@id": "H58868C2B213C4ADBBABDAE3B8CDC5AA8"}, {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(d)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Dispenser\n\t\t\t\trequirements"}, "paragraph": [{"#tail": "\n              ", "subparagraph": [{"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "shall not accept\n\t\t\t\townership of a prescription drug product, unless the previous owner prior to,\n\t\t\t\tor at the time of, the transaction, provides transaction history and a\n\t\t\t\ttransaction statement;"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "HD2A20DD221674EEEAC9D798AE128F8B4", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "prior to, or at the time\n\t\t\t\tof, each transaction in which the dispenser transfers ownership of a\n\t\t\t\tprescription drug product (but not including dispensing to a patient or\n\t\t\t\treturns) shall provide the subsequent owner with transaction history and a\n\t\t\t\ttransaction statement for the prescription drug product, except that the\n\t\t\t\trequirements of this clause shall not apply to sales by a dispenser to another\n\t\t\t\tdispenser to fulfill a specific patient need; and"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "HCC0CAD74E9004E9DB800288D69D98F71", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "shall maintain\n\t\t\t\ttransaction information for a period of not less than 3 years after the date of\n\t\t\t\tthe transaction."}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "@id": "HCEE282EC55D34140AEA034C56AF0826C", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Beginning not later than July 1, 2015, a\n\t\t\t\tdispenser\u2014"}, "#text": "\n                  ", "@id": "H136BA1AE421D4D7D968168384C4C2D1D"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "A dispenser may enter into a written agreement with a\n\t\t\t\tthird party, including an authorized wholesale distributor, under which the\n\t\t\t\tthird party confidentially maintains the transaction information required to be\n\t\t\t\tmaintained under this subsection on behalf of the dispenser. If a dispenser\n\t\t\t\tenters into such an agreement, the dispenser shall maintain a copy of the\n\t\t\t\twritten agreement."}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Agreements with third\n\t\t\t\tparties"}, "#text": "\n                  ", "@id": "H141E2C1455B44D9188A758FF4FBCFFCD"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", a dispenser may return prescription drug product to the\n\t\t\t\ttrading partner from which the dispenser obtained the prescription drug product\n\t\t\t\twithout providing the information required under such subparagraph.", "@entity-type": "act", "#text": "subparagraph (A)(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:d/p:1/sp:A/cl:ii", "@proposed": "true"}, "#text": "Notwithstanding\n\t\t\t\t", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "header": {"#tail": "\n                    ", "#text": "Saleable\n\t\t\t\treturns"}, "#text": "\n                    ", "@id": "H00D06C83E9614D28B39E3EA1639CF725", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", a dispenser may\n\t\t\t\treturn a nonsaleable prescription drug to the manufacturer or repackager, to\n\t\t\t\tthe wholesale distributor from whom such prescription drug was purchased, to a\n\t\t\t\treturns processor, or to a person acting on behalf of such persons without\n\t\t\t\tproviding the information required under such subparagraph.", "@entity-type": "act", "#text": "subparagraph (A)(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:d/p:1/sp:A/cl:ii", "@proposed": "true"}, "#text": "Notwithstanding "}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "header": {"#tail": "\n                    ", "#text": "Nonsaleable\n\t\t\t\treturns"}, "#text": "\n                    ", "@id": "H3969FD9651F84D018484CDD86D903B2B", "@commented": "no"}], "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Returns\n\t\t\t\texception"}, "#text": "\n                  ", "@id": "H7C36FF334936433283ED8F105268D966", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or other appropriate\n\t\t\t\tFederal or State official, in the event of a recall or for the purpose of\n\t\t\t\tinvestigating a suspect prescription drug product or an illegitimate\n\t\t\t\tprescription drug product, a dispenser shall, not later than 2 business days\n\t\t\t\tafter receiving the request or in another such reasonable time as determined by\n\t\t\t\tthe ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ", provide lot level transaction information.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "Upon a request by the "}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "header": {"#tail": "\n                  ", "#text": "Requests for\n\t\t\t\tinformation"}, "#text": "\n                  ", "@id": "H5E24FDD7903342ECB491C056B580E63A"}], "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Prescription drug\n\t\t\t\tproduct tracing"}, "#text": "\n                ", "@id": "HE073273C83794A32931614623CBD3943"}, {"#tail": "\n              ", "text": {"short-title": {"#tail": ", a dispenser may engage in\n\t\t\t\ttransactions involving a prescription drug product only if such prescription\n\t\t\t\tdrug product is encoded with a prescription drug product identifier, except as\n\t\t\t\tprovided in ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                  ", "@entity-type": "act", "#text": "Safeguarding\n\t\t\t\tAmerica\u2019s Pharmaceuticals Act of 2013", "@value": "Safeguarding America\u2019s Pharmaceuticals Act of 2013", "@proposed": "true"}, "#text": "\n                    "}, "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subsection (a)(4)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:a/p:4", "@proposed": "true"}, "#tail": "\n\t\t\t\t\t\t\t", "#text": "Beginning not later than 8 years after the\n\t\t\t\tdate of the enactment of the "}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Prescription drug\n\t\t\t\tproduct identifier"}, "#text": "\n                ", "@id": "H96692F40884E4153A3BC0175F443CDBE"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Beginning not later\n\t\t\t\tthan January 1, 2015, a dispenser shall ensure that each of its trading\n\t\t\t\tpartners is authorized.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n                ", "#text": "Authorized trading\n\t\t\t\tpartners"}, "#text": "\n                ", "@id": "H314CC3E84F74473D9642DC67A974EFA7"}, {"#tail": "\n            ", "@id": "HF626AFA60463465EBE3641711C59A84E", "enum": {"#tail": "\n                ", "#text": "(4)"}, "header": {"#tail": "\n                ", "#text": "Verification"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Beginning\n\t\t\t\tnot later than January 1, 2015, a dispenser shall implement systems to enable\n\t\t\t\tthe dispenser to comply with the following requirements:"}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "verifying whether the lot\n\t\t\t\tnumber of a suspect prescription drug product corresponds with the lot number\n\t\t\t\tfor such prescription drug product;"}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "@id": "H4484B4BDAFF1474A9F281B5739CE5BCD", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"short-title": {"#tail": ", verifying that the product\n\t\t\t\tidentifier of at least 3 packages or 10 percent of such suspect prescription\n\t\t\t\tdrug product, whichever is greater, or all packages, if there are fewer than 3,\n\t\t\t\tcorresponds with the prescription drug product identifier for such\n\t\t\t\tproduct;", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                        ", "@entity-type": "act", "#text": "Safeguarding America\u2019s\n\t\t\t\tPharmaceuticals Act of 2013", "@value": "Safeguarding America\u2019s Pharmaceuticals Act of 2013", "@proposed": "true"}, "#text": "\n                          "}, "#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "beginning 8 years after the date of the\n\t\t\t\tenactment of the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "@id": "H9599B24113464AD0AA3724B524AA3A95", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "validating any\n\t\t\t\tapplicable transaction history in the possession of the dispenser; and"}, "enum": {"#tail": "\n                      ", "#text": "(III)"}, "@id": "H10FC1E00BA7049A18E1011E581D0763D", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "otherwise investigating\n\t\t\t\tto determine whether the prescription drug product is an illegitimate\n\t\t\t\tprescription drug product."}, "enum": {"#tail": "\n                      ", "#text": "(IV)"}, "@id": "H78BAE27DF10F493DAE4F398A6C4D8F3B", "#text": "\n                      "}], "enum": {"#tail": "\n                    ", "#text": "(i)"}, "header": {"#tail": "\n                    ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n\t\t\t\tthat a prescription drug product within the possession or control of a\n\t\t\t\tdispenser is a suspect prescription drug product, a dispenser shall promptly\n\t\t\t\tconduct an investigation to determine whether the prescription drug product is\n\t\t\t\tan illegitimate prescription drug product. Such investigation shall\n\t\t\t\tinclude\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Upon making a determination that a prescription drug\n\t\t\t\tproduct in the possession or control of the dispenser is a suspect prescription\n\t\t\t\tdrug product, or upon receiving a request for verification from the "}, "#text": "\n                    ", "@id": "H04CF72124E4D4A5C81ED42AF82BEC6D6"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " of\n\t\t\t\tsuch determination and such prescription drug product may be further\n\t\t\t\tdispensed.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "If the dispenser makes the\n\t\t\t\tdetermination that a suspect prescription drug product is not an illegitimate\n\t\t\t\tprescription drug product, the dispenser shall promptly notify the "}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "header": {"#tail": "\n                    ", "#text": "Cleared prescription\n\t\t\t\tdrug product"}, "#text": "\n                    ", "@id": "HC6EDB63FDB554C0BB0774433A2279FED"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "A\n\t\t\t\tdispenser shall keep records of its investigation of a suspect prescription\n\t\t\t\tdrug product for not less than 3 years after the conclusion of the\n\t\t\t\tinvestigation."}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "header": {"#tail": "\n                    ", "#text": "Records"}, "#text": "\n                    ", "@id": "H2788FF59BDAB41FEAA2E00BB1B73E7BF"}], "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Suspect prescription\n\t\t\t\tdrug product"}, "#text": "\n                  ", "@id": "H99AB8A4166724E129F9351B78197EA42"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "quarantine such\n\t\t\t\tprescription drug product within the possession or control of the dispenser\n\t\t\t\tfrom prescription drug product intended for distribution; and"}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "@id": "H1B8F9F69D4C241C8B48CF5517B598688", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "provide for the disposition of the\n\t\t\t\tillegitimate prescription drug product within the possession or control of the\n\t\t\t\tdispenser.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "@id": "HF5AD999B4DEB4CE98A9C0A9480456EFC", "#text": "\n                      "}], "enum": {"#tail": "\n                    ", "#text": "(i)"}, "header": {"#tail": "\n                    ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "Upon receiving notice\n\t\t\t\tthat a manufacturer of a prescription drug product has determined that a\n\t\t\t\tprescription drug product in the possession or control of a dispenser is an\n\t\t\t\tillegitimate prescription drug product, the dispenser shall\u2014", "@display-inline": "yes-display-inline"}, "#text": "\n                    ", "@id": "HB36DE180C3F74A67895EAD1AFC5D3D13"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Upon determining\n\t\t\t\tthat a prescription drug product in the possession or control of a trading\n\t\t\t\tpartner is an illegitimate prescription drug product, the dispenser shall take\n\t\t\t\treasonable steps to assist a trading partner to provide for the disposition of\n\t\t\t\tthe illegitimate prescription drug product.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "header": {"#tail": "\n                    ", "#text": "Trading\n\t\t\t\tpartners"}, "#text": "\n                    ", "@id": "H639BCE528A99464BADC6C1E99659D2CA"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " of such determination not\n\t\t\t\tlater than 24 hours after making such determination. The ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " shall\n\t\t\t\tdetermine whether additional trading partner notification is\n\t\t\t\tappropriate.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "Upon determining that a prescription drug product in\n\t\t\t\tthe possession or control of the dispenser is an illegitimate prescription drug\n\t\t\t\tproduct, the dispenser shall notify the "}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "header": {"#tail": "\n                    ", "#text": "Making a\n\t\t\t\tnotification"}, "#text": "\n                    ", "@id": "H7C8E149F79E6409191D07F4023B7A397"}, {"#tail": "\n                  ", "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "identify all illegitimate\n\t\t\t\tprescription drug products that are subject to such notification and in the\n\t\t\t\tpossession or control of the dispenser, including any prescription drug product\n\t\t\t\tthat is subsequently received; and"}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "@id": "HC9248DFD9A7F4B099239B4EC70636B5F", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "clause (i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:d/p:4/sp:B/cl:i", "@proposed": "true"}, "#text": "perform the activities\n\t\t\t\tdescribed in "}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "@id": "H7E77403DCC02420F9D98C3BB9BE6C875", "#text": "\n                      "}], "enum": {"#tail": "\n                    ", "#text": "(iv)"}, "header": {"#tail": "\n                    ", "#text": "Responding to a\n\t\t\t\tnotification"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " that a determination has been made that a prescription drug product\n\t\t\t\tis an illegitimate prescription drug product, a dispenser shall\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Upon the receipt of a notification from the\n\t\t\t\t"}, "#text": "\n                    ", "@id": "HC71E9737987D4FA5936BEBA63926E482"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "A\n\t\t\t\tdispenser shall keep records of the disposition of an illegitimate prescription\n\t\t\t\tdrug product for not less than 3 years after the conclusion of the\n\t\t\t\tdisposition."}, "enum": {"#tail": "\n                    ", "#text": "(v)"}, "header": {"#tail": "\n                    ", "#text": "Records"}, "#text": "\n                    ", "@id": "H435E0BD350D045B8A2B2A1C2502D7F1C", "@commented": "no"}], "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Illegitimate\n\t\t\t\tprescription drug product"}, "#text": "\n                  ", "@id": "H5F710087AEA3410384BD3DA1F857EADE"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "A dispenser may satisfy the requirements of this\n\t\t\t\tparagraph through the use of a secure electronic database developed and\n\t\t\t\toperated by the manufacturer or another entity. The owner of such database\n\t\t\t\tshall establish the requirements and processes to enable responding to requests\n\t\t\t\tand may provide for data access to other members of the pharmaceutical\n\t\t\t\tdistribution supply chain, as appropriate. The development and operation of\n\t\t\t\tsuch a database shall not relieve a dispenser of the requirement under this\n\t\t\t\tparagraph to respond to a verification request submitted by means other than a\n\t\t\t\tsecure electronic database."}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n                  ", "#text": "Electronic\n\t\t\t\tdatabase"}, "#text": "\n                  ", "@id": "HAA2D1214C86E4C70A35BE951D1A98E2C"}]}], "#text": "\n              ", "@id": "H46745F1642F140D8A92AF66DAD9F72BE"}, {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(e)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Repackager\n\t\t\t\trequirements"}, "paragraph": [{"#tail": "\n              ", "subparagraph": [{"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "not accept ownership of a\n\t\t\t\tprescription drug product unless the previous owner, prior to, or at the time\n\t\t\t\tof, the transaction, provides transaction history and a transaction statement\n\t\t\t\tfor the prescription drug product;"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "H2A048A735C61473BBCD42B690431AC10", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "prior to, or at the time\n\t\t\t\tof, each transaction in which the repackager transfers ownership of a\n\t\t\t\tprescription drug product, provide the subsequent owner with transaction\n\t\t\t\thistory and a transaction statement;"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "HBF4E2F0AAB764EFBBB809CC126D3F6B5", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or ", "@entity-type": "act", "#text": "clause (i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:e/p:1/sp:A/cl:i", "@proposed": "true"}, {"#tail": "\n\t\t\t\tfor not less than 3 years after the transaction; and", "@entity-type": "act", "#text": "(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:e/p:1/sp:A/cl:ii", "@proposed": "true"}], "#text": "maintain the\n\t\t\t\ttransaction information for each transaction described in "}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "@id": "H8D0274E034B04FF6A99554F4F7C15F0A", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "maintain records that\n\t\t\t\tallow the repackager to associate the prescription drug product identifier the\n\t\t\t\trepackager affixes or imprints with the prescription drug product identifier\n\t\t\t\tassigned by the original manufacturer of the prescription drug product."}, "enum": {"#tail": "\n                    ", "#text": "(iv)"}, "@id": "HF7CE362D36C646E59F8754E546796312", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Beginning not later\n\t\t\t\tthan April 1, 2015, with respect to a prescription drug product received by a\n\t\t\t\trepackager from a wholesale distributor, and beginning not later than January\n\t\t\t\t1, 2015, with respect to any other prescription drug product, a repackager\n\t\t\t\tshall\u2014", "@display-inline": "yes-display-inline"}, "#text": "\n                  ", "@id": "HB50716EBAC6F4A789B4214F0229079CB"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", a repackager may return prescription drug product to the\n\t\t\t\ttrading partner from whom the repackager obtained the prescription drug product\n\t\t\t\twithout providing the information required under such subparagraph.", "@entity-type": "act", "#text": "subparagraph (A)(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:e/p:1/sp:A/cl:ii", "@proposed": "true"}, "#text": "Notwithstanding\n\t\t\t\t", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Nonsaleable\n\t\t\t\treturns"}, "@display-inline": "no-display-inline", "#text": "\n                  ", "@id": "H720E6B2FD98C413E951C37B3AAA255D7"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or other appropriate\n\t\t\t\tFederal or State official, in the event of a recall or for the purpose of\n\t\t\t\tinvestigating a suspect prescription drug product or an illegitimate\n\t\t\t\tprescription drug product, a repackager shall, not later than 2 business days\n\t\t\t\tafter receiving the request or in such other reasonable time as determined by\n\t\t\t\tthe ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ", provide the applicable transaction history and transaction\n\t\t\t\tstatement for the prescription drug product.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "Upon a request by the "}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n                  ", "#text": "Requests for\n\t\t\t\tinformation"}, "#text": "\n                  ", "@id": "H68D7445092434AE889E0168E1D586B9C"}], "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Prescription drug\n\t\t\t\tproduct tracing"}, "#text": "\n                ", "@id": "HF0897F1FF0B2444FB86D18BA83792E51"}, {"#tail": "\n              ", "@id": "H13DB5ADE630D43528F19B2151A4AA8C5", "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Prescription drug\n\t\t\t\tproduct identifier"}, "text": {"short-title": {"#tail": ", a repackager\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                  ", "@entity-type": "act", "#text": "Safeguarding\n\t\t\t\tAmerica\u2019s Pharmaceuticals Act of 2013", "@value": "Safeguarding America\u2019s Pharmaceuticals Act of 2013", "@proposed": "true"}, "#text": "\n                    "}, "#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Beginning not later than 6 years after the\n\t\t\t\tdate of the enactment of the "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "shall affix or imprint a\n\t\t\t\tprescription drug product identifier to each package and homogenous case of\n\t\t\t\tprescription drug product intended to be introduced in a transaction;"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "H59DE548C5A4C4F51A8A92F305276B1EC", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "shall maintain the\n\t\t\t\tprescription drug product identifier for such prescription drug product for not\n\t\t\t\tless than 3 years after the date of the transaction; and"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "H2AC2E0457F0B49DCA83ED87B5B10119E", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subsection (a)(4)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:a/p:4", "@proposed": "true"}, "#text": "may engage in\n\t\t\t\ttransactions involving a prescription drug product only if such prescription\n\t\t\t\tdrug product is encoded with a prescription drug product identifier except as\n\t\t\t\tprovided in "}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@id": "H7BB8F6F860D84934A100C431E558514F", "#text": "\n                  "}]}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Beginning on January\n\t\t\t\t1, 2015, a repackager shall ensure that each of its trading partners is\n\t\t\t\tauthorized.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n                ", "#text": "Authorized trading\n\t\t\t\tpartners"}, "#text": "\n                ", "@id": "H119FBB713E9F4F13B60CF086539D36D9"}, {"#tail": "\n            ", "@id": "HBE4F6805D8274E63A0337D1BB1DE436B", "enum": {"#tail": "\n                ", "#text": "(4)"}, "header": {"#tail": "\n                ", "#text": "Verification"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Beginning\n\t\t\t\tnot later than January 1, 2015, a repackager shall implement systems to enable\n\t\t\t\tthe repackager to comply with the following requirements:"}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "subclause": [{"#tail": "\n                    ", "text": {"short-title": {"#tail": ", verifying the prescription drug product at the package\n\t\t\t\tlevel;", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                        ", "@entity-type": "act", "#text": "Safeguarding America\u2019s Pharmaceuticals Act of\n\t\t\t\t2013", "@value": "Safeguarding America\u2019s Pharmaceuticals Act of 2013", "@proposed": "true"}, "#text": "\n                          "}, "#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "beginning not later than\n\t\t\t\t6 years after the date of the enactment of the\n\t\t\t\t"}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "@id": "HED20DF6BC9C5460D8B5E1B769F1F6EC5", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "validating any\n\t\t\t\tapplicable transaction information in the possession of the repackager;\n\t\t\t\tand"}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "@id": "H983661F36FAD4B4B96C017497595776F", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "otherwise investigating\n\t\t\t\tto determine whether the prescription drug product is an illegitimate\n\t\t\t\tprescription drug product."}, "enum": {"#tail": "\n                      ", "#text": "(III)"}, "@id": "H2955E923ADF2493F8F814EFF8CFFF7ED", "#text": "\n                      "}], "enum": {"#tail": "\n                    ", "#text": "(i)"}, "header": {"#tail": "\n                    ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " that a prescription drug product within the possession or control\n\t\t\t\tof a repackager is a suspect prescription drug product, a repackager shall\n\t\t\t\tpromptly conduct an investigation to determine whether the prescription drug\n\t\t\t\tproduct is an illegitimate prescription drug product, including\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Upon making a determination that a prescription drug\n\t\t\t\tproduct in the possession or control of the repackager is a suspect\n\t\t\t\tprescription drug product, or upon receiving a request for verification from\n\t\t\t\tthe "}, "#text": "\n                    ", "@id": "HFAE8FEFD2A714CBC9DC8B81D91AC9BA7"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " of such\n\t\t\t\tdetermination and such prescription drug product may be further\n\t\t\t\tdistributed.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "If the repackager determines that a\n\t\t\t\tsuspect prescription drug product is not an illegitimate prescription drug\n\t\t\t\tproduct, the repackager shall promptly notify the "}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "header": {"#tail": "\n                    ", "#text": "Cleared prescription\n\t\t\t\tdrug product"}, "#text": "\n                    ", "@id": "H28CF68539D794115B4595F1927DED33F"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "A\n\t\t\t\trepackager shall keep records of its investigation of a suspect prescription\n\t\t\t\tdrug product for not less than 3 years after the conclusion of the\n\t\t\t\tinvestigation."}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "header": {"#tail": "\n                    ", "#text": "Records"}, "#text": "\n                    ", "@id": "H9B6D178FCD2A427287F1750B958F55CE"}], "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Suspect prescription\n\t\t\t\tdrug product"}, "#text": "\n                  ", "@id": "HB899FCD6F0964DF99E4CAB75E9013938"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "quarantine such\n\t\t\t\tprescription drug product within the possession or control of the repackager\n\t\t\t\tfrom prescription drug product intended for distribution; and"}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "@id": "H41EF3A798E5C46B7BCE9E4E80ED7FA6A", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "provide for the disposition of the\n\t\t\t\tillegitimate prescription drug product within the possession or control of the\n\t\t\t\trepackager.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "@id": "H40B9E61FC097429DB0DAE65498CFC630", "#text": "\n                      "}], "enum": {"#tail": "\n                    ", "#text": "(i)"}, "header": {"#tail": "\n                    ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "Upon receiving notice\n\t\t\t\tthat a manufacturer of a prescription drug product has determined that a\n\t\t\t\tprescription drug product in the possession or control of a repackager is an\n\t\t\t\tillegitimate prescription drug product, the repackager shall\u2014", "@display-inline": "yes-display-inline"}, "#text": "\n                    ", "@id": "H71FC084E093745AB96C9D1D0847247DC"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Upon determining that\n\t\t\t\ta prescription drug product in the possession or control of a trading partner\n\t\t\t\tis an illegitimate prescription drug product, the repackagers shall take\n\t\t\t\treasonable steps to assist the trading partner to provide for the disposition\n\t\t\t\tof the illegitimate prescription drug product.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "header": {"#tail": "\n                    ", "#text": "Trading\n\t\t\t\tpartner"}, "#text": "\n                    ", "@id": "H904737B9548540DAA576CF8AA8AC2837"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " of such determination\n\t\t\t\tnot later than 24 hours after making such determination. The ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " shall\n\t\t\t\tdetermine whether additional trading partner notification is\n\t\t\t\tappropriate.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "Upon determining that a prescription drug product in\n\t\t\t\tthe possession or control of the repackager is an illegitimate prescription\n\t\t\t\tdrug product, the repackager shall notify the "}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "header": {"#tail": "\n                    ", "#text": "Making a\n\t\t\t\tnotification"}, "#text": "\n                    ", "@id": "HBD23715E1D214C64B84B3DBDE38428D2"}, {"#tail": "\n                  ", "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "identify all illegitimate\n\t\t\t\tprescription drug products that are subject to such notification and in the\n\t\t\t\tpossession or control of the repackager, including any prescription drug\n\t\t\t\tproduct that is subsequently received; and"}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "@id": "H44813CAACCBC4790B6207F1CE05B0907", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "clause (i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:e/p:4/sp:B/cl:i", "@proposed": "true"}, "#text": "perform the activities\n\t\t\t\tdescribed in "}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "@id": "H1361F88A31E24BAD91D50A31AEDD6A19", "#text": "\n                      "}], "enum": {"#tail": "\n                    ", "#text": "(iv)"}, "header": {"#tail": "\n                    ", "#text": "Responding to a\n\t\t\t\tnotification"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " that a determination has been made that a prescription drug product\n\t\t\t\tis an illegitimate prescription drug product, a repackager shall\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Upon the receipt of a notification from the\n\t\t\t\t"}, "#text": "\n                    ", "@id": "H4D5305C6EED34AAF8E363390C095006D"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "A\n\t\t\t\trepackager shall keep records of the disposition of an illegitimate\n\t\t\t\tprescription drug product for not less than 3 years after the conclusion of the\n\t\t\t\tdisposition."}, "enum": {"#tail": "\n                    ", "#text": "(v)"}, "header": {"#tail": "\n                    ", "#text": "Records"}, "#text": "\n                    ", "@id": "HF2EF9F10BF9048E98C8D9298AD6BBF01"}], "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Illegitimate\n\t\t\t\tprescription drug product"}, "#text": "\n                  ", "@id": "H6F87925838854548BCC73CE960999F71"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "A repackager may satisfy the requirements of this\n\t\t\t\tparagraph through the use of a secure electronic database developed and\n\t\t\t\toperated by the manufacturer or another entity. The owner of such database\n\t\t\t\tshall establish the requirements and processes to respond to requests and may\n\t\t\t\tprovide for data access to other members of the pharmaceutical distribution\n\t\t\t\tsupply chain, as appropriate. The development and operation of such a database\n\t\t\t\tshall not relieve a repackager of the requirement under this paragraph to\n\t\t\t\trespond to a verification request submitted by means other than a secure\n\t\t\t\telectronic database."}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n                  ", "#text": "Electronic\n\t\t\t\tdatabase"}, "#text": "\n                  ", "@id": "H45CCDA0C783C4EF5B86F527B968FFD17"}, {"#tail": "\n              ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "verify the prescription\n\t\t\t\tdrug product identifier for each sealed homogeneous case of such prescription\n\t\t\t\tdrug product; or"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "H9385AC877A9F40E7878E02FCA5B55489", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "if such prescription\n\t\t\t\tdrug product is not in a sealed homogeneous case, verify the prescription drug\n\t\t\t\tproduct identifier on each package."}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "H30109B2C8DE1460C9014A58D2A003D37", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(D)"}, "header": {"#tail": "\n                  ", "#text": "Returned prescription\n\t\t\t\tdrug product"}, "text": {"short-title": {"#tail": ", upon receipt of a returned\n\t\t\t\tprescription drug product that the repackager intends to further distribute,\n\t\t\t\tbefore further distributing such prescription drug product, the repackager\n\t\t\t\tshall\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                    ", "@entity-type": "act", "#text": "Safeguarding America\u2019s\n\t\t\t\tPharmaceuticals Act of 2013", "@value": "Safeguarding America\u2019s Pharmaceuticals Act of 2013", "@proposed": "true"}, "#text": "\n                      "}, "#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Beginning not later than 6 years after the date of\n\t\t\t\tthe enactment of the "}, "#text": "\n                  ", "@id": "H531148A4E27949C68C1A8A386FFD76EB"}]}], "#text": "\n              ", "@id": "H2F39161D7B3A4419A9D0ABB66EA7642F"}, {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(f)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Third-Party logistics\n\t\t\t\tprovider requirements"}, "paragraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Beginning on January\n\t\t\t\t1, 2015, a third-party logistics provider shall ensure that each of its trading\n\t\t\t\tpartners is authorized.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "Authorized trading\n\t\t\t\tpartners"}, "#text": "\n                ", "@id": "HFE401356BD2D43A39A5690512F0C143C"}, {"#tail": "\n            ", "@id": "HED8FCFC5E66549F28F7F300783FB901E", "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Verification"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Beginning not later than January 1, 2015, a\n\t\t\t\tthird-party logistics provider shall implement systems to enable the\n\t\t\t\tthird-party logistics provider to comply with the following\n\t\t\t\trequirements:", "@display-inline": "yes-display-inline"}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Upon making a determination that a prescription drug\n\t\t\t\tproduct in the possession or control of a third-party logistics provider is a\n\t\t\t\tsuspect prescription drug product, a third-party logistics provider shall\n\t\t\t\tpromptly notify the owner of such prescription drug product of the need to\n\t\t\t\tconduct an investigation to determine whether the prescription drug product is\n\t\t\t\tan illegitimate prescription drug product."}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "header": {"#tail": "\n                    ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n                    ", "@id": "HE4071CDC1F93437B9AB2857C89E7BD39"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "If the owner of the prescription drug product\n\t\t\t\tnotifies the third-party logistics provider of the determination that a suspect\n\t\t\t\tprescription drug product is not an illegitimate prescription drug product,\n\t\t\t\tsuch prescription drug product may be further distributed."}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "header": {"#tail": "\n                    ", "#text": "Cleared prescription\n\t\t\t\tdrug product"}, "#text": "\n                    ", "@id": "H8C5FFBDD06FB403E9473105717AE0262"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " and ", "@entity-type": "act", "#text": "clauses (i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:f/p:2/sp:A/cl:i", "@proposed": "true"}, {"#tail": " with respect to a suspect prescription drug product for\n\t\t\t\tnot less than 3 years after the conclusion of the investigation.", "@entity-type": "act", "#text": "(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:f/p:2/sp:A/cl:ii", "@proposed": "true"}], "#text": "A\n\t\t\t\tthird-party logistics provider shall keep records of the activities described\n\t\t\t\tin "}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "header": {"#tail": "\n                    ", "#text": "Records"}, "#text": "\n                    ", "@id": "H7C0654F7E7B1451691C5D20ED837048C"}], "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Suspect prescription\n\t\t\t\tdrug product"}, "#text": "\n                  ", "@id": "H6505B9B48D7F4980B438C4475B9024AB"}, {"#tail": "\n              ", "clause": [{"#tail": "\n                  ", "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "quarantine such\n\t\t\t\tprescription drug product within the possession or control of the third-party\n\t\t\t\tlogistics provider from prescription drug product intended for\n\t\t\t\tdistribution;"}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "@id": "H9C079DF560C5404DAC24774F531DBEB4", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "promptly notify the owner of such\n\t\t\t\tprescription drug product of the need to provide for the disposition of such\n\t\t\t\tprescription drug product; and", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "@id": "H5A387364665C4B64AF7826867E322789", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "promptly transfer possession of the\n\t\t\t\tprescription drug product to the owner of such prescription drug product to\n\t\t\t\tprovide for the disposition of the prescription drug product.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                      ", "#text": "(III)"}, "@id": "HB67453BEA78D471F9888A5AE4DCA9C11", "#text": "\n                      "}], "enum": {"#tail": "\n                    ", "#text": "(i)"}, "header": {"#tail": "\n                    ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "Upon receiving notice\n\t\t\t\tthat a manufacturer of a prescription drug product has determined that a\n\t\t\t\tprescription drug product in the possession or control of a third-party\n\t\t\t\tlogistics provider is an illegitimate prescription drug product, the\n\t\t\t\tthird-party logistics provider shall\u2014", "@display-inline": "yes-display-inline"}, "#text": "\n                    ", "@id": "H61A5B0B7C2B441B09024F724411F255B"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " not later than 24 hours after making such\n\t\t\t\tdetermination. The ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " shall determine whether additional trading partner\n\t\t\t\tnotification is appropriate.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "Upon determining that a prescription drug product in\n\t\t\t\tthe possession or control of the third-party logistics provider is an\n\t\t\t\tillegitimate prescription drug product, the third-party logistics provider\n\t\t\t\tshall notify the "}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "header": {"#tail": "\n                    ", "#text": "Making a\n\t\t\t\tnotification"}, "#text": "\n                    ", "@id": "H47A2985946A54CA7A90C24140701A75D"}, {"#tail": "\n                  ", "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "identify all illegitimate\n\t\t\t\tprescription drug product subject to such notification that is in the\n\t\t\t\tpossession or control of the third-party logistics provider, including any\n\t\t\t\tprescription drug product that is subsequently received; and"}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "@id": "H01D1C549ED25454DB0CA4A32788F4FA1", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "clause (i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:f/p:2/sp:B/cl:i", "@proposed": "true"}, "#text": "perform the activities\n\t\t\t\tdescribed in "}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "@id": "H9D31B19922904A13BA58E0C2D7830EAC", "#text": "\n                      "}], "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "header": {"#tail": "\n                    ", "#text": "Responding to a\n\t\t\t\tnotification"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", a third-party logistics provider shall\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Upon the receipt of a notification from the\n\t\t\t\t"}, "#text": "\n                    ", "@id": "H77B0343100364221A812A99B43ADCA6C"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " and ", "@entity-type": "act", "#text": "clauses (i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:f/p:2/sp:A/cl:i", "@proposed": "true"}, {"#tail": " with respect to an illegitimate prescription drug\n\t\t\t\tproduct for not less than 3 years after the conclusion of the\n\t\t\t\tdisposition.", "@entity-type": "act", "#text": "(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:f/p:2/sp:A/cl:ii", "@proposed": "true"}], "#text": "A\n\t\t\t\tthird-party logistics provider shall keep records of the activities described\n\t\t\t\tin "}, "enum": {"#tail": "\n                    ", "#text": "(iv)"}, "header": {"#tail": "\n                    ", "#text": "Records"}, "#text": "\n                    ", "@id": "HE22310DE9E0941D2AA003AD2B251A8D8"}], "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Illegitimate\n\t\t\t\tprescription drug product"}, "#text": "\n                  ", "@id": "H92A5627042D2450F906FE321F64A7866"}]}], "#text": "\n              ", "@id": "HC42879DDE21C481B8A2F597C086C82F2"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "This section does not apply to any entity,\n\t\t\t\tnotwithstanding its status as a wholesale distributor or repackager, or other\n\t\t\t\tstatus that is not involved in the physical handling, distribution, or storage\n\t\t\t\tof a prescription drug product. For purposes of this subsection, facilitating\n\t\t\t\tthe distribution of a prescription drug product by providing various\n\t\t\t\tadministrative services, including processing of orders and payments, shall\n\t\t\t\tnot, by itself, be construed as being involved in the handling, distribution,\n\t\t\t\tor storage of a prescription drug\n\t\t\t\tproduct."}, "enum": {"#tail": "\n              ", "#text": "(g)"}, "header": {"#tail": "\n              ", "#text": "Drop\n\t\t\t\tshipments"}, "#text": "\n              ", "@id": "HF3360432FEE64C2CB148A4C828590301"}], "#text": "\n            ", "@id": "HED98662786454151A0601BAC078873CC"}], "enum": {"#tail": "\n          ", "#text": "H"}, "header": {"#tail": "\n\t\t\t\t\t", "#text": "Pharmaceutical\n\t\t\t\tDistribution Supply Chain"}, "#text": "\n          ", "@id": "H0017A679F7A742AF9142B52D8A4F7E49"}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t", "@id": "H27DE264365594ADEBDAA79F018B2A9AA"}, "#text": "\n      ", "@id": "H8C3B46F2AAE44EE2BECDF948ECC53678"}, {"#tail": "\n    ", "enum": {"#tail": "\n      ", "#text": "3."}, "header": {"#tail": "\n\t\t\t", "#text": "Enhanced drug\n\t\t\t distribution security"}, "subsection": [{"#tail": "\n      ", "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n\t\t\t\t", "#text": "Pilot projects"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall establish one or more pilot projects in\n\t\t\t coordination with manufacturers, repackagers, wholesale distributors,\n\t\t\t third-party logistics providers, and dispensers to explore and evaluate methods\n\t\t\t to enhance the safety and security of the pharmaceutical distribution supply\n\t\t\t chain.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Not later than 2 years after the date of the enactment of\n\t\t\t this Act, the "}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "header": {"#tail": "\n          ", "#text": "In\n\t\t\t general"}, "#text": "\n          ", "@id": "H5835F10FEFE043BC9C97A9C83BD19EEF"}, {"#tail": "\n      ", "subparagraph": [{"#tail": "\n          ", "clause": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "reflect the diversity of\n\t\t\t the pharmaceutical distribution supply chain; and"}, "enum": {"#tail": "\n              ", "#text": "(i)"}, "@id": "HBE826EF989714FD0BB6D51999CC3D50D", "#text": "\n              "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "include participants\n\t\t\t representative of every sector within the pharmaceutical distribution supply\n\t\t\t chain, including participants representative of small businesses."}, "enum": {"#tail": "\n              ", "#text": "(ii)"}, "@id": "H4ACEB4A42A0F4F56BAEA8F5B8F03BB23", "#text": "\n              "}], "enum": {"#tail": "\n            ", "#text": "(A)"}, "header": {"#tail": "\n            ", "#text": "In\n\t\t\t general"}, "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall ensure that the pilot projects under\n\t\t\t ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " collectively\u2014", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Safeguarding America\u2019s Pharmaceuticals Act of 2013/s:3/ss:a/p:1", "@proposed": "true"}], "#text": "The "}, "#text": "\n            ", "@id": "HC5F4D72E7119462C885E6C70193B2CD8"}, {"#tail": "\n        ", "clause": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "utilize the prescription\n\t\t\t drug product identifier for tracing of a prescription drug product, which\n\t\t\t utilization may include\u2014"}, "enum": {"#tail": "\n              ", "#text": "(i)"}, "subclause": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "verification of the\n\t\t\t prescription drug product identifier of a prescription drug product; and"}, "enum": {"#tail": "\n                ", "#text": "(I)"}, "@id": "H7B61A802F4014A61A94B5975F8087EEB", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "the use of aggregation\n\t\t\t and inference;"}, "enum": {"#tail": "\n                ", "#text": "(II)"}, "@id": "H6FA403667370445DA1E33BBDA856B143", "#text": "\n                "}], "#text": "\n              ", "@id": "H0984D3265C7B43C7B61C60CCD56F9C1F"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "improve the technical\n\t\t\t capabilities of each sector within the pharmaceutical supply chain to comply\n\t\t\t with systems and processes needed to utilize the prescription drug product\n\t\t\t identifiers to enhance tracing of a prescription drug product; and"}, "enum": {"#tail": "\n              ", "#text": "(ii)"}, "@id": "H0FE3BF4CAD6F4FA2835F8C428D97F8ED", "#text": "\n              "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " determines appropriate to explore and\n\t\t\t evaluate methods to enhance the safety and security of the pharmaceutical\n\t\t\t distribution supply chain.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "conduct such\n\t\t\t other activities as the "}, "enum": {"#tail": "\n              ", "#text": "(iii)"}, "@id": "HB8B4FBB318024F53BBD43C12DBC6A3C9", "#text": "\n              "}], "enum": {"#tail": "\n            ", "#text": "(B)"}, "header": {"#tail": "\n            ", "#text": "Project\n\t\t\t design"}, "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "The pilot projects shall be designed to\u2014"}, "#text": "\n            ", "@id": "H13F3B557C35244A1B7AAFCD148D213AF"}], "enum": {"#tail": "\n          ", "#text": "(2)"}, "header": {"#tail": "\n\t\t\t\t\t", "#text": "Content"}, "#text": "\n          ", "@id": "H45C7CFB830EF4501B15F32CF4C0E25EC"}], "#text": "\n        ", "@id": "H63D08C9825694896B5A2EB566DC9C5EA"}, {"#tail": "\n      ", "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n\t\t\t\t", "#text": "Public\n\t\t\t meetings"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the ", "@entity-type": "act", "#text": "subsection (e)(2)", "@value": "Safeguarding America\u2019s Pharmaceuticals Act of 2013/s:3/ss:e/p:2", "@proposed": "true"}, {"#tail": " shall hold a public meeting\n\t\t\t to enhance the safety and security of the pharmaceutical distribution supply\n\t\t\t chain. In conducting such meetings, the Secretary shall take all measures\n\t\t\t reasonable and practicable to ensure the protection of confidential commercial\n\t\t\t information and trade secrets.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "Not later than 6 months after the date of the enactment\n\t\t\t of this Act, and at least every 6 months thereafter until the submission of the\n\t\t\t report required by "}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "header": {"#tail": "\n          ", "#text": "In\n\t\t\t general"}, "#text": "\n          ", "@id": "H8BA45409BE154E908552500A7A8F83DD"}, {"#tail": "\n      ", "@id": "HDDA5A42BD6AD4B0BA5B6529E6769B4E5", "enum": {"#tail": "\n          ", "#text": "(2)"}, "header": {"#tail": "\n          ", "#text": "Content"}, "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall seek to address,\n\t\t\t in at least one such meeting, each of the following topics:", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "In\n\t\t\t conducting meetings under this subsection, the "}, "#text": "\n          ", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", as added by ", "@entity-type": "act", "#text": "section 582 of the Federal Food, Drug, and\n\t\t\t Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:582", "@proposed": "true"}, {"#tail": ".", "@entity-type": "act", "#text": "section 2", "@value": "Safeguarding America\u2019s Pharmaceuticals Act of 2013/s:2", "@proposed": "true"}], "#text": "Best practices in\n\t\t\t each of the sectors within the pharmaceutical distribution supply chain to\n\t\t\t implement the requirements of "}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "@id": "HD0795D0423D44AFDA57D9C3EE8D10DA2", "#text": "\n            "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", including the impact on each\n\t\t\t pharmaceutical distribution supply chain sector and on public health.", "@entity-type": "act", "#text": "section 582", "@value": "Federal Food, Drug, and Cosmetic Act/s:582", "@proposed": "true"}, "#text": "The costs and\n\t\t\t benefits of implementation of such "}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "@id": "HA599D5E9ABA14DC9977E64EC93877C0F", "#text": "\n            "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "Whether additional\n\t\t\t electronic traceability requirements, including tracing of prescription drug\n\t\t\t product at the package level, are feasible, cost effective, overly burdensome\n\t\t\t on small businesses, and needed to protect public health."}, "enum": {"#tail": "\n            ", "#text": "(C)"}, "#text": "\n            ", "@id": "HD3B1970723254644AEA263BA6B8624DD", "@commented": "no"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "The systems and processes\n\t\t\t needed to utilize the prescription drug product identifiers to enhance tracing\n\t\t\t of prescription drug product at the package level."}, "enum": {"#tail": "\n            ", "#text": "(D)"}, "@id": "H865020E196024A4A8DE400F5553FC2F2", "#text": "\n            "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "The technical\n\t\t\t capabilities and legal authorities, if any, needed to establish an electronic\n\t\t\t system that provides for enhanced tracing of prescription drug product at the\n\t\t\t package level."}, "enum": {"#tail": "\n            ", "#text": "(E)"}, "@id": "HC8AE5DC714B044C9B3C4AD725672D0DD", "#text": "\n            "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", ", "@entity-type": "act", "#text": "subparagraphs (C)", "@value": "Safeguarding America\u2019s Pharmaceuticals Act of 2013/s:3/ss:b/p:2/sp:C", "@proposed": "true"}, {"#tail": ", and ", "@entity-type": "act", "#text": "(D)", "@value": "Safeguarding America\u2019s Pharmaceuticals Act of 2013/s:3/ss:b/p:2/sp:D", "@proposed": "true"}, {"#tail": " would have on patient safety,\n\t\t\t the drug supply, cost and regulatory burden, the timeliness of patient access\n\t\t\t to prescription drugs, and small businesses.", "@entity-type": "act", "#text": "(E)", "@value": "Safeguarding America\u2019s Pharmaceuticals Act of 2013/s:3/ss:b/p:2/sp:E", "@proposed": "true"}], "#text": "The impact that\n\t\t\t the requirements, systems, processes, capabilities, and legal authorities\n\t\t\t referred to in "}, "enum": {"#tail": "\n            ", "#text": "(F)"}, "@id": "H33C6BD97F3024B56B776EA0ABB569028", "#text": "\n            "}]}], "#text": "\n        ", "@id": "H4BFE59CAF17F4D9AA79F95C1E5AF90D7"}, {"#tail": "\n      ", "enum": {"#tail": "\n        ", "#text": "(c)"}, "header": {"#tail": "\n\t\t\t\t", "#text": "Study of the\n\t\t\t pharmaceutical distribution supply chain"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall conduct a study to examine implementation of\n\t\t\t the requirements established under ", "@entity-type": "federal-body", "#text": "Comptroller\n\t\t\t General of the United States", "@entity-id": "0500"}, {"#tail": ", as added by ", "@entity-type": "act", "#text": "subchapter H of chapter V of the Federal\n\t\t\t Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/ch:V/sch:H", "@proposed": "true"}, {"#tail": ", in order to inform the\n\t\t\t regulations promulgated under this section.", "@entity-type": "act", "#text": "section 2", "@value": "Safeguarding America\u2019s Pharmaceuticals Act of 2013/s:2", "@proposed": "true"}], "#text": "The ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "header": {"#tail": "\n          ", "#text": "In\n\t\t\t general"}, "#text": "\n          ", "@id": "H75EDCDD350AB47E2B49A004662D2BC33"}, {"#tail": "\n      ", "@id": "H89A5FA34D38D425884E2A6C5C9503736", "enum": {"#tail": "\n          ", "#text": "(2)"}, "header": {"#tail": "\n          ", "#text": "Consideration"}, "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall\n\t\t\t provide for stakeholder input and shall consider the following:", "@entity-type": "federal-body", "#text": "Comptroller General", "@entity-id": "0500"}, "#text": "In\n\t\t\t conducting the study under this subsection, the "}, "#text": "\n          ", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " with respect to\u2014", "@entity-type": "act", "#text": "subchapter H", "@value": "Federal Food, Drug, and Cosmetic Act/ch:V/sch:H", "@proposed": "true"}, "#text": "The implementation\n\t\t\t of the requirements established under such "}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "clause": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "the ability of the health\n\t\t\t care system collectively to maintain patient access to medicines;"}, "enum": {"#tail": "\n              ", "#text": "(i)"}, "@id": "HCE5934647DED4B95811DB4B01A95D1D3", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "the scalability of such\n\t\t\t requirements, including with respect to prescription drug product lines;\n\t\t\t and"}, "enum": {"#tail": "\n              ", "#text": "(ii)"}, "@id": "H675E5A6F506B48C5B8DB2AA825B0C156", "#text": "\n              "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "the capability of\n\t\t\t different sectors within the pharmaceutical distribution supply chain,\n\t\t\t including small businesses, to affix and utilize the prescription drug product\n\t\t\t identifier."}, "enum": {"#tail": "\n              ", "#text": "(iii)"}, "@id": "HB1A43BE97D54496AB7AC0849F2130AE0", "#text": "\n              "}], "#text": "\n            ", "@id": "H1D1E5AA295804D0F83E2C86E62EC6CF2"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " with respect to\u2014", "@entity-type": "act", "#text": "such subchapter H", "@value": "Federal Food, Drug, and Cosmetic Act/ch:V/sch:H", "@proposed": "true"}, "#text": "The need for\n\t\t\t additional legal authorities and activities to address additional gaps in the\n\t\t\t pharmaceutical distribution supply chain, if any, after the implementation of\n\t\t\t the requirements established under "}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "clause": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "the systems and processes\n\t\t\t needed to enhance tracing of prescription drug product at the package\n\t\t\t level;"}, "enum": {"#tail": "\n              ", "#text": "(i)"}, "@id": "HFD4109F70EAD4B388578CEA22B522258", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "the impact, feasibility,\n\t\t\t and cost effectiveness that additional requirements pursuant to this section\n\t\t\t would have on each pharmaceutical distribution supply chain sector and the\n\t\t\t public health; and"}, "enum": {"#tail": "\n              ", "#text": "(ii)"}, "@id": "H249B62B086E24EF3BBD7E91248D8EE36", "#text": "\n              "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "the systems and\n\t\t\t processes needed to enhance interoperability among trading partners."}, "enum": {"#tail": "\n              ", "#text": "(iii)"}, "@id": "HAB8CE421A8764114AD704263684E9D8F", "#text": "\n              "}], "#text": "\n            ", "@id": "HE416B9957BC846DEB112556AF735E211"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "Risks to the security and privacy of data\n\t\t\t collected, maintained, or exchanged pursuant to the requirements established\n\t\t\t under such subchapter H.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(C)"}, "@id": "HD82F45D1455B4BD78C419002488D7C6B", "#text": "\n            "}]}], "#text": "\n        ", "@id": "H4D03CBBFD6FC46C98F2DBE1977545945"}, {"#tail": "\n      ", "enum": {"#tail": "\n        ", "#text": "(d)"}, "header": {"#tail": "\n\t\t\t\t", "#text": "Small\n\t\t\t dispensers"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall enter\n\t\t\t into a contract with a private, independent consulting firm with relevant\n\t\t\t expertise to conduct a technology and software study on the feasibility of\n\t\t\t dispensers that have 25 or fewer full-time employees conducting interoperable,\n\t\t\t electronic tracing of prescription drug products at the package level.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Not later than 10\n\t\t\t years after the date of the enactment of this Act, the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "header": {"#tail": "\n          ", "#text": "In\n\t\t\t general"}, "#text": "\n          ", "@id": "H163C9D47D33540B185C4CE15B5FA960D"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", the private independent consulting firm awarded such\n\t\t\t contract shall agree to consult with dispensers that have 25 or fewer full-time\n\t\t\t employees when conducting the study under such subparagraph.", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Safeguarding America\u2019s Pharmaceuticals Act of 2013/s:3/ss:d/p:1", "@proposed": "true"}, "#text": "As a condition of the award of a contract\n\t\t\t under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "header": {"#tail": "\n          ", "#text": "Condition"}, "#text": "\n          ", "@id": "H2FB32942E85047FBABFE4BE5DAD71F28"}, {"#tail": "\n        ", "@id": "HB55F577E5B5144E2B1BCD08439567A82", "enum": {"#tail": "\n          ", "#text": "(3)"}, "header": {"#tail": "\n          ", "#text": "Study\n\t\t\t content"}, "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall assess\n\t\t\t whether, with respect to conducting interoperable, electronic tracing of\n\t\t\t prescription drug products at the package level, the necessary hardware and\n\t\t\t software\u2014", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Safeguarding America\u2019s Pharmaceuticals Act of 2013/s:3/ss:d/p:1", "@proposed": "true"}, "#text": "The study conducted under "}, "#text": "\n          ", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "is readily accessible to such\n\t\t\t dispensers;", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "@id": "H1D8F03C66C2E48098D5DD0DD7FDFAD10", "#text": "\n            "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "is not prohibitively expensive to obtain,\n\t\t\t install, and maintain for such dispensers; and", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "@id": "H809C5A24FC6F4DC5BD9D5A6979CF99CF", "#text": "\n            "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "can be integrated into business practices,\n\t\t\t such as interoperability with wholesale distributors, for such\n\t\t\t dispensers.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(C)"}, "@id": "H34CDBB7A1AD246D28318DFC7C594E0AC", "#text": "\n            "}]}, {"#tail": "\n        ", "@id": "HB24EADD1642348409613D99BCA1142B2", "enum": {"#tail": "\n          ", "#text": "(4)"}, "header": {"#tail": "\n          ", "#text": "Publication"}, "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall publish\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The\n\t\t\t "}, "#text": "\n          ", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " for public comment not later than 30 days before\n\t\t\t commencing the study; and", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Safeguarding America\u2019s Pharmaceuticals Act of 2013/s:3/ss:d/p:1", "@proposed": "true"}, "#text": "the statement of work for the study\n\t\t\t conducted under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "@id": "HC004A61FE5114785971680AB493DDCA0", "#text": "\n            "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "the final version of such study for public\n\t\t\t comment not later than 30 days after such study is completed.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "@id": "HC21B6588559142AE84612860D48CC2B9", "#text": "\n            "}]}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " is\n\t\t\t completed, the ", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Safeguarding America\u2019s Pharmaceuticals Act of 2013/s:3/ss:d/p:1", "@proposed": "true"}, {"#tail": " shall submit to the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " and the ", "@entity-type": "committee", "#text": "Committee on Energy and Commerce\n\t\t\t of the House of Representatives", "@entity-id": "HIF00"}, {"#tail": ", a report on the findings of the study and any\n\t\t\t recommendations to improve the technology and software available to small\n\t\t\t dispensers for purposes of conducting electronic, interoperable tracing of\n\t\t\t prescription drug products at the package level.", "@entity-type": "committee", "#text": "Committee on Health, Education, Labor,\n\t\t\t and Pensions of the Senate", "@entity-id": "SSHR00"}], "#text": "Not later than 30\n\t\t\t days after the date on which the study conducted under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n          ", "#text": "(5)"}, "header": {"#tail": "\n          ", "#text": "Report to\n\t\t\t Congress"}, "#text": "\n          ", "@id": "H60A5A82CABA141E49D4F25B2483F5965"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " is\n\t\t\t completed, the ", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Safeguarding America\u2019s Pharmaceuticals Act of 2013/s:3/ss:d/p:1", "@proposed": "true"}, {"#tail": " shall hold a public meeting at which members of the\n\t\t\t public, including stakeholders, may present their views on the study.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "Not later than 180\n\t\t\t days after the date on which the study conducted under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n          ", "#text": "(6)"}, "header": {"#tail": "\n          ", "#text": "Public\n\t\t\t meeting"}, "#text": "\n          ", "@id": "H69D770BE659B4572B13A3BEC3C118006"}], "#text": "\n        ", "@id": "H832012B42C2643D6B31B677207EA496C"}, {"#tail": "\n      ", "enum": {"#tail": "\n        ", "#text": "(e)"}, "header": {"#tail": "\n\t\t\t\t", "#text": "Reports"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall submit to the ", "@entity-type": "federal-body", "#text": "Comptroller General", "@entity-id": "0500"}, {"#tail": " and the ", "@entity-type": "committee", "#text": "Committee on Energy and\n\t\t\t Commerce of the House of Representatives", "@entity-id": "HIF00"}, {"#tail": " a report on the results of the\n\t\t\t study conducted under ", "@entity-type": "committee", "#text": "Committee on Health,\n\t\t\t Education, Labor, and Pensions of the Senate", "@entity-id": "SSHR00"}, {"#tail": ".", "@entity-type": "act", "#text": "subsection (c)", "@value": "Safeguarding America\u2019s Pharmaceuticals Act of 2013/s:3/ss:c", "@proposed": "true"}], "#text": "Not later than 12 years after the date of the enactment of\n\t\t\t this Act, the "}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "header": {"#tail": "\n          ", "#text": "GAO\n\t\t\t report"}, "#text": "\n          ", "@id": "H16358891067C436B9F238771EF5E0343"}, {"#tail": "\n      ", "@id": "HC60AFC040A5C46CBAA97756613386100", "enum": {"#tail": "\n          ", "#text": "(2)"}, "header": {"#tail": "\n          ", "#text": "FDA\n\t\t\t report"}, "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall submit to the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " and the ", "@entity-type": "committee", "#text": "Committee on Energy and Commerce of\n\t\t\t the House of Representatives", "@entity-id": "HIF00"}, {"#tail": " a report on the results of the pilot program conducted\n\t\t\t under ", "@entity-type": "committee", "#text": "Committee on Health, Education, Labor, and\n\t\t\t Pensions of the Senate", "@entity-id": "SSHR00"}, {"#tail": ", taking into consideration\u2014", "@entity-type": "act", "#text": "subsection (a)", "@value": "Safeguarding America\u2019s Pharmaceuticals Act of 2013/s:3/ss:a", "@proposed": "true"}], "#text": "Not later than 12 years after the date of the enactment of\n\t\t\t this Act, the "}, "#text": "\n          ", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "; and", "@entity-type": "act", "#text": "subsection (b)", "@value": "Safeguarding America\u2019s Pharmaceuticals Act of 2013/s:3/ss:b", "@proposed": "true"}, "#text": "the comments\n\t\t\t received during the public meetings conducted under "}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "@id": "HF30E021D5A8D4E2B9C2DB612FF661271", "#text": "\n            "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subsection (d)", "@value": "Safeguarding America\u2019s Pharmaceuticals Act of 2013/s:3/ss:d", "@proposed": "true"}, "#text": "the results of the\n\t\t\t study conducted, and the public comments received during the public meeting\n\t\t\t held, under "}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "@id": "H64FA8973FAE54762BDBEA25D47B5492D", "#text": "\n            "}]}], "#text": "\n        ", "@id": "H45B2E69017B048CF80DAE86E70F6C79E"}, {"#tail": "\n      ", "enum": {"#tail": "\n        ", "#text": "(f)"}, "header": {"#tail": "\n\t\t\t\t", "#text": "Establishment of\n\t\t\t additional requirements"}, "paragraph": [{"#tail": "\n        ", "@id": "HAD104C9BCF5E41B1A0DD16B82AFA4379", "enum": {"#tail": "\n          ", "#text": "(1)"}, "header": {"#tail": "\n          ", "#text": "In\n\t\t\t general"}, "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n\t\t\t shall issue proposed regulations that establish additional requirements to\n\t\t\t prevent a suspect product, illegitimate product, or a product that is\n\t\t\t counterfeit, stolen, diverted, or otherwise unfit for distribution from\n\t\t\t entering into or being further distributed in the supply chain,\n\t\t\t including\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Notwithstanding any\n\t\t\t other provision of this Act, including the amendments made by this Act, not\n\t\t\t earlier than January 1, 2027, and not later than March 1, 2027, the ", "@display-inline": "yes-display-inline"}, "#text": "\n          ", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "requirements related to the use of\n\t\t\t interoperable electronic systems and technologies for enhanced tracing of\n\t\t\t prescription drug product at the package level, which may include verification\n\t\t\t of the prescription drug product identifier of a package of prescription drug\n\t\t\t product and enhanced verification of saleable returns;", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "@id": "HD74800A4889F4C9FA7BAE9FEEE150A8E", "#text": "\n            "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", as added by ", "@entity-type": "act", "#text": "section 582(a)(2)\n\t\t\t of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:a/p:2", "@proposed": "true"}, {"#tail": ";", "@entity-type": "act", "#text": "section 2", "@value": "Safeguarding America\u2019s Pharmaceuticals Act of 2013/s:2", "@proposed": "true"}], "#text": "requirements related to the use of\n\t\t\t additional prescription drug product identifiers or prescription drug product\n\t\t\t identifier technology that meet the standards developed under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "@id": "H3ED05F909D0647A4BF6DBFFA30B2B23E", "#text": "\n            "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";\n\t\t\t and", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Safeguarding America\u2019s Pharmaceuticals Act of 2013/s:3/ss:f/p:1/sp:A", "@proposed": "true"}, "#text": "requirements related to the use of\n\t\t\t aggregation, inference, and other methods, if determined to be necessary\n\t\t\t components of the systems and technologies referred to in ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(C)"}, "@id": "H43EDF2A558A7444BBF300DA5A8A6627D", "#text": "\n            "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "other data transmission\n\t\t\t and maintenance requirements and interoperability standards."}, "enum": {"#tail": "\n            ", "#text": "(D)"}, "@id": "H3D294C5CF2EE4993A56938FD1B7E47E2", "#text": "\n            "}]}, {"#tail": "\n        ", "@id": "H39AD93DF60C141E0A7E6F1AFF9F0E09A", "enum": {"#tail": "\n          ", "#text": "(2)"}, "header": {"#tail": "\n          ", "#text": "Flexibility"}, "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall provide for flexibility for a\n\t\t\t member of the pharmaceutical supply chain, by\u2014", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Safeguarding America\u2019s Pharmaceuticals Act of 2013/s:3/ss:f/p:1", "@proposed": "true"}, "#text": "The\n\t\t\t requirements described in "}, "#text": "\n          ", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "with respect to dispensers, allowing a\n\t\t\t dispenser to enter into a written agreement with a third party, including an\n\t\t\t authorized wholesale distributor, under which\u2014", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "clause": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "the third party\n\t\t\t confidentially maintains any information required to be maintained under such\n\t\t\t requirements for the dispenser; and"}, "enum": {"#tail": "\n              ", "#text": "(i)"}, "@id": "HEDC252E244F74BD791E1F6012326FC76", "#text": "\n              "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "the dispenser maintains\n\t\t\t a copy of the written agreement and is not relieved of the other obligations of\n\t\t\t the dispenser under such requirements;"}, "enum": {"#tail": "\n              ", "#text": "(ii)"}, "@id": "HDD7DCFA2F8C243E7805AB82975566F5F", "#text": "\n              "}], "#text": "\n            ", "@id": "H65EA7883B5924C3DBFD732763C56633D"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " determines that\n\t\t\t such requirements would result in an undue economic hardship on the\n\t\t\t manufacturer, wholesale distributor, or dispenser;", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "establishing a process by which an\n\t\t\t authorized manufacturer, repackager, wholesale distributor, or dispenser may\n\t\t\t request a waiver from any such requirements if the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "@id": "HC4AA2377745A4A1F8C5FE0D1C2D15801", "#text": "\n            "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "not requiring the adoption of specific\n\t\t\t business systems by a member of the pharmaceutical supply chain for the\n\t\t\t maintenance and transmission of prescription drug product tracing data;\n\t\t\t and", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(C)"}, "@id": "H65472E4EEA324327AA296414B24FC00A", "#text": "\n            "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "paragraph (4)", "@value": "Safeguarding America\u2019s Pharmaceuticals Act of 2013/s:3/ss:f/p:4", "@proposed": "true"}, "#text": "prescribing alternative methods of\n\t\t\t compliance for small businesses, as specified in ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(D)"}, "@id": "H23BB5BC7CA4F40318B01C84982D6D949", "#text": "\n            "}]}, {"#tail": "\n        ", "@id": "H12B84A8FD0D24872B2CB9F051BCD67A7", "enum": {"#tail": "\n          ", "#text": "(3)"}, "header": {"#tail": "\n          ", "#text": "Considerations"}, "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the ", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Safeguarding America\u2019s Pharmaceuticals Act of 2013/s:3/ss:f/p:1", "@proposed": "true"}, {"#tail": " shall\n\t\t\t consider\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "In\n\t\t\t issuing proposed regulations under "}, "#text": "\n          ", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "act", "#text": "subsection (a)", "@value": "Safeguarding America\u2019s Pharmaceuticals Act of 2013/s:3/ss:a", "@proposed": "true"}, "#text": "the results of the pilot project conducted\n\t\t\t under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "@id": "HFF77259218B3452B82E55D01C6669C40", "#text": "\n            "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "act", "#text": "subsection (b)", "@value": "Safeguarding America\u2019s Pharmaceuticals Act of 2013/s:3/ss:b", "@proposed": "true"}, "#text": "the public\n\t\t\t meetings held under "}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "@id": "HF5FD5B1E3DD74980BAACA55B10975278", "#text": "\n            "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " and ", "@entity-type": "act", "#text": "subsections (c)", "@value": "Safeguarding America\u2019s Pharmaceuticals Act of 2013/s:3/ss:c", "@proposed": "true"}, {"#tail": ";", "@entity-type": "act", "#text": "(d)", "@value": "Safeguarding America\u2019s Pharmaceuticals Act of 2013/s:3/ss:d", "@proposed": "true"}], "#text": "the studies\n\t\t\t conducted under "}, "enum": {"#tail": "\n            ", "#text": "(C)"}, "@id": "HC57892BCA69349E594ECFD7D8411F351", "#text": "\n            "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "act", "#text": "subsection (e)", "@value": "Safeguarding America\u2019s Pharmaceuticals Act of 2013/s:3/ss:e", "@proposed": "true"}, "#text": "the reports\n\t\t\t submitted under "}, "enum": {"#tail": "\n            ", "#text": "(D)"}, "@id": "HD79486BEC1474AA09356B6874A20A869", "#text": "\n            "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "the public health benefits of such\n\t\t\t regulations compared with the cost of compliance with the requirements\n\t\t\t contained in such regulations, including with respect to entities of varying\n\t\t\t sizes and capabilities; and", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(E)"}, "@id": "H5CF930B0612243E2957F7A3B9F5B3158", "#text": "\n            "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "the diversity of the pharmaceutical\n\t\t\t distribution supply chain by providing appropriate flexibility for each sector\n\t\t\t in the supply chain, including small businesses.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(F)"}, "@id": "HB7EAB30F6BB84FEBBFBAF2AFB077F697", "#text": "\n            "}]}, {"#tail": "\n        ", "@id": "H54EDD61E7E164D8EB83818C7468CA224", "enum": {"#tail": "\n          ", "#text": "(4)"}, "header": {"#tail": "\n          ", "#text": "Small business\n\t\t\t protection"}, "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ",\n\t\t\t taking into consideration the study conducted under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ", shall, if\n\t\t\t the ", "@entity-type": "act", "#text": "paragraph (d)", "@value": "Safeguarding America\u2019s Pharmaceuticals Act of 2013/s:3/ss:d", "@proposed": "true"}, {"#tail": " determines that the requirements established pursuant to\n\t\t\t ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " would result in an undue economic hardship on small businesses,\n\t\t\t provide for alternative methods of compliance with any such requirement by\n\t\t\t small businesses, including\u2014", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Safeguarding America\u2019s Pharmaceuticals Act of 2013/s:3/ss:f/p:1", "@proposed": "true"}], "#text": "The ", "@display-inline": "yes-display-inline"}, "#text": "\n          ", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "establishing timelines for such compliance\n\t\t\t (including compliance by dispensers with 25 or fewer full-time employees) that\n\t\t\t do not impose undue economic hardship for small businesses, including\n\t\t\t dispensers with respect to which the study concluded has insufficient hardware\n\t\t\t and software to conduct interoperable, electronic tracing of prescription drug\n\t\t\t products at the package level; and", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "@id": "H4BB33CD0B70946FF94652BBFD6E38C50", "#text": "\n            "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "establishing a process by which a dispenser\n\t\t\t may request a waiver from any such requirement.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "@id": "H3F8EA71792134D87AFF08D8E7911D7D1", "#text": "\n            "}]}, {"#tail": "\n        ", "@id": "H19F18981EC7D4DD199AD5C229BDA4AA8", "enum": {"#tail": "\n          ", "#text": "(5)"}, "header": {"#tail": "\n          ", "#text": "Regulations"}, "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "In\n\t\t\t issuing regulations to carry out this subsection, the "}, "#text": "\n          ", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "issue a notice of proposed rulemaking that\n\t\t\t includes a copy of the proposed rule;", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "@id": "HF623EC5EB3084B319F3124E23CFCAEB0", "#text": "\n            "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "provide for a period of not less than 60\n\t\t\t days for comments on the proposed rule; and", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "@id": "H5D6CCFB35665442D9363C9CCD15F7A5C", "#text": "\n            "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "provide for an effective date of the final\n\t\t\t rule that is 2 years after the date on which such final rule is\n\t\t\t published.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(C)"}, "@id": "HDA548BE124E543CE97E843016CF9BD98", "#text": "\n            "}]}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", as added by ", "@entity-type": "act", "#text": "section 582\n\t\t\t of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:582", "@proposed": "true"}, {"#tail": ", shall cease\n\t\t\t to be effective on the date on which the regulations issued under this section\n\t\t\t are fully implemented.", "@entity-type": "act", "#text": "section 2", "@value": "Safeguarding America\u2019s Pharmaceuticals Act of 2013/s:2", "@proposed": "true"}], "#text": "The requirements regarding the provision\n\t\t\t and receipt of transaction history and transaction statements under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n          ", "#text": "(6)"}, "header": {"#tail": "\n          ", "#text": "Sunset"}, "#text": "\n          ", "@id": "H4F24FF296B064C96911700001B2CE23A"}], "#text": "\n        ", "@id": "H415636184ED24746BB4E9A3D959264EC"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t\t", "#text": "In this section:", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(g)"}, "header": {"#tail": "\n        ", "#text": "Definitions"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", as added by ", "@entity-type": "act", "#text": "section 581 of the\n\t\t\t Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:581", "@proposed": "true"}, {"#tail": ", shall have the\n\t\t\t same meanings in this section as such terms are given in such ", "@entity-type": "act", "#text": "section 2", "@value": "Safeguarding America\u2019s Pharmaceuticals Act of 2013/s:2", "@proposed": "true"}, {"#tail": ".", "@entity-type": "act", "#text": "section\n\t\t\t 581", "@value": "Federal Food, Drug, and Cosmetic Act/s:581", "@proposed": "true"}], "#text": "The terms defined in ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "#text": "\n          ", "@id": "H5280CC7D1C944A5D805EA73C934BFEB2", "@commented": "no"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", acting\n\t\t\t through the ", "@entity-type": "federal-body", "#text": "Secretary of Health and Human Services", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "federal-body", "#text": "Commissioner of Food and Drugs", "@entity-id": "7524"}], "term": {"#tail": " means the ", "#text": "Secretary"}, "#text": "The term\n\t\t\t "}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "#text": "\n          ", "@id": "HA0578AE80A3343D2A081CD2C2DC99512", "@commented": "no"}], "#text": "\n        ", "@id": "HB98139E427144BE8993EAFB55AA03FA2", "@commented": "no"}], "#text": "\n      ", "@id": "HA83B5AC46DD248C5807C0CAD38E0EBCE"}, {"#tail": "\n    ", "enum": {"#tail": "\n      ", "#text": "4."}, "header": {"#tail": "\n\t\t\t", "#text": "National standards for\n\t\t\t wholesale distributors"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is\n\t\t\t amended\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Chapter\n\t\t\t V of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/ch:V"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 351 et seq.", "@value": "usc/21/351/etseq"}, "@parsable-cite": "usc/21/351", "#text": "\n              ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "Standards"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "quote": [{"#tail": " and all that follows through\n\t\t\t ", "#text": "(e)(1)(A)"}, {"#tail": " and\n\t\t\t inserting the following:", "#text": "(3) For the purposes of this subsection and subsection (d)\u2014"}], "#text": "in ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ", by striking ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "section 503", "@value": "Federal Food, Drug, and Cosmetic Act/s:503"}, {"#tail": ")", "@entity-type": "uscode", "#text": "21 U.S.C.\n\t\t\t 353", "@value": "usc/21/353"}], "@entity-type": "law-citation", "#text": "\n              "}}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "quoted-block": {"@style": "OLC", "@committee-id": "HIF00", "@changed": "added", "after-quoted-block": {"#tail": "\n          ", "#text": ";"}, "#tail": "\n\t\t\t\t", "@reported-display-style": "italic", "subsection": {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\u2014", "@entity-type": "act", "#text": "subsection\n\t\t\t\t(d)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503/ss:d"}, "#text": "For purposes of ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(e)"}, "@id": "H12FCCE5BCACE4C8DB72BD10C15BBBD1E", "#text": "\n              "}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t\t", "@id": "H170B0A932CBB4052B944296304AF67C3"}, "#text": "\n          ", "@id": "H7C27A70A6FD74C2C8890DEF75CD94F14"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " as ", "@entity-type": "act", "#text": "subparagraphs (A) and (B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503/ss:e/p:1/sp:A, B"}, {"#tail": ",\n\t\t\t respectively; and", "@entity-type": "act", "#text": "paragraphs (1) and (2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503/ss:e/p:1, 2", "@proposed": "true"}], "#text": "in ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ", by\n\t\t\t redesignating ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 503(e)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503/ss:e"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "uscode", "#text": "21 U.S.C. 353(e)", "@value": "usc/21/353/e"}, "@parsable-cite": "usc/21/353", "#text": "\n                ", "@legal-doc": "usc"}}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "@id": "HCC7E43279166433A9CC257C39AD6560C", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", by adding at the end the following:", "@entity-type": "act", "#text": "section 2", "@value": "Safeguarding America\u2019s Pharmaceuticals Act of 2013/s:2", "@proposed": "true"}, "#text": "in subchapter H, as added\n\t\t\t by "}, "enum": {"#tail": "\n          ", "#text": "(3)"}, "quoted-block": {"@style": "OLC", "@committee-id": "HIF00", "@changed": "added", "after-quoted-block": {"#tail": "\n          ", "#text": "."}, "#tail": "\n\t\t\t\t", "section": {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "583."}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "National standards for\n\t\t\t\twholesale distributors"}, "subsection": [{"#tail": "\n              ", "enum": {"#tail": "\n                ", "#text": "(a)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Standards"}, "paragraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall establish, by regulation, standards\n\t\t\t\tfor the licensing of persons that make wholesale distributions.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The "}, "enum": {"#tail": "\n                  ", "#text": "(1)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n                  ", "@id": "HBAFC4423E48A47FDBA62D75C44645555"}, {"#tail": "\n                ", "@id": "H5FDE0A61D761408785E78B15B4696AA2", "enum": {"#tail": "\n                  ", "#text": "(2)"}, "header": {"#tail": "\n                  ", "#text": "Requirements"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall, with respect to wholesale distributions,\n\t\t\t\tinclude requirements for\u2014", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:583/ss:a/p:1", "@proposed": "true"}, "#text": "The\n\t\t\t\tstandards under "}, "#text": "\n                  ", "subparagraph": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", including facility\n\t\t\t\trequirements;", "@entity-type": "act", "#text": "section 503(b)(1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503/ss:b/p:1"}, "#text": "the storage and\n\t\t\t\thandling of drugs subject to "}, "enum": {"#tail": "\n                    ", "#text": "(A)"}, "@id": "HF5394A33239847FCB0A0EA6360B3F148", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the establishment and\n\t\t\t\tmaintenance of records of the distributions of such drugs;"}, "enum": {"#tail": "\n                    ", "#text": "(B)"}, "@id": "HA75E231FA74A4AF8A18E0FBB203FD626", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "act", "#text": "paragraph\n\t\t\t\t(3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:583/ss:a/p:3", "@proposed": "true"}, "#text": "the furnishing of\n\t\t\t\ta bond or other equivalent means of security in accordance with "}, "enum": {"#tail": "\n                    ", "#text": "(C)"}, "#text": "\n                    ", "@id": "HA84936C90E77478C80E9D3DF903CB4B3", "@commented": "no"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "mandatory background\n\t\t\t\tchecks and fingerprinting of facility managers or designated\n\t\t\t\trepresentatives;"}, "enum": {"#tail": "\n                    ", "#text": "(D)"}, "@id": "H5D93D89CA3674C9CA7AA97B868017A6E", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the establishment and\n\t\t\t\timplementation of qualifications for key personnel;"}, "enum": {"#tail": "\n                    ", "#text": "(E)"}, "@id": "H9A611F419314496C9783F4577A508B9E", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the mandatory physical\n\t\t\t\tinspection of any facility to be used in wholesale distribution within a\n\t\t\t\treasonable timeframe from the initial application for licensure of the\n\t\t\t\twholesale distributor; and"}, "enum": {"#tail": "\n                    ", "#text": "(F)"}, "@id": "H50843A6AF17749639EAE7BF5E2A16C9D", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", the prohibition of certain persons from engaging in wholesale\n\t\t\t\tdistribution.", "@entity-type": "act", "#text": "paragraph (5)", "@value": "Federal Food, Drug, and Cosmetic Act/s:583/ss:a/p:5", "@proposed": "true"}, "#text": "in accordance with\n\t\t\t\t"}, "enum": {"#tail": "\n                    ", "#text": "(G)"}, "@id": "H93E8D01553C44ABB9DF395A034A03F70", "#text": "\n                    "}]}, {"#tail": "\n                ", "@id": "H9452CCACFA75463D857316189BEE1AA3", "enum": {"#tail": "\n                  ", "#text": "(3)"}, "header": {"#tail": "\n                  ", "#text": "Bond or other\n\t\t\t\tsecurity"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall provide\n\t\t\t\tfor the following:", "@entity-type": "act", "#text": "paragraph (2)(C)", "@value": "Federal Food, Drug, and Cosmetic Act/s:583/ss:a/p:2/sp:C", "@proposed": "true"}, "#text": "The requirements under "}, "#text": "\n                  ", "subparagraph": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "An applicant that is not\n\t\t\t\ta government-owned-and-operated wholesale distributor, for the issuance or\n\t\t\t\trenewal of a wholesale distributor license, shall submit a surety bond of\n\t\t\t\t$100,000 or other equivalent means of security acceptable to the applicable\n\t\t\t\tlicensing authority."}, "enum": {"#tail": "\n                    ", "#text": "(A)"}, "#text": "\n                    ", "@id": "H3CEDA7D6693340F2B6E8909C425D2F1A", "@commented": "no"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", the applicable licensing authority may accept a surety bond\n\t\t\t\tless than $100,000 if the annual gross receipts of the previous tax year for\n\t\t\t\tthe wholesale distributor is $10,000,000 or less, in which case the surety bond\n\t\t\t\tmay not be less than $25,000.", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:583/ss:a/p:3/sp:A", "@proposed": "true"}, "#text": "For purposes of\n\t\t\t\t"}, "enum": {"#tail": "\n                    ", "#text": "(B)"}, "#text": "\n                    ", "@id": "H4952E3C450EB46F8A7682E240EC14F09", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "If a wholesale\n\t\t\t\tdistributor can provide evidence that it possesses the required bond in a\n\t\t\t\tState, the requirement for a bond in another State is waived."}, "enum": {"#tail": "\n                    ", "#text": "(C)"}, "#text": "\n                    ", "@id": "HA11CAC7853AA411B9C9AE77EE77022D6", "@commented": "no"}], "@commented": "no"}, {"#tail": "\n                ", "@id": "H887FA4A13C5340B0A817E0D18BB1E073", "enum": {"#tail": "\n                  ", "#text": "(4)"}, "header": {"#tail": "\n                  ", "#text": "Inspections"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the ", "@entity-type": "act", "#text": "paragraph (2)(F)", "@value": "Federal Food, Drug, and Cosmetic Act/s:583/ss:a/p:2/sp:F", "@proposed": "true"}, {"#tail": " may\n\t\t\t\tconduct the inspection, or may accept an inspection by\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "To\n\t\t\t\tsatisfy the inspection requirement under "}, "#text": "\n                  ", "subparagraph": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the government of the\n\t\t\t\tState in which the facility is located; or"}, "enum": {"#tail": "\n                    ", "#text": "(A)"}, "@id": "H031BE44DC700441F8232D7EC7A822363", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "a third-party\n\t\t\t\taccreditation or inspection service approved by the "}, "enum": {"#tail": "\n                    ", "#text": "(B)"}, "@id": "H483009ABE8254BBB829CFB506B496DE8", "#text": "\n                    "}], "@commented": "no"}, {"#tail": "\n              ", "@id": "H2C5CE7B01F614FE5A67BBC6471573919", "enum": {"#tail": "\n                  ", "#text": "(5)"}, "header": {"#tail": "\n                  ", "#text": "Prohibited\n\t\t\t\tpersons"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall include\n\t\t\t\trequirements to prohibit a person from receiving or maintaining licensure for\n\t\t\t\twholesale distribution if the person\u2014", "@entity-type": "act", "#text": "paragraph (2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:583/ss:a/p:2", "@proposed": "true"}, "#text": "The requirements under "}, "#text": "\n                  ", "subparagraph": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or ", "@entity-type": "act", "#text": "section 301(i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:301/ss:i"}, {"#tail": "; or any felony violation of ", "@entity-type": "act", "#text": "301(k)", "@value": "Federal Food, Drug, and Cosmetic Act/s:301/ss:k"}, {"#tail": ", relating to prescription drug product\n\t\t\t\ttampering; or", "@entity-type": "uscode", "#text": "section 1365\n\t\t\t\tof title 18, United States Code", "@value": "usc/18/1365"}], "#text": "has been convicted\n\t\t\t\tof any felony for conduct relating to wholesale distribution; any felony\n\t\t\t\tviolation of "}, "enum": {"#tail": "\n                    ", "#text": "(A)"}, "@id": "HA847C1A0A226465AB95D26904F994543", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "has engaged in a pattern\n\t\t\t\tof violating the requirements of this section that presents a threat of serious\n\t\t\t\tadverse health consequences or death to humans."}, "enum": {"#tail": "\n                    ", "#text": "(B)"}, "@id": "H1B7198CB6A054B269DADCEE60D25B552", "#text": "\n                    "}]}], "#text": "\n                ", "@id": "HC36F197C1D6A45F9A7E1EBD6C2798DC6", "@commented": "no"}, {"#tail": "\n              ", "enum": {"#tail": "\n                ", "#text": "(b)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Reporting by licensed\n\t\t\t\twholesale distributors"}, "paragraph": [{"#tail": "\n                ", "@id": "HD9C435BF89C545ACA8E972973E03DC54", "enum": {"#tail": "\n                  ", "#text": "(1)"}, "header": {"#tail": "\n                  ", "#text": "Annual\n\t\t\t\treport"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " including\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Beginning not later than 1 year after the date of the\n\t\t\t\tenactment of this section, each person engaged in wholesale distribution in\n\t\t\t\tinterstate commerce shall submit on an annual basis, and update as necessary, a\n\t\t\t\treport to the "}, "#text": "\n                  ", "subparagraph": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the wholesale\n\t\t\t\tdistributor\u2019s name;"}, "enum": {"#tail": "\n                    ", "#text": "(A)"}, "#text": "\n                    ", "@id": "HDB039225E892414A9F200CCA75866846", "@commented": "no"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the wholesale\n\t\t\t\tdistributor\u2019s address;"}, "enum": {"#tail": "\n                    ", "#text": "(B)"}, "#text": "\n                    ", "@id": "HF41D86EF43054CF5A448EA743B02A1BA", "@commented": "no"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "a listing of each State\n\t\t\t\tin which the wholesale distributor is licensed for wholesale distribution;\n\t\t\t\tand"}, "enum": {"#tail": "\n                    ", "#text": "(C)"}, "#text": "\n                    ", "@id": "HB8E7849F4DB44E90A993C46B0A5E5760", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "any disciplinary actions\n\t\t\t\ttaken by a State, the Federal Government, or a foreign government during the\n\t\t\t\treporting period against the wholesale distributor."}, "enum": {"#tail": "\n                    ", "#text": "(D)"}, "#text": "\n                    ", "@id": "H27DCEB529B584F2BB2F46E91F9B134B3", "@commented": "no"}], "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall post on the public Internet Website\n\t\t\t\tof the Food and Drug Administration the name of each wholesale distributor, and\n\t\t\t\tthe State in which each such distributor is licensed, based on reports under\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:583/ss:b/p:1", "@proposed": "true"}], "#text": "The "}, "enum": {"#tail": "\n                  ", "#text": "(2)"}, "header": {"#tail": "\n                  ", "#text": "Posting on\n\t\t\t\tInternet"}, "#text": "\n                  ", "@id": "H6B5656018F3945A2AAA3B954EE6A24DB", "@commented": "no"}], "#text": "\n                ", "@id": "H53975084302E47478E2B26956E51F889", "@commented": "no"}, {"continuation-text": {"#tail": "\n              ", "@continuation-text-level": "subsection", "#text": "so\n\t\t\t\tlong as the State does not require such licensure to the extent to which an\n\t\t\t\tentity is engaged in third-party logistics provider activities.", "@commented": "no"}, "#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "This subchapter does not prohibit a State from\u2014"}, "enum": {"#tail": "\n                ", "#text": "(c)"}, "header": {"#tail": "\n                ", "#text": "Preservation of State\n\t\t\t\tauthority"}, "paragraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "licensing wholesale\n\t\t\t\tdistributors for the conduct of wholesale distribution activities in the State\n\t\t\t\tin accordance with this subchapter; and"}, "enum": {"#tail": "\n                  ", "#text": "(1)"}, "#text": "\n                  ", "@id": "H89DDC7ECB6774C56A1AF8500F0F22F3E", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "collecting fees from\n\t\t\t\twholesale distributors in connection with such licensing,"}, "enum": {"#tail": "\n                  ", "#text": "(2)"}, "#text": "\n                  ", "@id": "H8516ED33E46249ECA9D4D62A346A28CF", "@commented": "no"}], "#text": "\n                ", "@id": "H41B048640BA746A2B66555E40237DD34", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " to a person other than a\n\t\t\t\tconsumer or patient, but does not include\u2014", "@entity-type": "act", "#text": "section 503(b)(1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503/ss:b/p:1"}, "term": {"#tail": " means the\n\t\t\t\tdistribution of a drug subject to ", "#text": "wholesale distribution"}, "#text": "In\n\t\t\t\tthis section, the term "}, "enum": {"#tail": "\n                ", "#text": "(d)"}, "header": {"#tail": "\n                ", "#text": "Definition"}, "paragraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ");", "@entity-type": "act", "#text": "section\n\t\t\t\t1504(a) of the Internal Revenue Code of 1986", "@value": "Internal Revenue Code of 1986/s:1504/ss:a"}, "#text": "intracompany distribution\n\t\t\t\tof any drug between members of an affiliated group (as defined in "}, "enum": {"#tail": "\n                  ", "#text": "(1)"}, "@id": "HD91E7CB11C974B0B8E98E6B4567A5088", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the distribution of a\n\t\t\t\tdrug, or an offer to distribute a drug among hospitals or other health care\n\t\t\t\tentities which are under common control;"}, "enum": {"#tail": "\n                  ", "#text": "(2)"}, "@id": "H9AB11D311D594A5481598603FA77C4E7", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", except that a drug shortage not caused by a public\n\t\t\t\thealth emergency shall not constitute such an emergency medical reason;", "@entity-type": "act", "#text": "section 319 of the\n\t\t\t\tPublic Health Service Act", "@value": "Public Health Service Act/s:319"}, "#text": "the distribution\n\t\t\t\tof a drug or an offer to distribute a drug for emergency medical reasons,\n\t\t\t\tincluding a public health emergency declaration pursuant to "}, "enum": {"#tail": "\n                  ", "#text": "(3)"}, "@id": "H6B3F9FA13A014EFB8EC23E1D74DCC4A8", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "act", "#text": "section\n\t\t\t\t503(b)(1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503/ss:b/p:1"}, "#text": "dispensing of a\n\t\t\t\tdrug pursuant to a valid prescription executed in accordance with sub"}, "enum": {"#tail": "\n                  ", "#text": "(4)"}, "@id": "H0626EC9C504D4569BC3F6CB56E33F7D7", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the distribution of\n\t\t\t\tminimal quantities of drug by a licensed retail pharmacy to a licensed\n\t\t\t\tpractitioner for office use;"}, "enum": {"#tail": "\n                  ", "#text": "(5)"}, "@id": "H6F78E0AC60BC4DAAAA224FDEC5B5859E", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the distribution of a\n\t\t\t\tdrug or an offer to distribute a drug by a charitable organization to a\n\t\t\t\tnonprofit affiliate of the organization to the extent otherwise permitted by\n\t\t\t\tlaw;"}, "enum": {"#tail": "\n                  ", "#text": "(6)"}, "@id": "H70E15890E7634B22AA47A98D02D0EAFB", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the purchase or other\n\t\t\t\tacquisition by a dispenser, hospital, or other health care entity of a drug for\n\t\t\t\tuse by such dispenser, hospital, or other health care entity;"}, "enum": {"#tail": "\n                  ", "#text": "(7)"}, "@id": "H2BA919A74C6C42779E5CFA488419EA62", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the distribution of a\n\t\t\t\tdrug by the manufacturer of such drug;"}, "enum": {"#tail": "\n                  ", "#text": "(8)"}, "@id": "HCD6E01B42AB64CDA8107B35A91440253", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the receipt or transfer\n\t\t\t\tof a drug by an authorized third-party logistics provider provided that such\n\t\t\t\tthird-party logistics provider does not take ownership of the drug;"}, "enum": {"#tail": "\n                  ", "#text": "(9)"}, "@id": "H8B21E3CAE8F946C0B0179527B2D6B5B7", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the transport of a drug\n\t\t\t\tby a common carrier, provided that the common carrier does not take ownership\n\t\t\t\tof the drug;"}, "enum": {"#tail": "\n                  ", "#text": "(10)"}, "@id": "H1190347793C34E68A122909C26CDD88D", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "act", "#text": "section\n\t\t\t\t582(e)", "@value": "Public Health Service Act/s:582/ss:e", "@proposed": "true"}, "#text": "the distribution\n\t\t\t\tof a drug, or an offer to distribute a drug, by an authorized repackager that\n\t\t\t\thas taken ownership of the drug and repacked it in accordance with "}, "enum": {"#tail": "\n                  ", "#text": "(11)"}, "@id": "H50E02B09443F40EF83554823B9C8AAA0", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "saleable drug returns\n\t\t\t\twhen conducted by a dispenser in accordance with ", "external-xref": {"#tail": " of title 21,\n\t\t\t\tCode of Federal Regulations (or any successor regulation);", "@parsable-cite": "usc/21/203", "#text": "section 203.23", "@legal-doc": "usc"}}, "enum": {"#tail": "\n                  ", "#text": "(12)"}, "@id": "HC6436E4A56C7452BBC7A592B7372DDCE", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "act", "#text": "section\n\t\t\t\t581(20)(B)(xiii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:581/p:20/sp:B/cl:xiii", "@proposed": "true"}, "#text": "the distribution\n\t\t\t\tof a combination prescription drug product described in "}, "enum": {"#tail": "\n                  ", "#text": "(13)"}, "#text": "\n                  ", "@id": "H98E2F1C8453947D3A97F67C6CCD98AD9", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "act", "#text": "section 581(21)(B)(xiv)", "@value": "Federal Food, Drug, and Cosmetic Act/s:581/p:21/sp:B/cl:xiv", "@proposed": "true"}, "#text": "the distribution\n\t\t\t\tof a medical convenience kit described in "}, "enum": {"#tail": "\n                  ", "#text": "(14)"}, "@id": "H2A2797C9FE9644228E0FDBB4DEF3619F", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the distribution of an\n\t\t\t\tintravenous drug that, by its formulation, is intended for the replenishment of\n\t\t\t\tfluids and electrolytes (such as sodium, chloride, and potassium) or calories\n\t\t\t\t(such as dextrose and amino acids);"}, "enum": {"#tail": "\n                  ", "#text": "(15)"}, "@id": "H16BAB91B59E843DCABF59D0567144135", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the distribution of an\n\t\t\t\tintravenous drug used to maintain the equilibrium of water and minerals in the\n\t\t\t\tbody, such as dialysis solutions;"}, "enum": {"#tail": "\n                  ", "#text": "(16)"}, "@id": "H68205AA83BEB4C93A1978F4D931471D6", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the distribution of a\n\t\t\t\tdrug that is intended for irrigation or reconstitution, or sterile water,\n\t\t\t\twhether intended for such purposes or for injection;"}, "enum": {"#tail": "\n                  ", "#text": "(17)"}, "@id": "H063A2A9CC90F474E8081C9B05BF59805", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ");", "@entity-type": "act", "#text": "section 581(21)(C)", "@value": "Federal Food, Drug, and Cosmetic Act/s:581/p:21/sp:C", "@proposed": "true"}, "#text": "the distribution of\n\t\t\t\tcompressed medical gas (as defined in "}, "enum": {"#tail": "\n                  ", "#text": "(18)"}, "@id": "HF1E0EAC16C99470F944236DA4DCCE3B2", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "facilitating the\n\t\t\t\tdistribution of a prescription drug product by providing administrative\n\t\t\t\tservices, such as processing of orders and payments, without physical handling,\n\t\t\t\tdistribution, or storage of a prescription drug product; or"}, "enum": {"#tail": "\n                  ", "#text": "(19)"}, "@id": "H00EEC060EDFC465B9BD7878E52859AE6", "#text": "\n                  "}, {"#tail": "\n              ", "subparagraph": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the distribution of a\n\t\t\t\tproduct by a dispenser, or a wholesale distributor acting at the direction of\n\t\t\t\tthe dispenser, to a repackager registered under section 510 for the purpose of\n\t\t\t\trepackaging the drug for use by that dispenser or another health care entity\n\t\t\t\tthat is under the dispenser\u2019s ownership or control, so long as the dispenser\n\t\t\t\tretains ownership of the prescription drug product; and"}, "enum": {"#tail": "\n                    ", "#text": "(A)"}, "@display-inline": "yes-display-inline", "#text": "\n                    ", "@id": "HAC25CFDAA817449CA709CD8F43AA5F6D", "@commented": "no"}, {"@committee-id": "HIF00", "@changed": "added", "@indent": "up1", "#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the saleable or nonsaleable return by such\n\t\t\t\trepackager of such prescription drug product.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(B)"}, "@reported-display-style": "italic", "#text": "\n                    ", "@id": "HFC4E2A0C2DB24B458C93B9998A327415"}], "enum": {"#tail": "\n                  ", "#text": "(20)"}, "@id": "HFAC457C63A0D495D8B7020EFE6F1C850", "#text": "\n                  "}], "#text": "\n                ", "@id": "HB459511103C64E97A95B55F873AEA490"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall take effect\n\t\t\t\tnot later than 2 years after the date of the enactment of this section. The\n\t\t\t\t", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:583/ss:a", "@proposed": "true"}, {"#tail": " shall issue the regulations required by ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " not later than\n\t\t\t\t1 year after the date of the enactment of this\n\t\t\t\tAct.", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:583/ss:a", "@proposed": "true"}], "#text": "The standards required by "}, "enum": {"#tail": "\n                ", "#text": "(e)"}, "header": {"#tail": "\n                ", "#text": "Effective\n\t\t\t\tdate"}, "#text": "\n                ", "@id": "HB7AD84D4B5A846508E38957E7007A2DE"}], "#text": "\n              ", "@id": "H5CFA7030195A429B9E0C33E1B51C0308"}, "@reported-display-style": "italic", "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t\t", "@id": "H29DA8FB595C4417EA3B7A9B1B262D183"}, "#text": "\n          ", "@id": "HFDE25CBA8C954DD4AC4A60CD1C51277F"}], "#text": "\n        ", "@id": "HCD3ADFF8C80D431199A709BCD6F1B1E8"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "quote": [{"#tail": " and inserting ", "#text": "503(e)(2)(A)"}, {"#tail": ".", "#text": "583(a)"}], "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by striking\n\t\t\t ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 804(a)(5)(A) of the Federal Food, Drug, and\n\t\t\t Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:804/ss:a/p:5/sp:A"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 384(a)(5)(A)", "@value": "usc/21/384/a/5/A"}, "@parsable-cite": "usc/21/384", "#text": "\n              ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Conforming\n\t\t\t amendment"}, "#text": "\n        ", "@id": "H5B71084C1EB24C3D8A6393D040BDDA1D"}], "#text": "\n      ", "@id": "H275CD30A7EED4A5C864C253ABCAEFE7D"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", as amended by ", "@entity-type": "act", "#text": "Subchapter H of chapter V of the Federal\n\t\t\t Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/ch:V/sch:H", "@proposed": "true"}, {"#tail": ", is further amended by\n\t\t\t adding at the end the following:", "@entity-type": "act", "#text": "section 4", "@value": "Safeguarding America\u2019s Pharmaceuticals Act of 2013/s:4", "@proposed": "true"}], "#text": "\n        ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "5."}, "header": {"#tail": "\n      ", "#text": "National licensure\n\t\t\t standards for third-party logistics providers"}, "quoted-block": {"@style": "OLC", "@committee-id": "HIF00", "@changed": "added", "after-quoted-block": {"#tail": "\n      ", "#text": "."}, "#tail": "\n\t\t", "section": {"#tail": "\n        ", "enum": {"#tail": "\n          ", "#text": "584."}, "header": {"#tail": "\n\t\t\t\t\t", "#text": "National licensure\n\t\t\t\tstandards for third-party logistics providers"}, "subsection": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "No facility may engage in the activities of a\n\t\t\t\tthird-party logistics provider in any State unless\u2014"}, "enum": {"#tail": "\n            ", "#text": "(a)"}, "header": {"#tail": "\n            ", "#text": "License\n\t\t\t\trequirement"}, "paragraph": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "the facility is\n\t\t\t\tlicensed\u2014"}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "#text": "\n              ", "@id": "HE5491D6444AC48D8B09835A6D2C76729", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "by the State from which the drug is\n\t\t\t\tdistributed by the third-party logistics provider in accordance with a\n\t\t\t\tqualified licensing program, if the State has such a program; or", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "H8C7721E9BD4C49E798F7BCF4BAF5D37F", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n\t\t\t\tunder this section, if the State from which the drug is distributed does not\n\t\t\t\thave such a program; and", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "by the "}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "HFE9ED9B090394A8AA4774EA00E8E4FD0", "#text": "\n                "}]}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ", registers\n\t\t\t\twith the State into which the drug is distributed if such State requires such\n\t\t\t\tregistration.", "@entity-type": "act", "#text": "paragraph (1)(B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:584/ss:a/p:1/sp:B", "@proposed": "true"}], "#text": "if the drug is distributed interstate and\n\t\t\t\tthe facility is not licensed by the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(2)"}, "@id": "HCEF59246D9FB439B9CF7198517EFFDC6", "#text": "\n              "}], "#text": "\n            ", "@id": "H92830846BBF74D1989C8CE0152A55D69"}, {"#tail": "\n          ", "enum": {"#tail": "\n            ", "#text": "(b)"}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "Reporting by licensed\n\t\t\t\tthird-Party logistics providers"}, "paragraph": [{"#tail": "\n            ", "@id": "HA002C5BE131B4DC0AA68E45C47D2330B", "enum": {"#tail": "\n              ", "#text": "(1)"}, "header": {"#tail": "\n              ", "#text": "Annual\n\t\t\t\treport"}, "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " including\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Beginning not later than 1 year after the date of the\n\t\t\t\tenactment of this section, each facility engaged in the activities of a\n\t\t\t\tthird-party logistics provider shall submit on an annual basis, and update as\n\t\t\t\tnecessary, a report to the "}, "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "the facility\u2019s\n\t\t\t\tname;"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "#text": "\n                ", "@id": "H258A20179FED4432B3ABD404188F6E80", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "the facility\u2019s\n\t\t\t\taddress;"}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "#text": "\n                ", "@id": "H8BA2A0D45EF444A3A5CB5950FF4DBFCC", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "a listing of each\n\t\t\t\tjurisdiction (whether State or Federal) in which the facility is licensed for\n\t\t\t\tthird-party logistics provider activities; and"}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "#text": "\n                ", "@id": "HF4CA0E778A59444B8CF78D177C66A0AE", "@commented": "no"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "any disciplinary actions\n\t\t\t\ttaken by a State or Federal licensing authority during the reporting period\n\t\t\t\tagainst the facility."}, "enum": {"#tail": "\n                ", "#text": "(D)"}, "#text": "\n                ", "@id": "H6E6C3EEE4B3248C1945844B0967A84ED", "@commented": "no"}], "@commented": "no"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall\n\t\t\t\tpost on the public Internet Website of the Food and Drug Administration the\n\t\t\t\tname of each third-party logistics provider, and each jurisdiction (whether\n\t\t\t\tState or Federal) in which the provider is licensed, based on reports under\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:584/ss:b/p:1", "@proposed": "true"}], "#text": "The ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(2)"}, "header": {"#tail": "\n              ", "#text": "Posting on\n\t\t\t\tInternet"}, "#text": "\n              ", "@id": "H99BB7DE3F76441458BC4A240C9746381", "@commented": "no"}], "#text": "\n            ", "@id": "HCF21C4019B554816B7A85C0B8EC4056C", "@commented": "no"}, {"continuation-text": {"#tail": "\n          ", "@continuation-text-level": "subsection", "#text": "so\n\t\t\t\tlong as the State does not require such licensure to the extent to which an\n\t\t\t\tentity is engaged in wholesale distribution.", "@commented": "no"}, "#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "This subchapter does not prohibit a State from\u2014"}, "enum": {"#tail": "\n            ", "#text": "(c)"}, "header": {"#tail": "\n            ", "#text": "Preservation of State\n\t\t\t\tauthority"}, "paragraph": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "licensing third-party\n\t\t\t\tlogistic providers for the conduct of third-party logistics provider activities\n\t\t\t\tin the State in accordance with this subchapter; and"}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "#text": "\n              ", "@id": "H575F00FD118E4E148D80EF6D15E6F2EE", "@commented": "no"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "collecting fees from\n\t\t\t\tthird-party logistics providers in connection with such licensing,"}, "enum": {"#tail": "\n              ", "#text": "(2)"}, "#text": "\n              ", "@id": "HAE43DC96D21B428B989425D0FD07A923", "@commented": "no"}], "#text": "\n            ", "@id": "H938AC643E9FB45CFAE2122CBC6BFDB62", "@commented": "no"}, {"#tail": "\n          ", "enum": {"#tail": "\n            ", "#text": "(d)"}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "Costs"}, "paragraph": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " under\n\t\t\t\tthis section, the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " may assess and collect a reasonable fee in an\n\t\t\t\tamount equal to the costs to the Federal Government of establishing and\n\t\t\t\tadministering the licensure program established, and conducting period\n\t\t\t\tinspections, under this section.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "In the case of a facility engaging in the\n\t\t\t\tactivities of a third-party logistics provider licensed by the "}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "header": {"#tail": "\n              ", "#text": "Authorized licensure\n\t\t\t\tfees"}, "#text": "\n              ", "@id": "H8614E0572C324C84A50C7DD18BD89033"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall adjust the amount of the fee under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " on an annual\n\t\t\t\tbasis, if necessary, to generate an amount of revenue equal to the costs\n\t\t\t\treferred to in such paragraph.", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:584/ss:d/p:1", "@proposed": "true"}], "#text": "The\n\t\t\t\t"}, "enum": {"#tail": "\n              ", "#text": "(2)"}, "header": {"#tail": "\n              ", "#text": "Adjustment"}, "#text": "\n              ", "@id": "HB0BBF0A5C29E479B847A032AC67F6D13"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "Fees assessed and collected under this\n\t\t\t\tsubsection shall be available for obligation only to the extent and in the\n\t\t\t\tamount provided in advance in appropriations Acts. Such fees shall remain\n\t\t\t\tavailable until expended.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(3)"}, "header": {"#tail": "\n              ", "#text": "Availability"}, "#text": "\n              ", "@id": "HCA4D688FE2CD4328B2100D9F54D189E5"}], "#text": "\n            ", "@id": "H4F50F234C59E421C85A3344E1921EB2C"}, {"#tail": "\n          ", "enum": {"#tail": "\n            ", "#text": "(e)"}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "License\n\t\t\t\tregulations"}, "paragraph": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall establish, by regulation, standards,\n\t\t\t\tterms, and conditions for licensing persons to engage in third-party logistics\n\t\t\t\tprovider activities.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The "}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "header": {"#tail": "\n              ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n              ", "@id": "H091C7803337C4538B631B71C06460078"}, {"#tail": "\n          ", "@id": "HB0C273221D1B4881999BB44BEAF0A6A7", "enum": {"#tail": "\n              ", "#text": "(2)"}, "header": {"#tail": "\n              ", "#text": "Content"}, "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall\u2014", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:584/ss:e/p:1", "@proposed": "true"}, "#text": "The\n\t\t\t\tregulations under "}, "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "include standards relating to eligibility\n\t\t\t\tfor, and revocation and reissuance of, licenses;", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "H410D17A8006D46F29ABD80F9E42C5B7A", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", issue a license to the\n\t\t\t\tprovider;", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "establish a\n\t\t\t\tprocess by which the applicable licensing authority will, upon request by a\n\t\t\t\tthird-party logistics provider that is accredited by a third-party\n\t\t\t\taccreditation program approved by the "}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "HED0832026CB74D129921DD1796C1E1C7", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall issue a license to a third-party logistics\n\t\t\t\tprovider if the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " is not able to approve a third-party accreditation\n\t\t\t\tprogram because no such program meets the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": "\u2019s requirements necessary\n\t\t\t\tfor approval of such a third-party accreditation program;", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "establish a\n\t\t\t\tprocess by which the "}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "@id": "H978ED554418E4857BE1E8586D8A794E4", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", at the provider\u2019s facilities, including\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "require that the\n\t\t\t\tthird-party logistics provider comply with storage practices, as determined by\n\t\t\t\tthe "}, "enum": {"#tail": "\n                ", "#text": "(D)"}, "clause": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "maintaining access to\n\t\t\t\twarehouse space of suitable size to facilitate safe operations, including a\n\t\t\t\tsuitable area to quarantine suspect prescription drug product;"}, "enum": {"#tail": "\n                  ", "#text": "(i)"}, "@id": "H2A2CE550C25D48D1BAFA700F23E1C36C", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "maintaining adequate\n\t\t\t\tsecurity; and"}, "enum": {"#tail": "\n                  ", "#text": "(ii)"}, "@id": "HFCE23539E9284DC59B8B0E9213A72676", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "having written policies\n\t\t\t\tand procedures to\u2014"}, "enum": {"#tail": "\n                  ", "#text": "(iii)"}, "subclause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "address receipt,\n\t\t\t\tsecurity, storage, inventory, shipment, and distribution of a prescription drug\n\t\t\t\tproduct;"}, "enum": {"#tail": "\n                    ", "#text": "(I)"}, "@id": "HDC4AAB082EBC4262A227946799F818CA", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "identify, record, and\n\t\t\t\treport confirmed losses or thefts in the United States;"}, "enum": {"#tail": "\n                    ", "#text": "(II)"}, "@id": "HD7C2BFA221DF40D2B87372F48894927F", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "correct errors and\n\t\t\t\tinaccuracies in inventories;"}, "enum": {"#tail": "\n                    ", "#text": "(III)"}, "@id": "H8AFC94D12A0F456A9C89E427ABF15329", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "provide support for\n\t\t\t\tmanufacturer recalls;"}, "enum": {"#tail": "\n                    ", "#text": "(IV)"}, "@id": "H19F637B6F8FE48FF8B1EE220D6DFB4A8", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "prepare for, protect\n\t\t\t\tagainst, and address any reasonably foreseeable crisis that affects security or\n\t\t\t\toperation at the facility, such as a strike, fire, or flood;"}, "enum": {"#tail": "\n                    ", "#text": "(V)"}, "@id": "HA8AB16CAA36A43E0B4E09236A87275F4", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "ensure that any expired\n\t\t\t\tprescription drug product is segregated from other prescription drug products\n\t\t\t\tand returned to the manufacturer or repackager or destroyed;"}, "enum": {"#tail": "\n                    ", "#text": "(VI)"}, "@id": "H7480E13A525A456D88A5AD602A767C76", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "maintain the capability\n\t\t\t\tto electronically trace the receipt and outbound distribution of a prescription\n\t\t\t\tdrug product, and supplies and records of inventory; and"}, "enum": {"#tail": "\n                    ", "#text": "(VII)"}, "@id": "HEDF91CCB07754DDAA8D9609354C51ECE", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "quarantine or destroy\n\t\t\t\ta suspect prescription drug product if directed to do so by the respective\n\t\t\t\tmanufacturer, wholesale distributor, dispenser, or an authorized government\n\t\t\t\tagency;"}, "enum": {"#tail": "\n                    ", "#text": "(VIII)"}, "@id": "H08AA79F48ADA4B78992AF9FAF82133F1", "#text": "\n                    "}], "#text": "\n                  ", "@id": "HF6F678E2DA4C4A0DA6BEE06358B0D100"}], "#text": "\n                ", "@id": "HB6E8AC6713674C30805FBC81622D9736"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", of such facility warehouse\n\t\t\t\tspace to ensure compliance with this section;", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "provide for\n\t\t\t\tperiodic inspection, as determined by the "}, "enum": {"#tail": "\n                ", "#text": "(E)"}, "@id": "H52BE32F3BD8846F6A0E8D59A6C3C1FA3", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or ", "@entity-type": "act", "#text": "section 301(i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:301/ss:i"}, {"#tail": " or any felony violation of\n\t\t\t\t", "@entity-type": "act", "#text": "301(k)", "@value": "Federal Food, Drug, and Cosmetic Act/s:301/ss:k"}, {"#tail": ", relating to prescription drug\n\t\t\t\tproduct tampering;", "@entity-type": "uscode", "#text": "\n                    ", "external-xref": {"#tail": " of title 18, United States Code", "@parsable-cite": "usc/18/1365", "#text": "section 1365", "@legal-doc": "usc"}, "@value": "usc/18/1365"}], "#text": "prohibit a\n\t\t\t\tfacility from having as a manager or designated representative anyone convicted\n\t\t\t\tof any felony violation of "}, "enum": {"#tail": "\n                ", "#text": "(F)"}, "@id": "H0617E57BF6994F58A6B435F9E96DD576", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "perform mandatory\n\t\t\t\tbackground checks of the provider\u2019s facility managers or designated\n\t\t\t\trepresentatives of such managers;"}, "enum": {"#tail": "\n                ", "#text": "(G)"}, "@id": "H3E9B4DF196284D7CBBA04947247B5FD7", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "require a third-party\n\t\t\t\tlogistics provider to provide to the applicable licensing authority, upon the\n\t\t\t\tauthority\u2019s request, a list of all prescription drug product manufacturers,\n\t\t\t\twholesale distributors, and dispensers for whom the third-party logistics\n\t\t\t\tprovider provides services at the provider\u2019s facilities; and"}, "enum": {"#tail": "\n                ", "#text": "(H)"}, "@id": "H903368D1DC054D6CB13FF33AAD6B5D1C", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "include procedures under\n\t\t\t\twhich any third-party logistics provider license\u2014"}, "enum": {"#tail": "\n                ", "#text": "(I)"}, "clause": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "will expire on the date\n\t\t\t\tthat is 3 years after issuance of the license; and"}, "enum": {"#tail": "\n                  ", "#text": "(i)"}, "@id": "H73B353E01ABE4A1B94F4A871419F7CF5", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "may be renewed for\n\t\t\t\tadditional 3-year periods."}, "enum": {"#tail": "\n                  ", "#text": "(ii)"}, "@id": "HE7D34EA2E5524A4CAA26677B083A29EE", "#text": "\n                  "}], "#text": "\n                ", "@id": "H9C9B28341E9341849908A54EF6BFAF54"}]}], "#text": "\n            ", "@id": "HA471407AC79E4560847489157B8AAC00"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", subject to renewal under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ". If the ", "@entity-type": "act", "#text": "subsection (d)", "@value": "Federal Food, Drug, and Cosmetic Act/s:584/ss:d", "@proposed": "true"}, {"#tail": " finds that\n\t\t\t\tthe third-party accreditation program demonstrates that all applicable\n\t\t\t\trequirements for licensure under this section are met, the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " shall\n\t\t\t\tissue a license under this section to a third-party logistics provider\n\t\t\t\treceiving accreditation.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "A license issued under this section shall remain valid as\n\t\t\t\tlong as such third-party logistics provider remains accredited by the\n\t\t\t\t"}, "enum": {"#tail": "\n            ", "#text": "(f)"}, "header": {"#tail": "\n            ", "#text": "Validity of\n\t\t\t\tlicense"}, "#text": "\n            ", "@id": "HC70A113D3D994B5EBD2F2034B3D2B7C1"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "term": {"#tail": " means a program meeting the requirements of this\n\t\t\t\tsection and the regulations thereunder.", "#text": "qualified\n\t\t\t\tlicensing program"}, "#text": "In this section, the term "}, "enum": {"#tail": "\n            ", "#text": "(g)"}, "header": {"#tail": "\n            ", "#text": "Qualified licensing\n\t\t\t\tprogram defined"}, "#text": "\n            ", "@id": "H23FC4ABF3C2940159C56BF24CFF253CD"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "\n\t\t\t\tshall issue the regulations required by ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " not later than 180 days\n\t\t\t\tafter the date of the enactment of this\n\t\t\t\tsection.", "@entity-type": "act", "#text": "subsection (d)", "@value": "Federal Food, Drug, and Cosmetic Act/s:584/ss:d", "@proposed": "true"}], "#text": "The requirements of this section shall take effect not later\n\t\t\t\tthan 1 year after the date of the enactment of this section. The "}, "enum": {"#tail": "\n            ", "#text": "(h)"}, "header": {"#tail": "\n            ", "#text": "Effective\n\t\t\t\tdate"}, "#text": "\n            ", "@id": "HB42FF2C569704CE8ACCF1D61D6F7A208"}], "#text": "\n          ", "@id": "H28ADA15D2FB74E3A8A14A7014C59CE6E"}, "@reported-display-style": "italic", "#text": "\n\t\t\t\t", "@id": "H6E6AD0D4C1144A0097ED6A266811B52E"}, "#text": "\n      ", "@id": "H234964F3A89244CA806374D5863C9AFF"}, {"#tail": "\n    ", "enum": {"#tail": "\n      ", "#text": "6."}, "header": {"#tail": "\n\t\t\t", "#text": "Penalties"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "quote": [{"#tail": " and inserting ", "#text": "or the distribution of drugs\n\t\t\t in violation of section 503(e) or the failure to otherwise comply with the\n\t\t\t requirements of section 503(e)"}, {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", engaging in the wholesale\n\t\t\t distribution of a drug in violation of ", "@entity-type": "act", "#text": "section 582", "@value": "Federal Food, Drug, and Cosmetic Act/s:582", "@proposed": "true"}, {"#tail": " or the failure to otherwise\n\t\t\t comply with the requirements of ", "@entity-type": "act", "#text": "section 583", "@value": "Federal Food, Drug, and Cosmetic Act/s:583", "@proposed": "true"}, {"#tail": ", or engaging in the activities of a\n\t\t\t third-party logistics provider in violation of ", "@entity-type": "act", "#text": "section 583", "@value": "Federal Food, Drug, and Cosmetic Act/s:583", "@proposed": "true"}, {"#tail": " or the failure to\n\t\t\t otherwise comply with the requirements of ", "@entity-type": "act", "#text": "section 584", "@value": "Federal Food, Drug, and Cosmetic Act/s:584", "@proposed": "true"}, {"#tail": "\n          ", "@entity-type": "act", "#text": "section 584", "@value": "Federal Food, Drug, and Cosmetic Act/s:584", "@proposed": "true"}], "#text": "the failure to\n\t\t\t comply with any requirement of "}], "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by striking ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n\t\t\t (", "@entity-type": "act", "#text": "Section 301(t) of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:301/ss:t"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 331(t)", "@value": "usc/21/331/t"}, "@parsable-cite": "usc/21/331", "#text": "\n              ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "Prohibited\n\t\t\t acts"}, "#text": "\n        ", "@id": "H80BF408E5D0F4839989435E6C9F9B60E"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "quote": [{"#tail": " and inserting ", "#text": "503(e)(2)(A)"}, {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or ", "@entity-type": "act", "#text": "583", "@value": "Federal Food, Drug, and Cosmetic Act/s:583", "@proposed": "true"}, {"#tail": "\n          ", "@entity-type": "act", "#text": "584", "@value": "Federal Food, Drug, and Cosmetic Act/s:584", "@proposed": "true"}], "#text": "\n            "}], "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by striking\n\t\t\t ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 303(b)(1)(D) of the Federal\n\t\t\t Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:303/ss:b/p:1/sp:D"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 333(b)(1)(D)", "@value": "usc/21/333/b/1/D"}, "@parsable-cite": "usc/21/333", "#text": "\n              ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Enhanced penalty for\n\t\t\t knowing unlicensed activities"}, "#text": "\n        ", "@id": "HC9768C15A49D4A2CA050BF2A57C1CE4E"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by\n\t\t\t adding at the end the following:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section\n\t\t\t 502 of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:502"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 352", "@value": "usc/21/352"}, "@parsable-cite": "usc/21/352", "#text": "\n              ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n        ", "#text": "(c)"}, "header": {"#tail": "\n        ", "#text": "Misbranding"}, "quoted-block": {"@style": "OLC", "@committee-id": "HIF00", "@changed": "added", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "subsection": {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "section\n\t\t\t\t582", "@value": "Federal Food, Drug, and Cosmetic Act/s:582", "@proposed": "true"}, "#text": "If it is a drug\n\t\t\t\tand it fails to bear a prescription drug product identifier as required by\n\t\t\t\t"}, "enum": {"#tail": "\n            ", "#text": "(bb)"}, "@id": "HAE8A0E11144F4A91897594C221E768D4", "#text": "\n            "}, "@reported-display-style": "italic", "#text": "\n\t\t\t\t\t", "@id": "HC0CE60A8D2E94F49BD5DCFCE9FA56D2D"}, "#text": "\n        ", "@id": "H55C12693660747B98E605D4773592195"}], "#text": "\n      ", "@id": "H98BFCC8873964CF8BC1EA3D5994BAD56"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", as amended by ", "@entity-type": "act", "#text": "Subchapter H of chapter\n\t\t\t V of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/ch:V/sch:H", "@proposed": "true"}, {"#tail": ", is\n\t\t\t further amended by adding at the end the following:", "@entity-type": "act", "#text": "section 5", "@value": "Safeguarding America\u2019s Pharmaceuticals Act of 2013/s:5", "@proposed": "true"}], "#text": "\n        ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "7."}, "header": {"#tail": "\n      ", "#text": "Uniform national\n\t\t\t policy"}, "quoted-block": {"@style": "OLC", "@committee-id": "HIF00", "@changed": "added", "after-quoted-block": {"#tail": "\n      ", "#text": "."}, "#tail": "\n\t\t", "section": {"#tail": "\n        ", "enum": {"#tail": "\n          ", "#text": "585."}, "header": {"#tail": "\n\t\t\t\t\t", "#text": "Uniform national\n\t\t\t\tpolicy"}, "subsection": [{"#tail": "\n          ", "text": {"short-title": {"#tail": ", no State or political subdivision of a State may establish\n\t\t\t\tor continue in effect any requirements for tracing drugs through the\n\t\t\t\tdistribution system (including any requirements with respect to paper or\n\t\t\t\telectronic pedigrees, track and trace, statements of distribution history,\n\t\t\t\ttransaction history, or transaction statements, or verification, investigation,\n\t\t\t\tdisposition, alerts, or recordkeeping relating to the pharmaceutical\n\t\t\t\tdistribution supply chain system) that\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "act", "#text": "Safeguarding America\u2019s Pharmaceuticals Act of\n\t\t\t\t2013", "@value": "Safeguarding America\u2019s Pharmaceuticals Act of 2013", "@proposed": "true"}, "#text": "\n                "}, "#tail": "\n\t\t\t\t\t\t", "#text": "Beginning on the date of the enactment of the\n\t\t\t\t"}, "enum": {"#tail": "\n            ", "#text": "(a)"}, "header": {"#tail": "\n            ", "#text": "Preemption of State\n\t\t\t\tprescription drug product tracing and other\n\t\t\t\trequirements"}, "paragraph": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "are inconsistent with,\n\t\t\t\tmore stringent than, or in addition to any requirements applicable under this\n\t\t\t\tAct; or"}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "@id": "HC91D4EFABAEA4958B6A047DAE4E14C41", "#text": "\n              "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "\n\t\t\t\tunder ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "act", "#text": "section 582(a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:582/ss:a", "@proposed": "true"}], "#text": "are inconsistent\n\t\t\t\twith any applicable waiver, exception, or exemption issued by the "}, "enum": {"#tail": "\n              ", "#text": "(2)"}, "@id": "H73C833C0BA294D018911C61AA9F61973", "#text": "\n              "}], "#text": "\n            ", "@id": "HB4C7040A85754DB78F22A1D12D448C46"}, {"#tail": "\n        ", "enum": {"#tail": "\n            ", "#text": "(b)"}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "Standards or\n\t\t\t\tlicensure"}, "paragraph": [{"#tail": "\n            ", "text": {"short-title": {"#tail": ", no State or political subdivision of a State may establish\n\t\t\t\tor continue any standards, requirements, or regulations with respect to\n\t\t\t\twholesale drug distributor or third-party logistics provider licensure which\n\t\t\t\tare inconsistent with, less stringent than, in addition to, or more stringent\n\t\t\t\tthan, the standards and requirements under this Act.", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                ", "@entity-type": "act", "#text": "Safeguarding America\u2019s Pharmaceuticals Act of\n\t\t\t\t2013", "@value": "Safeguarding America\u2019s Pharmaceuticals Act of 2013", "@proposed": "true"}, "#text": "\n                  "}, "#tail": "\n\t\t\t\t\t\t", "#text": "Beginning on the date of the enactment of\n\t\t\t\t"}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "header": {"#tail": "\n              ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n              ", "@id": "H3A7DC526904449B4BD50CE4D2EC4A8F0"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " does not\n\t\t\t\taffect the authority of a State to collect fees from wholesale drug\n\t\t\t\tdistributors or third-party logistics providers in connection with State\n\t\t\t\tlicensing under ", "@entity-type": "act", "#text": "Paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:585/ss:b/p:1", "@proposed": "true"}, {"#tail": " or ", "@entity-type": "act", "#text": "section 583", "@value": "Federal Food, Drug, and Cosmetic Act/s:583", "@proposed": "true"}, {"#tail": " pursuant to a licensing program meeting the\n\t\t\t\trequirements of such sections.", "@entity-type": "act", "#text": "584", "@value": "Federal Food, Drug, and Cosmetic Act/s:584", "@proposed": "true"}], "#text": "\n                ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(2)"}, "header": {"#tail": "\n              ", "#text": "Licensing\n\t\t\t\tfees"}, "#text": "\n              ", "@id": "H7484D38D9E8946E483AC26848CB366CF"}, {"#tail": "\n          ", "@id": "HEEA6E5D79EBA4A90846997D080ACC63F", "enum": {"#tail": "\n              ", "#text": "(3)"}, "header": {"#tail": "\n              ", "#text": "Enforcement,\n\t\t\t\tsuspension, and revocation of licenses"}, "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", a\n\t\t\t\tState\u2014", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:585/ss:b/p:1", "@proposed": "true"}, "#text": "Notwithstanding ", "@display-inline": "yes-display-inline"}, "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "may take administrative\n\t\t\t\taction, including fines, to enforce a licensure requirement promulgated by the\n\t\t\t\tState in accordance with this Act;"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "HDD38914C157249CE8C3E025AC3F005FE", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "may provide for the\n\t\t\t\tsuspension or revocation of licenses issued by the State for violations of the\n\t\t\t\tlaws of such State;"}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "H7380720F232D479C945B0F37E25268F8", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "upon conviction of a\n\t\t\t\tperson for a violation of Federal, State, or local controlled substance laws or\n\t\t\t\tregulations, may provide for fines, imprisonment, or civil penalties;\n\t\t\t\tand"}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "@id": "HB44DF9F7F92E46DCA23355C8B5CBBF82", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or ", "@entity-type": "act", "#text": "section 583", "@value": "Federal Food, Drug, and Cosmetic Act/s:583", "@proposed": "true"}, {"#tail": " in a manner that\n\t\t\t\tis consistent with the provisions of this\n\t\t\t\tsubchapter.", "@entity-type": "act", "#text": "584", "@value": "Federal Food, Drug, and Cosmetic Act/s:584", "@proposed": "true"}], "#text": "may regulate\n\t\t\t\tactivities of entities licensed pursuant to "}, "enum": {"#tail": "\n                ", "#text": "(D)"}, "#text": "\n                ", "@id": "HACEED83C9C92471DAD53DE76701F7915", "@commented": "no"}]}], "#text": "\n            ", "@id": "H4AD8B39395D44C5DA871418F17C535C2"}], "#text": "\n          ", "@id": "H35095A22C7AA49DDADE96130E8C52699"}, "@reported-display-style": "italic", "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t", "@id": "H745C63AC1D9A45B5A9F001E44F108C49"}, "#text": "\n      ", "@id": "H65A0970BAB5D488AB99FA4A9B23BF9D6"}, {"#tail": "\n  ", "enum": {"#tail": "\n      ", "#text": "8"}, "header": {"#tail": "\n\t\t\t", "#text": "Electronic\n\t\t\t labeling"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "quote": {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", may (except as necessary\n\t\t\t to mitigate a safety risk, as specified by the ", "@entity-type": "act", "#text": "section 503(b)(1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503/ss:b/p:1"}, {"#tail": " in regulation) be made\n\t\t\t available by electronic means instead of paper form, provided that such\n\t\t\t labeling complies with all applicable requirements of law, the manufacturer or\n\t\t\t distributor, as applicable, affords health care professionals and authorized\n\t\t\t dispensers (as defined in ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ") the opportunity to request the labeling\n\t\t\t in paper form, and after such a request the manufacturer or distributor\n\t\t\t promptly provides the requested information without additional\n\t\t\t cost.", "@entity-type": "act", "#text": "section 581", "@value": "Federal Food, Drug, and Cosmetic Act/s:581", "@proposed": "true"}], "#text": "Required labeling (other than\n\t\t\t immediate container or carton labels) that is intended for use by a physician,\n\t\t\t a pharmacist, or another health care professional, and that provides directions\n\t\t\t for human use of a drug subject to "}, "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by adding at\n\t\t\t the end the following new sentence: ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 502(f) of the\n\t\t\t Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:502/ss:f"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 352(f)", "@value": "usc/21/352/f"}, "@parsable-cite": "usc/21/352", "#text": "\n              ", "@legal-doc": "usc"}}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "In\n\t\t\t general"}, "#text": "\n        ", "@id": "H6F75511D34864D2EBD99319804ECD98C"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "\n\t\t\t shall promulgate regulations implementing the amendment made by ", "@entity-type": "federal-body", "#text": "Secretary of Health and Human Services", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "act", "#text": "subsection\n\t\t\t (a)", "@value": "Safeguarding America\u2019s Pharmaceuticals Act of 2013/s:8/ss:a", "@proposed": "true"}], "#text": "The ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Regulations"}, "#text": "\n        ", "@id": "H8BB249D941624DF39814973FC884D760"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", shall apply beginning on the\n\t\t\t earlier of\u2014", "@entity-type": "act", "#text": "subsection (a)", "@value": "Safeguarding America\u2019s Pharmaceuticals Act of 2013/s:8/ss:a", "@proposed": "true"}, "#text": "The\n\t\t\t last sentence of ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ", as added by ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "section 502(f) of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:502/ss:f", "@proposed": "true"}, {"#tail": ")", "@entity-type": "uscode", "#text": "21\n\t\t\t U.S.C. 352(f)", "@value": "usc/21/352/f", "@proposed": "true"}], "@entity-type": "law-citation", "#text": "\n            "}}, "enum": {"#tail": "\n        ", "#text": "(c)"}, "header": {"#tail": "\n        ", "#text": "Application"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "; or", "@entity-type": "act", "#text": "subsection (b)", "@value": "Safeguarding America\u2019s Pharmaceuticals Act of 2013/s:8/ss:b", "@proposed": "true"}, "#text": "the effective date of\n\t\t\t final regulations promulgated under "}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "@id": "HDCAC86FC42054BD2BAD99C92A75088A0", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "the day that is 180 days\n\t\t\t after the date of enactment of this Act."}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "@id": "H375B61FF59B440D1B6E332DDBEEB5E1A", "#text": "\n          "}], "#text": "\n        ", "@id": "HFD69A21135C044899945EEFCC354611B"}], "#text": "\n      ", "@id": "H25613E0FA319451691D41BB6A9CAAABD"}], "@display-enacting-clause": "yes-display-enacting-clause", "@reported-display-style": "italic", "#text": "\n\t\t", "@id": "HD714D1F1561C4232B0D0E4F021CFBE3D"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2013-06-03"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 HR 1919 RH: Safeguarding America\u2019s Pharmaceuticals Act of 2013"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. House of Representatives"}, "#text": "\n"}, "#text": "\n"}}}